<SEC-DOCUMENT>0001193125-21-102324.txt : 20210331
<SEC-HEADER>0001193125-21-102324.hdr.sgml : 20210331
<ACCEPTANCE-DATETIME>20210331163110
ACCESSION NUMBER:		0001193125-21-102324
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210330
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210331
DATE AS OF CHANGE:		20210331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			II-VI INC
		CENTRAL INDEX KEY:			0000820318
		STANDARD INDUSTRIAL CLASSIFICATION:	OPTICAL INSTRUMENTS & LENSES [3827]
		IRS NUMBER:				251214948
		STATE OF INCORPORATION:			PA
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39375
		FILM NUMBER:		21793856

	BUSINESS ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
		BUSINESS PHONE:		724-352-4455

	MAIL ADDRESS:	
		STREET 1:		375 SAXONBURG BLVD
		CITY:			SAXONBURG
		STATE:			PA
		ZIP:			16056
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d135490d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iivi="http://www.ii-vi.com/20210330" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2021-03-30_to_2021-03-30">II-VI INC</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityIncorporationStateCountryCode" name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-03-30_to_2021-03-30">PA</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-03-30_to_2021-03-30">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-03-30_to_2021-03-30">0000820318</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_CurrentFiscalYearEndDate_duration_2021-03-30_to_2021-03-30" name="dei:CurrentFiscalYearEndDate" contextRef="duration_2021-03-30_to_2021-03-30">--06-30</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="iivi-20210330.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-03-30_to_2021-03-30"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-03-30</xbrli:startDate> <xbrli:endDate>2021-03-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-03-30</xbrli:startDate> <xbrli:endDate>2021-03-30</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000820318</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iivi:SeriesAMandatoryConvertiblePreferredStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-03-30</xbrli:startDate> <xbrli:endDate>2021-03-30</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-03-30_to_2021-03-30">8-K</ix:nonNumeric></p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): March 31, 2021 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt:datemonthdayyearen">March 30, 2021</ix:nonNumeric>)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName"><span style="white-space:nowrap">II-VI</span> Incorporated</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Charter)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"> <span style=" -sec-ix-hidden:Hidden_dei_EntityIncorporationStateCountryCode">PENNSYLVANIA</span> </span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-03-30_to_2021-03-30">001-39375</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-03-30_to_2021-03-30">25-1214948</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-03-30_to_2021-03-30">375 Saxonburg Boulevard</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-03-30_to_2021-03-30">Saxonburg</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:stateprovnameen">Pennsylvania</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-03-30_to_2021-03-30">16056</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-03-30_to_2021-03-30">(724)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-03-30_to_2021-03-30">352-4455</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:11pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, no par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">IIVI</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">Series A Mandatory Convertible Preferred Stock, no par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">IIVIP</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember" format="ixt-sec:exchnameen">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter). Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-03-30_to_2021-03-30" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:11pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Amended and Restated Investment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March 30, 2021, <span style="white-space:nowrap">II-VI</span> Incorporated, a Pennsylvania corporation <span style="white-space:nowrap">(&#8220;II-VI&#8221;</span> or the &#8220;Company&#8221;), and BCPE Watson (DE) SPV, LP, a Delaware limited partnership and an affiliate of Bain Capital, LP (the &#8220;Investor&#8221;), entered into an Amended and Restated Investment Agreement (the &#8220;Amended and Restated Investment Agreement&#8221;). The Amended and Restated Investment Agreement amends and restates in its entirety the previously reported Investment Agreement, dated as of March&#160;25, 2021, by and between the Company and the Investor. The Amended and Restated Investment Agreement reflects a $300&#160;million increased commitment of the Investor in the <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock (as defined below), subject to the terms and conditions set forth in the Amended and Restated Investment Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the terms of the Amended and Restated Investment Agreement: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">on March&#160;31, 2021, <span style="white-space:nowrap">II-VI</span> issued, sold and delivered to the Investor 75,000 shares of a new Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock of the Company, having no par value per share <span style="white-space:nowrap">(&#8220;II-VI</span> Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock&#8221;), for $10,000 per share (the &#8220;Equity Per Share Price&#8221;) and an aggregate purchase price of $750,000,000 (the &#8220;Initial Investment&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">subject to the terms and conditions set forth in the Amended and Restated Investment Agreement, <span style="white-space:nowrap">II-VI</span> agreed to issue, sell and deliver to the Investor (collectively with the Initial Investment, the &#8220;Equity Investment&#8221;): </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">105,000 shares of a new Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock of the Company, having no par value per share <span style="white-space:nowrap">(&#8220;II-VI</span> Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock&#8221; and together with the <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock, &#8220;New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock&#8221;), for a purchase price per share equal to the Equity Per Share Price and an aggregate purchase price of $1,050,000,000, immediately prior to the closing (the &#8220;Closing&#8221;) of the business combination with Coherent, Inc., a Delaware corporation (&#8220;Coherent&#8221;), pursuant to the Agreement and Plan of Merger, dated as of March&#160;25, 2021, by and among Coherent, <span style="white-space:nowrap">II-VI</span> and Watson Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of <span style="white-space:nowrap">II-VI</span> (the &#8220;Merger Agreement&#8221;); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:14%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:2%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">immediately prior to the Closing, if elected by the Company and agreed by the Investor, up to an additional 35,000 shares of <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock for a purchase price per share equal to the Equity Per Share Price and an aggregate maximum purchase price of $350,000,000. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the Amended and Restated Investment Agreement, in connection with the Initial Investment, <span style="white-space:nowrap">II-VI</span> entered into a Registration Rights Agreement with the Investor providing for customary registration rights in respect of the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock and shares of <span style="white-space:nowrap">II-VI</span> common stock issuable upon the conversion thereof. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the Amended and Restated Investment Agreement, the Investor has the right to nominate one designee and to designate one observer to the Board of Directors of <span style="white-space:nowrap">II-VI</span> (the &#8220;Board of Directors&#8221;) for so long as the Investor maintains a specified level of ownership of the shares of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock or shares of <span style="white-space:nowrap">II-VI</span> common stock issued upon conversion thereof. The Investor&#8217;s initial designee and observer to the Board of Directors will be Stephen Pagliuca and Joseph Robbins, respectively. The Investor has also agreed in the Investment Agreement to certain transfer restrictions and standstill provisions. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Statement with Respect to Shares for the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the execution of the Amended and Restated Investment Agreement, on March&#160;30, 2021, the Company filed a Statement with Respect to Shares (the &#8220;Statement&#8221;) with the Pennsylvania Department of State Corporation Bureau to establish the designation, rights and preferences of the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock. The Statement became effective on March&#160;30, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock accrue dividends at 5.00% per annum, subject to increase if <span style="white-space:nowrap">II-VI</span> defaults on payment obligations with respect to the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock, not to exceed 14% per annum. Until the fourth anniversary of the applicable issuance date of each series of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock, dividends are payable solely <span style="white-space:nowrap">in-kind.</span> After the fourth anniversary, dividends are payable on the applicable series, at the Company&#8217;s option, in cash, <span style="white-space:nowrap">in-kind</span> or as a combination of both. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock are convertible into shares of <span style="white-space:nowrap">II-VI</span> common stock as follows: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">at any time after their issuance, at the election of the holder, each share of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock may be converted into shares of <span style="white-space:nowrap">II-VI</span> common stock at a conversion price of $85.00 per share (&#8220;Conversion Price&#8221;); except that the shares of <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock will be so convertible only after the earliest to occur of (i)&#160;the issuance of shares of <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-2</span> Convertible Preferred Stock upon the Closing, (ii)&#160;the termination of the Merger Agreement or (iii)&#160;the delivery by <span style="white-space:nowrap">II-VI</span> to the Investor of an offer to repurchase the <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock upon the occurrence of a Fundamental Change (as defined in the Statement); and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%">&#160;</td>
<td style="width:2%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">beginning three years after the applicable date of issuance of the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock, at the election of <span style="white-space:nowrap">II-VI,</span> each share of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock may be converted into shares of <span style="white-space:nowrap">II-VI</span> common stock at the applicable Conversion Price if the volume-weighted average price of <span style="white-space:nowrap">II-VI</span> common stock exceeds 150% of the applicable Conversion Price for 20 trading days out of any 30 consecutive trading days. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of <span style="white-space:nowrap">II-VI</span> Series <span style="white-space:nowrap">B-1</span> Convertible Preferred Stock will initially be nonvoting. Following the expiration of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, the issued shares of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock will have voting rights, voting as one class with the <span style="white-space:nowrap">II-VI</span> common stock, on an <span style="white-space:nowrap">as-converted</span> basis, subject to limited exceptions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the Statement and Amended and Restated Investment Agreement are attached as Exhibits 3.1 and 10.1, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K</span> and are incorporated herein by reference. The foregoing description of the Statement and Amended and Restated Investment Agreement does not purport to be complete and is qualified in its entirety by reference to the Statement and Amended and Restated Investment Agreement. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Unregistered Sales of Equity Securities. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The disclosure set forth above under Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference into this Item 3.02. The shares of New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock issued in connection with the Initial Investment have not been, and the additional shares issuable in connection with the Equity Investment and Amended and Restated Investment Agreement are not to be, registered under the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), in reliance on the exemption from registration provided by Section&#160;4(a)(2) of the Securities Act. The shares of <span style="white-space:nowrap">II-VI</span> common stock issuable upon conversion of shares of the New <span style="white-space:nowrap">II-VI</span> Convertible Preferred Stock will be issued in reliance upon the exemption from registration in Section&#160;3(a)(9) of the Securities Act. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Material Modification to Rights of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 of this Current Report on Form <span style="white-space:nowrap">8-K</span> is incorporated by reference into this Item 3.03. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective March&#160;31, 2021, immediately following the closing of the Initial Investment, the Board of Directors appointed Stephen Pagliuca to serve as a member of the Board of Directors. Mr.&#160;Pagliuca will serve in the class of directors with terms expiring in 2021. Mr.&#160;Pagliuca has not been appointed to any committees<span style="font-style:italic"></span>&#160;of the Board of Directors at<span style="font-style:italic"></span>&#160;this<span style="font-style:italic"></span>&#160;time. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Pagliuca, age 66, is a Managing Director of Bain Capital Private Equity, LP, a global private equity firm, <span style="white-space:nowrap">and&#160;Co-Chairman&#160;of</span> Bain Capital, LP.&#160;He is also a Managing Partner and <span style="white-space:nowrap">co-owner</span> of the Boston Celtics basketball franchise.&#160;Mr.&#160;Pagliuca joined Bain&#160;&amp; Company in 1982, and founded the Information Partners private equity fund for Bain Capital in 1989.&#160;Prior to joining Bain, Mr.&#160;Pagliuca worked as a senior accountant and international tax specialist for Peat Marwick Mitchell&#160;&amp; Company in the Netherlands.&#160;Mr.&#160;Pagliuca is a former director of Burger King Holdings, Inc., HCA, Inc. (Hospital Corporation of America), Kioxia Holdings Corporation, Quintiles Transnational Corporation, Warner Chilcott PLC and the Weather Company.&#160;He currently serves on the boards of directors of Axis Bank, Ltd., Gartner, Inc. and Virgin Voyages. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with Mr.&#160;Pagliuca&#8217;s appointment to the Board of Directors, and consistent with the Board of Directors&#8217; current compensation arrangements <span style="white-space:nowrap">for&#160;non-employee&#160;directors,</span> Mr.&#160;Pagliuca will be eligible to receive the Company&#8217;s standard annual cash compensation and expense reimbursement <span style="white-space:nowrap"><span style="white-space:nowrap">for&#160;non-employee&#160;directors,&#160;pro-rated&#160;for</span></span> the remainder of the Company&#8217;s 2021 fiscal year. Mr.&#160;Pagliuca also will be eligible to receive equity awards as part of the Company&#8217;s standard compensation <span style="white-space:nowrap">for&#160;non-employee&#160;directors,</span> as well as reimbursement of expenses. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Pagliuca was designated by the Investor for appointment to the Board of Directors pursuant to the Amended and Restated Investment Agreement. Except as described in this Current Report on Form <span style="white-space:nowrap">8-K,</span> there are no transactions between Mr.&#160;Pagliuca, on the one hand, and the Company, on the other hand, that would be reportable under Item&#160;404(a) of Regulation <span style="white-space:nowrap">S-K.</span></p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information regarding the Statement as set forth in Item 1.01 of this Current Report on <span style="white-space:nowrap">Form&#160;8-K&#160;is</span> incorporated by reference into this Item 5.03. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Forward-looking Statements </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains forward-looking statements relating to future events and expectations that are based on certain assumptions and contingencies. The forward-looking statements are made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act&#160;of&#160;1995. The forward-looking statements in this communication involve risks and uncertainties, which could cause actual results, performance or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company believes that all forward-looking statements made in this communication have a reasonable basis, but there can be no assurance that management&#8217;s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct. Factors that could cause actual results to differ materially from those discussed in the forward-looking statements herein include, but are not limited to: (i)&#160;the failure of any one or more of the assumptions stated above to prove to be correct; (ii)&#160;the conditions to the completion of the business combination transaction with Coherent (the &#8220;Transaction&#8221;) and the additional equity investment by Bain, including the receipt of any required stockholder and regulatory approvals, and the risks that those conditions will not be satisfied in a timely manner or at all; (iii)&#160;the occurrence of any event, change or other circumstances that could give rise to an amendment or termination of the merger agreement, including the receipt by Coherent of an unsolicited proposal from a third party; (iv)&#160;the Company&#8217;s ability to finance the Transaction, the substantial indebtedness the Company expects to incur in connection with the Transaction and the need to generate sufficient cash flows to service and repay such debt; (v)&#160;the possibility that the Company may be unable </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to achieve expected synergies, operating efficiencies and other benefits within the expected time-frames or at all and to successfully integrate Coherent&#8217;s operations with those of the Company; (vi)&#160;the possibility that such integration may be more difficult, time-consuming or costly than expected or that operating costs and business disruption (including, without limitation, disruptions in relationships with employees, customers or suppliers) may be greater than expected in connection with the Transaction; (vii)&#160;litigation and any unexpected costs, charges or expenses resulting from the Transaction; (viii)&#160;the risk that disruption from the Transaction materially and adversely affects the respective businesses and operations of the Company and Coherent; (ix)&#160;potential adverse reactions or changes to business relationships resulting from the announcement, pendency or completion of the Transaction; (x)&#160;the ability of the Company to retain and hire key employees; (xi)&#160;the risks relating to forward-looking statements and other &#8220;Risk Factors&#8221; discussed in the Company&#8217;s Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended June&#160;30, 2020 and additional risk factors that may be identified from time to time in future filings of the Company; (xii)&#160;the purchasing patterns of customers and <span style="white-space:nowrap">end-users;</span> (xiii)&#160;the timely release of new products, and acceptance of such new products by the market; (xiv)&#160;the introduction of new products by competitors and other competitive responses; (xv)&#160;the Company&#8217;s ability to integrate recently acquired businesses and realize synergies, cost savings and opportunities for growth in connection therewith, together with the risks, costs and uncertainties associated with such acquisitions and integration efforts; (xvi)&#160;the Company&#8217;s ability to devise and execute strategies to respond to market conditions; (xvii)&#160;the risks to anticipated growth in industries and sectors in which the Company and Coherent operate; (xviii)&#160;the risks to realizing the benefits of investments in R&amp;D and commercialization of innovations; (xix)&#160;the risks that the Company&#8217;s stock price will not trade in line with industrial technology leaders; and (xx)&#160;the risks of business and economic disruption related to the currently ongoing <span style="white-space:nowrap">COVID-19</span> outbreak and any other worldwide health epidemics or outbreaks that may arise. The Company disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events or developments, or otherwise. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">No Offer or Solicitation </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section&#160;10 of the Securities Act. </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Additional Information and Where to Find It </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication does not constitute an offer to buy or solicitation of an offer to sell any securities. This communication relates to a proposal that <span style="white-space:nowrap">II-VI</span> has made for a business combination transaction with Coherent. In furtherance of this proposal and subject to future developments, <span style="white-space:nowrap">II-VI</span> may file one or more registration statements, proxy statements, tender offer statements or other documents with the SEC. This communication is not a substitute for any proxy statement, registration statement, tender offer statement, prospectus or other document <span style="white-space:nowrap">II-VI</span> and/or Coherent may file with the SEC in connection with the Transaction. INVESTORS AND SECURITY HOLDERS OF <span style="white-space:nowrap">II-VI</span> AND COHERENT ARE URGED TO READ THE PROXY STATEMENT(S), REGISTRATION STATEMENT, TENDER OFFER STATEMENT, PROSPECTUS AND/OR OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION. Any definitive proxy statement(s) or prospectus(es) (if and when available) will be mailed to stockholders of <span style="white-space:nowrap">II-VI</span> and/or Coherent, as applicable. Investors and security holders will be able to obtain free copies of these documents (if and when available) and other documents filed with the SEC by <span style="white-space:nowrap">II-VI</span> through the web site maintained by the SEC at www.sec.gov, and by visiting <span style="white-space:nowrap">II-VI&#8217;s</span> investor relations site at <span style="white-space:nowrap">https://ii-vi.com/investor-relations/.</span> </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">Participants in the Solicitation </span></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication is neither a solicitation of a proxy nor a substitute for any proxy statement or other filings that may be made with the SEC. Nonetheless, <span style="white-space:nowrap">II-VI</span> and its directors and executive officers and other members of management and employees may be deemed to be participants in the solicitation of proxies in respect of the Transaction. You can find information about <span style="white-space:nowrap">II-VI&#8217;s</span> executive officers and directors in <span style="white-space:nowrap">II-VI&#8217;s</span> proxy statement for its 2020 annual meeting, which was filed with the SEC on September&#160;29, 2020 and in <span style="white-space:nowrap">II-VI&#8217;s</span> Annual Report on Form <span style="white-space:nowrap">10-K</span> for the fiscal year ended June&#160;30, 2020, which was filed with the SEC on August&#160;26, 2020. Additional information regarding the interests of such potential participants will be included in one or more registration statements, proxy statements, tender offer statements or other documents filed with the SEC if and when they become available. These documents (if and when available) may be obtained free of charge from the SEC&#8217;s website www.sec.gov, and by visiting <span style="white-space:nowrap">II-VI&#8217;s</span> investor relations site at <span style="white-space:nowrap">https://ii-vi.com/investor-relations/.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:3%"></td>
<td style="width:94%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;3.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d135490dex31.htm">Statement with Respect to Shares, filed with the Pennsylvania Department of State Corporation Bureau and effective March&#160;30, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d135490dex101.htm">Amended and Restated Investment Agreement, dated as of March&#160;30, 2021, by and between <span style="white-space:nowrap">II-VI</span> Incorporated and BCPE Watson (DE) SPV, LP.</a>*</td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Certain of the schedules to this exhibit have been omitted in accordance with Regulation <span style="white-space:nowrap">S-K</span> Item 601(a)(5). The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request. </p></td></tr></table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold"><span style="white-space:nowrap">II-VI</span> Incorporated</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">&#160;&#160;Date: March&#160;31, 2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Walter R. Bashaw II</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Walter R. Bashaw II</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">President</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>d135490dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PENNSYLVANIA DEPARTMENT OF STATE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>BUREAU OF
CORPORATIONS AND CHARITABLE ORGANIZATIONS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B></B>&#9744;<B></B><B> Return document by mail to:</B></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" ROWSPAN="4" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">Statement with Respect to Shares<BR>Domestic Business Corporation<BR><FONT STYLE="white-space:nowrap">DSCB:15-1522</FONT> (rev. 7/2015)</P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g135490g0330234154664.jpg" ALT="LOGO">
</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center">1522</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address</P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">City State Zip Code</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">&#9746; <B>Return document by email to: pados@klgates.com</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Read all instructions prior to completing. This form may be submitted online at https://www.corporations.pa.gov/. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Fee: $70 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In compliance with the requirements of 15 Pa.C.S.
&#167;&nbsp;1522(b) (relating to statement with respect to shares), the undersigned corporation, desiring to state the designation and voting rights, preferences, limitations, and special rights, if any, of a class or series of its shares, hereby
states that: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">1. The name of the corporation is: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated </P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">2. <I>Check and complete one of the following:</I> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>&nbsp;&nbsp;</B>&#9744;<B></B><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The resolution amending the Articles under 15 Pa.C.S. &#167; 1522(b) (relating to divisions and
determinations by the board), set forth in full, is as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9746;<B></B><B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B>The resolution amending the Articles under 15 Pa.C.S. &#167; 1522(b) is set forth in full in Exhibit A
attached hereto and made a part hereof: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P></div>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:12pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">3. The aggregate number of shares of such class or series established and designated by (a)&nbsp;such resolution,
(b)&nbsp;all prior statements, if any, filed under 15 Pa.C.S. &#167; 1522 or corresponding provisions of prior law with respect thereto, and (c)&nbsp;any other provision of the Articles is 215,000 shares, consisting of 75,000 shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, and 140,000 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P></div>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. The resolution was adopted by the Board of Directors or an
authorized committee thereon on:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>03/29/2021</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">Date (MM/DD/YYYY)</TD></TR>
</TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><div style="max-width:100%;margin-left:0%; margin-right:0%;border:solid 1px;background-color:;;padding-top:2pt;padding-bottom:3pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; padding-top:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">5. <I>Check, and if appropriate complete, one of the following:</I> </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The resolution shall be effective upon the filing of this statement with respect to shares in the Department of
State. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The resolution shall be effective
on:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;at&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; . </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; padding-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman">Date (MM/DD/YYYY) Hour (if any) </P></div> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN TESTIMONY
WHEREOF, the undersigned corporation has caused this statement to be signed by a duly authorized officer thereof this</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>30th</U></B> day of <B><U>March</U></B>, <B><U>2021</U></B>.</P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Name of Corporation</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"><B>/s/ Walter R. Bashaw II</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>President</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">Title</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT&nbsp;A TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT WITH RESPECT TO SHARES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDING THE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND
RESTATED ARTICLES OF INCORPORATION OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES B CONVERTIBLE PREFERRED STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW THEREFORE BE IT RESOLVED</B>, that pursuant to Section&nbsp;1522(b) of the Pennsylvania Business Corporation Law of 1988, as amended,
and Section&nbsp;5(C) of the Amended and Restated Articles of Incorporation (the &#147;<U>Articles</U>&#148;) of <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;<U>Corporation</U>&#148;), there is
hereby designated and established a series of preferred stock of the Corporation denominated as the &#147;Series B Convertible Preferred Stock&#148;, and this Board of Directors of the Corporation hereby fixes and determines the number of such
shares and, subject to the provisions of such Section&nbsp;5(C) of the Articles, the relative rights and preferences of such shares as set forth in <B><U>Annex</U></B><B><U></U></B><B><U>&nbsp;A</U></B><B> </B>hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX&nbsp;A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(to Resolutions of the Board of Directors&#151;March&nbsp;29, 2021) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>ANNEX&nbsp;A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STATEMENT WITH RESPECT TO SHARES </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>STANDARD PROVISIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.
<U>General Matters</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each share of Series B Convertible Preferred Stock with no par value per share (the &#147;<B><I>Series B
Convertible Preferred Stock</I></B>&#148;) shall be identical in all respects to every other share of Series B Convertible Preferred Stock, except as set forth in <U>Sections 1(c)</U>, <U>1(d)</U>, <U>1(e</U><U>)</U>, <U>3</U><U>(a)</U> and
<U>5(a)</U> and the definitions of certain defined terms herein. There shall be (i)&nbsp;a series of Series B Convertible Preferred Stock designated as &#147;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock&#148; with
no par value per share (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock</I></B>&#148;) and (ii)&nbsp;a series of Series B Convertible Preferred Stock designated as &#147;Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock&#148; with no par value per share (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock</I></B>&#148;). The number of shares initially
constituting the Series B Convertible Preferred Stock shall be 215,000, consisting of 75,000 shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, and 140,000 shares of Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Series B Convertible Preferred Stock, with respect to
dividend rights and/or distribution rights upon a Liquidation Event, as applicable, shall rank (i)&nbsp;senior to each class or series of Junior Stock, (ii)&nbsp;on parity with each class or series of Parity Stock, (iii)&nbsp;junior to each class or
series of Senior Stock and (iv)&nbsp;junior to the Corporation&#146;s existing and future indebtedness and other liabilities (including trade payables). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Holder of a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall, at the Subsequent Closing
purchase from the Corporation 1.4 shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in respect of each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by such
Holder, in each case, pursuant to, and subject to, all of the terms and conditions of the Investment Agreement (the &#147;<B><I>Subsequent Investment Obligation</I></B>&#148;). Except as provided in Section&nbsp;5.08 of the Investment Agreement,
shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall not be transferred after issuance until the satisfaction or, with respect to such shares, termination of the Subsequent Investment Obligation pursuant to
<U>Section</U><U></U><U>&nbsp;1(e)</U>. The conditions precedent to the Holders&#146; Subsequent Investment Obligation (including, if applicable, the Upsize Investment) may be waived in writing by the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders. The conditions precedent to the Corporation&#146;s obligation to consummate the Subsequent Closing may be waived in writing by the Corporation. Any provision of the Investment Agreement
applicable to the Subsequent Investment Obligation, including the Upsize Investment, may be amended or otherwise modified in writing by the Corporation and the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event that the Corporation offers to the Investor the opportunity to purchase additional shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in accordance with Section&nbsp;2.01(b)(i) of the Investment Agreement, and the Investor elects to purchase additional shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock in accordance with Section&nbsp;2.01(b)(i) of the Investment Agreement, then, each Holder of a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall at the Subsequent Closing
purchase from the Corporation (in addition to the shares required to be purchased by such Holder pursuant to <U>Section</U><U></U><U>&nbsp;1(c</U>)) a number of shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
equal to the Pro Rata Amount of such Holder (the &#147;<B><I>Upsize Investment</I></B>&#148;). The Upsize Investment shall occur at the Subsequent Closing pursuant, and subject to, all of the terms and conditions of the Investment Agreement. The
obligation, if any, to purchase shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock pursuant to the Upsize Investment will constitute a component of the Subsequent Investment Obligation. &#147;<B><I>Pro Rata
Amount</I></B>&#148; means, with respect to any Holder, a number equal to (x)&nbsp;the number of shares of Series </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-1- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock the Investor has elected to be purchased pursuant to Section&nbsp;2.01(b)(i) of the Investment Agreement, multiplied by
(y)&nbsp;a ratio, the numerator of which is the number of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by such Holder and the denominator of which is the number of outstanding shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock held by all Holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding <U>Sections 1(c)</U> and
<U>1(d)</U>, the obligation of each Holder of a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock to purchase Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock pursuant to
<U>Section</U><U></U><U>&nbsp;1(c)</U> and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock pursuant to <U>Section</U><U></U><U>&nbsp;1(d)</U> (and any obligation of the Corporation to issue or sell any such securities) shall
terminate upon (i)&nbsp;a Transfer of such share upon a foreclosure pursuant to Section&nbsp;5.08(b)(vi) of the Investment Agreement or (ii)&nbsp;a Transfer of such share pursuant to Section&nbsp;5.08(b)(iv) or Section&nbsp;5.08(b)(v) of the
Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Dividends</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Dividend Rate on Series B Convertible Preferred Stock</U>. From the Issue Date of such share, dividends shall accrue on the applicable
Stated Value of each share of Series B Convertible Preferred Stock at the Annual Rate. Dividends on each share of Series B Convertible Preferred Stock shall accrue daily from and after the Issue Date of such share, but shall compound on a quarterly
basis on each Dividend Payment Date (i.e., no dividends shall accrue on other dividends unless and until the first Dividend Payment Date for such other dividends has passed without such other dividends having been paid on such date), whether or not
earned or declared, and whether or not there are earnings or profits, surplus or other funds or assets of the Corporation legally available for the payment of dividends. Dividends that are payable on the Series B Convertible Preferred Stock on any
Dividend Payment Date shall be payable to Holders as they appear on the stock register of the Corporation on the record date for such dividend, which shall be the date fifteen (15)&nbsp;days prior to the applicable Dividend Payment Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends payable at the Annual Rate on the Series B Convertible Preferred Stock in respect of any Dividend Period shall be payable in arrears and shall be
computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months. The amount of dividends payable at the Annual Rate on the Series B Convertible Preferred
Stock on any date prior to the end of a Dividend Period, and for the applicable initial Dividend Period, shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve
<FONT STYLE="white-space:nowrap">30-day</FONT> months, and actual days elapsed over a <FONT STYLE="white-space:nowrap">30-day</FONT> month. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Payment of Dividends</U>. Until the first Dividend Payment Date after the fourth anniversary of the applicable Initial Issue Date in
respect of each series of Series B Convertible Preferred Stock (the &#147;<B><I>Mandatory PIK Date</I></B>&#148;) all dividend payments shall compound and be added to the applicable Stated Value on each Dividend Payment Date, as provided in the
definition of &#147;Stated Value&#148; in <U>Section</U><U></U><U>&nbsp;15</U> (a &#147;<B><I>PIK Dividend</I></B>&#148;). Following the applicable Mandatory PIK Date, dividends shall be payable in the form of, in the Corporation&#146;s sole
discretion (which election, in respect of each dividend, the Corporation may make separately as to each series of Series B Convertible Preferred Stock), (i) solely cash, if, as and when authorized by the Board of Directors or any duly authorized
committee thereof, to the extent permitted by applicable law, or (ii)&nbsp;solely a PIK Dividend, or (iii)&nbsp;any combination of cash and PIK Dividend. The election of the Corporation to pay a dividend solely in cash or in any combination of cash
and PIK Dividend on a Dividend Payment Date shall be made by irrevocable notice to the Holders on or prior to the record date with respect to such Dividend Payment Date. To the extent that the Corporation does not elect to pay a dividend solely in
cash or in any combination of cash and PIK Dividend on or prior to the record date with respect to such Dividend Payment Date, the Corporation shall be deemed to have elected to pay such dividend solely as a PIK Dividend. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transactions</U>. In the event that
the Board of Directors shall declare a dividend in respect of a <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction, the Holders shall be entitled on the payment date for such dividend to receive such number of <FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Securities per share of Series B Convertible Preferred Stock as would be paid on the shares of the Common Stock into which a share of such Series B Convertible Preferred Stock held by such Holder could be
converted pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, such number to be determined as of the record date for the determination of holders of Common Stock entitled to receive the <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities in the
<FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Priority of Dividends</U>. Subject to <U>Sections 2(a)</U> and
<U>2(c)</U>, any dividends (payable in cash, securities or other property) as may be determined by the Board of Directors may be declared and paid on any capital stock, including Common Stock and other Junior Stock, from time to time out of any
funds legally available for such payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Liquidation Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Voluntary or Involuntary Liquidation</U>. In the event of any voluntary or involuntary liquidation, winding up or dissolution of the
Corporation (each, a &#147;<B><I>Liquidation Event</I></B>&#148;), (i) each Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall be entitled to receive for each share of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, an amount (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Liquidation Preference</I></B>&#148;) equal to the greater of (1)&nbsp;the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Stated Value plus an amount equal to all accrued or declared and unpaid dividends on such share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock that have not previously been
added to the Stated Value and (2)&nbsp;the amount per share as would have been payable in respect of the shares of Common Stock into which such share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock is then
convertible, assuming all outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock were converted into Common Stock immediately prior to such Liquidation Event in accordance with
<U>Section</U><U></U><U>&nbsp;5</U> (without regard as to whether sufficient shares of Common Stock are available out of the Corporation&#146;s authorized but unissued stock for the purpose of effecting the conversion of the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock) and (ii)&nbsp;each Holder of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock shall be entitled to receive for each share of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, an amount (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference</I></B>&#148;) equal to the greater of (1)&nbsp;the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Stated Value plus an amount equal to all accrued or declared and unpaid dividends on such share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock that have not previously been
added to the Stated Value and (2)&nbsp;the amount per share as would have been payable in respect of the shares of Common Stock into which such share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock is then
convertible, assuming all outstanding shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock were converted into Common Stock immediately prior to such Liquidation Event in accordance with
<U>Section</U><U></U><U>&nbsp;5</U> (without regard as to whether sufficient shares of Common Stock are available out of the Corporation&#146;s authorized but unissued stock for the purpose of effecting the conversion of the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock), in each case, to be paid out of the assets of the Corporation legally available for distribution to its shareholders, after satisfaction of indebtedness and other liabilities owed
to the Corporation&#146;s creditors and holders of Senior Stock and before any payment or distribution is made to holders of Junior Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Partial Payment</U>. If, upon a Liquidation Event, the amounts payable with respect to (i)&nbsp;the applicable Liquidation Preference
to all Holders and (ii)&nbsp;the liquidation preference, and the amount of accumulated and unpaid dividends, whether or not declared, to, but excluding, the date fixed for such Liquidation Event, on all Parity Stock, if applicable, are not paid in
full, all Holders and all holders of any such Parity Stock shall share equally and ratably in any distribution of the Corporation&#146;s assets in proportion to their respective liquidation preferences and amounts equal to the accumulated and unpaid
dividends (if any) to which they are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) After the payment to any Holder of the full amount of the applicable Liquidation
Preference for each of such Holder&#146;s shares of Series B Convertible Preferred Stock, such Holder shall have no right or claim to any of the remaining assets of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither the sale, lease nor exchange of all or substantially all of Corporation&#146;s
assets or business nor a Fundamental Change or the Corporation&#146;s merger or consolidation into or with any other Person, shall be deemed to be a Liquidation Event (in each case, other than in connection with the liquidation, <FONT
STYLE="white-space:nowrap">winding-up</FONT> or dissolution of the Corporation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Corporation shall not be required to set aside
funds to protect the respective Liquidation Preference of the Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Voting</U>. Except as otherwise
provided herein or by applicable law, on any matter presented to the shareholders of the Corporation for their action or consideration at any meeting of shareholders of the Corporation and on which matter holders of the Common Stock shall be
entitled to vote, each Holder shall be entitled to the number of votes equal to the number of whole shares of Common Stock (rounded to the nearest whole share) into which the shares of Series B Convertible Preferred Stock held by such Holder are
convertible on the record date for determining shareholders entitled to vote on such matter (as adjusted from time to time after the applicable Issue Date pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, but without regard as to whether sufficient
shares of Common Stock are available out of the Corporation&#146;s authorized but unissued stock for the purpose of effecting the conversion of the Series B Convertible Preferred Stock); <U>provided</U>, that each Holder of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock will not be entitled to vote until the condition set forth in Section&nbsp;6.01(b) of the Investment Agreement is satisfied, at which point such Holder of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock will automatically be entitled to vote. Holders shall be entitled to notice of any meeting of shareholders and, except as otherwise provided herein or otherwise required by law, to
vote together with the holders of Common Stock as a single class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Conversion</U>. The Holders shall have conversion rights as
follows (the &#147;<B><I>Conversion Rights</I></B>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Right to Convert</U>. Each share of Series B Convertible Preferred Stock
shall be convertible, at the option of the Holder, at any time and from time to time after the applicable Issue Date, and without the payment of additional consideration by the Holder, into such number of fully paid and nonassessable shares of
Common Stock as is determined by dividing (i)&nbsp;the applicable Stated Value as of the Conversion Date by (ii)&nbsp;the applicable Conversion Price in effect as of the Conversion Date. The &#147;<B><I>Conversion Price</I></B>&#148; shall initially
be equal to (i) $85.00, with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and (ii) $85.00, with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock;
<U>provided</U>, that each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall not be convertible, and no Holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock shall be
entitled to deliver a Notice of Conversion in respect of such share, until after the earliest to occur of (x)&nbsp;the Subsequent Closing, (y)&nbsp;the termination of the Target Merger Agreement in accordance with its terms and (z)&nbsp;the delivery
of a Fundamental Change Repurchase Offer; <U>provided</U>, that, in the case of clause (z), such share shall be convertible during the period from the date of receipt of such Fundamental Change Repurchase Offer until the earlier to occur of the
relevant Fundamental Change and the applicable Offer Consent Date, if any, in respect of such Share, until thereafter such share shall become exercisable pursuant to this <U>Section</U><U></U><U>&nbsp;5(a)</U>. The rate at which shares of Series B
Convertible Preferred Stock may be converted into shares of Common Stock shall be subject to adjustment as provided in <U>Sections</U> <U>5(d)</U>, <U>(e)</U>, <U>(f)</U>, <U>(g),</U> <U>(h)</U> and <U>(</U><U>i</U><U>)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of the delivery of a valid notice of redemption of any shares of Series B Convertible Preferred Stock pursuant to
<U>Section</U><U></U><U>&nbsp;8</U> (including a Holder Redemption Notice or Corporation Redemption Notice), the Conversion Rights of the shares designated for redemption shall terminate at the close of business on the date fixed for redemption,
unless the shares designated for redemption are not redeemed in full on the date of such redemption (including by way of deposit of funds in trust pursuant to <U>Section </U><U>8(e)</U>), in which case the Conversion Rights for all such shares shall
continue until such shares are redeemed in full. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event any shares of Series B Convertible Preferred Stock are to be repurchased by the Corporation
pursuant to <U>Section</U><U></U><U>&nbsp;9</U>, the Conversion Rights of the shares designated for repurchase shall terminate at the close of business on the Fundamental Change Repurchase Date, unless the applicable Fundamental Change Repurchase
Price is not paid in full on such date (including by way of deposit of funds in trust pursuant to <U>Section</U><U></U><U>&nbsp;9(d)</U>), in which case the Conversion Rights for such shares shall continue until such price is paid in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued upon conversion of the Series B Convertible Preferred
Stock. In lieu of any fractional shares to which the Holder would otherwise be entitled, the Corporation shall pay, to the extent of funds legally available therefor, cash equal to such fraction multiplied by the fair market value of a share of
Common Stock, which shall be the last reported closing sale price of a share of Common Stock on the Conversion Date if the Common Stock is then listed and trading on a Trading Market or, if the Common Stock is not then so listed and trading, as
determined in good faith by the Board of Directors. Whether or not fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Series B Convertible Preferred Stock the Holder is at the
time converting into Common Stock and the aggregate number of shares of Common Stock issuable to such Holder upon such conversion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Mechanics of Conversion</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Holders shall effect conversions by providing the Corporation with a written notice of conversion (a
&#147;<B><I>Notice of Conversion</I></B>&#148;) delivered in accordance with <U>Section</U><U></U><U>&nbsp;11</U> on the Trading Day on which such Holder wishes to effect such conversion (the &#147;<B><I>Conversion Date</I></B>&#148;). Each Notice
of Conversion shall specify the number of shares of each series of Series B Convertible Preferred Stock to be converted, the applicable Conversion Price for each series of Series B Convertible Preferred Stock to be converted, the number of shares of
Common Stock to be issued with respect to each series of Series B Convertible Preferred Stock to be converted, and the number of shares of each series of Series B Convertible Preferred Stock owned subsequent to the conversion at issue. The shares of
Common Stock shall be deemed to have been issued, and the Holder or any other person so designated to be deemed to have become a holder of record of such shares for all purposes, as of the close of business on the Conversion Date (prior to the close
of business on the Conversion Date, the Common Stock issuable upon conversion of Series B Convertible Preferred Stock shall not be outstanding, or deemed to be outstanding, for any purpose and Holders shall have no rights, powers, preferences or
privileges with respect to such Common Stock, including voting rights, rights to respond to tender offers and rights to receive any dividends or other distributions on the Common Stock, by virtue of holding Series B Convertible Preferred Stock). To
effect conversions of shares of Series B Convertible Preferred Stock in certificated form, a Holder shall not be required to surrender the certificate(s) representing the shares of Series B Convertible Preferred Stock to the Corporation unless all
of the shares of Series B Convertible Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Series B Convertible Preferred Stock promptly following the Conversion
Date at issue. Conversions of less than the total amount of shares of Series B Convertible Preferred Stock represented by a certificate held by the Holder will have the effect of lowering the outstanding number of shares of Series B Convertible
Preferred Stock of the applicable series held by such Holder by an amount equal to the number of such shares so converted, as if the original stock certificate(s) were cancelled and one or more new stock certificates evidencing the new number of
shares of the applicable series of Series B Convertible Preferred Stock were issued; <U>provided</U>, <U>however</U>, that in such cases the Holder may request that the Corporation deliver to the Holder a certificate representing such <FONT
STYLE="white-space:nowrap">non-converted</FONT> shares of Series B Convertible Preferred Stock; <U>provided</U>, <U>further</U>, that the failure of the Corporation to deliver such new </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate shall not affect the rights of the Holder to submit a further Notice of Conversion with respect to such Series B Convertible Preferred Stock and, in any such case, the Holder shall be
deemed to have submitted the original of such new certificate at the time that it submits such further Notice of Conversion. To effect conversion of shares of any Series B Convertible Preferred Stock held in book-entry form in accordance with
<U>Section</U><U></U><U>&nbsp;14</U>, Holders must comply with the applicable procedures established from time to time by DTC and the Transfer Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Not later than 10:00 am (New York City time) on the second Trading Day after each Conversion Date if shares are to be delivered in
book-entry form through the facilities of DTC or within five (5)&nbsp;Business Days otherwise (or, if later, the Trading Day after the Holder has paid in full any applicable transfer taxes and duties) (the &#147;<B><I>Share Delivery
Date</I></B>&#148;), the Corporation shall deliver, or cause to be delivered (through the facilities of DTC or in certificated form, as applicable), to the converting Holder the number of shares of Common Stock being acquired upon the conversion of
the applicable series of Series B Convertible Preferred Stock together with cash in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion (as provided in <U>Section</U><U></U><U>&nbsp;5(b)</U>). If, in the case of
any Notice of Conversion, such shares of Common Stock are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation in accordance with
<U>Section</U><U></U><U>&nbsp;11</U> at any time on or before its receipt of such shares of Common Stock, to rescind such conversion, in which event the Corporation shall promptly return to the Holder any original Series B Convertible Preferred
Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the shares of Common Stock issued to such Holder pursuant to the rescinded Notice of Conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Corporation shall at all times when Series B Convertible Preferred Stock shall be outstanding, reserve and keep available out of
its authorized but unissued capital stock, for the purpose of effecting the conversion of the Series B Convertible Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the
conversion of all outstanding shares of Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) All shares of Series B Convertible Preferred Stock
which shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares, including the rights, if any, to receive notices and to vote, shall immediately cease and
terminate at the time of conversion, except only the right of the Holders thereof to receive shares of Common Stock in exchange therefor, to receive payment in lieu of any fraction of a share otherwise issuable upon such conversion and payment of
cash dividends declared but unpaid on the Series B Convertible Preferred Stock (to the extent the amount of any such cash dividends shall not then be reflected in the applicable Stated Value). Any shares of Series B Convertible Preferred Stock so
converted shall be retired and canceled and shall not be reissued as shares of such series, and the Corporation (without the need for shareholder action) may from time to time take such appropriate action as may be necessary to reduce the authorized
number of shares of the applicable series of Series B Convertible Preferred Stock accordingly and restore such shares to the status of authorized but unissued shares of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or delivery of shares
of Common Stock upon conversion of shares of Series B Convertible Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;5</U>. The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer
involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Series B Convertible Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the
Person requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Adjustment for Stock Splits and Stock Combinations</U>. If the Corporation shall at
any time or from time to time after the Issue Date of a share of Series B Convertible Preferred Stock, effect a subdivision of the outstanding shares of Common Stock (a &#147;<B><I>Stock Split</I></B>&#148;), the applicable Conversion Price in
effect immediately before such Stock Split shall be proportionately decreased so that the number of shares of Common Stock issuable on conversion of each such share of Series B Convertible Preferred Stock shall be increased in proportion to such
increase in the aggregate number of shares of Common Stock outstanding. If the Corporation shall at any time or from time to time after the Issue Date of a share of Series B Convertible Preferred Stock combine the outstanding shares of Common Stock
(a &#147;<B><I>Stock Combination</I></B>&#148;), the applicable Conversion Price in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each such share
shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment under this <U>Section</U><U></U><U>&nbsp;5(d)</U> shall become effective at the close of business on the date the Stock
Split or Stock Combination becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Adjustment for Certain Dividends and Distributions</U>. In the event the Corporation
at any time or from time to time after the applicable Issue Date of a share of Series B Convertible Preferred Stock shall make or issue, or, if earlier than the applicable issue date, fix a record date for the determination of holders of Common
Stock entitled to receive, a dividend or other distribution payable in additional shares of Common Stock (other than a dividend described in <U>Section</U><U></U><U>&nbsp;5(d)</U>), then, upon the first such event to occur, the applicable Conversion
Price in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall previously have been fixed, as of the close of business on such record date, by multiplying the applicable
Conversion Price, then in effect by a fraction: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the numerator of which shall be the total number of shares of Common Stock issued and
outstanding immediately prior to the time of such issuance or the close of business on such record date, and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the denominator of
which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment of such
dividend or distribution; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that if such record date shall have been fixed and such dividend is not fully paid or if such
distribution is not fully made on the date fixed therefor, the applicable Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter the applicable Conversion Price shall be adjusted pursuant to
this <U>Section</U><U></U><U>&nbsp;5(e)</U> as of the time of actual payment of such dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Adjustment for
Reclassification, Exchange, or Substitution</U>. If the Common Stock issuable upon the conversion of the Series B Convertible Preferred Stock shall be changed into the same or a different number of shares of any class or classes of stock, whether by
capital reorganization, reclassification, or otherwise (other than a Stock Split, Stock Combination or stock dividend provided for in <U>Section</U><U></U><U>&nbsp;5(e)</U> above, or a reorganization, merger, consolidation, or sale of assets
provided for below), then and in each such event the Holder of each such share of Series B Convertible Preferred Stock shall have the right thereafter to convert such share into the kind and amount of shares of stock and other securities and
property receivable, upon such reorganization, reclassification, or other change, by holders of the number of shares of Common Stock into which such share of Series B Convertible Preferred Stock might have been converted immediately prior to such
reorganization, reclassification, or change, all subject to further adjustment as provided herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Adjustment for Merger or Reorganization, etc</U>. If there shall occur any
Reorganization Event involving the Corporation in which the Common Stock (but not the Series B Convertible Preferred Stock) is converted into or exchanged for securities, cash or other property (other than a transaction covered by <U>Sections
5(d)</U>, <U>5(e)</U>, or <U>5(f)</U>), then, following any such Reorganization Event, each share of Series B Convertible Preferred Stock shall be convertible into the kind and amount of securities, cash or other property which a holder of the
number of shares of Common Stock issuable upon conversion of such share of Series B Convertible Preferred Stock immediately prior to such Reorganization Event would have been entitled to receive pursuant to such transaction; and, in such case,
appropriate adjustment (as determined in good faith by the Board of Directors) shall be made in the application of the provisions in this <U>Section</U><U></U><U>&nbsp;5</U> with respect to the rights and interests thereafter of the Holders to the
end that the provisions set forth in this <U>Section</U><U></U><U>&nbsp;5</U> (including provisions with respect to changes in and other adjustments of the applicable Conversion Price) shall thereafter be applicable, as nearly as reasonably may be,
in relation to any securities or other property thereafter deliverable upon the conversion of the Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Adjustment for Rights Offering</U>. If the Corporation shall, at any time or from time to time, while any shares of Series B
Convertible Preferred Stock are outstanding, distribute rights, options or warrants (&#147;<B><I>Rights</I></B>&#148;) to all or substantially all holders of Common Stock entitling them for a period of not more than sixty (60)&nbsp;days from the
record date of such distribution to purchase shares of Common Stock, or securities convertible into, or exchangeable or exercisable for, Common Stock (such distribution, a &#147;<B><I>Rights Offering</I></B>&#148;) at less than the closing sale
price (as determined pursuant to this <U>Section</U><U></U><U>&nbsp;5(h)</U>) on the Trading Day immediately preceding the first public announcement of the Rights Offering, then the applicable Conversion Price in effect immediately before such
Rights Offering shall be adjusted as of the date of the distribution of the Rights, by multiplying the applicable Conversion Price then in effect by a fraction: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the numerator of which shall be the sum of (A)&nbsp;the number of shares of Common Stock outstanding on the Trading Day immediately
preceding the record date for such Rights Offering, plus (B)&nbsp;the (1) product of (x)&nbsp;the total number of shares of Common Stock issuable in the Rights Offering and (y)&nbsp;the exercise price so offered, divided by (2)&nbsp;the closing sale
price of the Common Stock on the Trading Day immediately preceding the first public announcement of the Rights Offering; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the
denominator of which shall be the number of shares of Common Stock outstanding at the close of business on the Trading Day immediately preceding the record date for the Rights Offering, plus the total number of additional shares of Common Stock
issuable pursuant to the Rights Offering; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, to the extent that shares of Common Stock are not delivered pursuant to such
Rights Offering or upon the expiration or termination of such Rights Offering, the applicable Conversion Price shall be readjusted to the Conversion Price that would then be in effect had the adjustments made upon the issuance of rights, options or
warrants been made on the basis of the delivery of only the number of shares of Common Stock actually delivered; <U>provided</U>, <U>further</U>, in the event that such rights, options or warrants are not so distributed, the applicable Conversion
Price shall again be adjusted to be the Conversion Price which would then be in effect if the record date for such Rights Offering had not occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
determining whether any rights, options or warrants entitle the holders of Common Stock to purchase shares of Common Stock at less than the closing sale price on the Trading Day immediately preceding the first public announcement of the Rights
Offering, if (A)&nbsp;the Common Stock is then listed and trading on a Trading Market, such closing sale price shall be the last reported closing price on such Trading Day and (B) if the Common Stock is not then so listed and trading, such closing
sale price shall be determined in good faith by, or pursuant to a formula or method or subject to relevant criteria prescribed by, the Board of Directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Adjustment for Ordinary Dividends</U>. In the event the Corporation shall make or
issue, or, if earlier, fix a record date for the determination of holders of Common Stock entitled to receive, an Ordinary Dividend, then, upon the first such event to occur, the applicable Conversion Price in effect immediately before such event
shall be decreased, as of the time of such payment or, in the event such a record date shall previously have been fixed, as of the close of business on such record date, in each case, by the amount of such Ordinary Dividend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Certificate as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of the applicable Conversion Price pursuant
to this <U>Section</U><U></U><U>&nbsp;5</U>, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than two (2)&nbsp;Trading Days thereafter (or in the case of an adjustment pursuant to
<U>Section</U><U></U><U>&nbsp;5(g)</U>, not later than five (5)&nbsp;Trading Days thereafter), compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment or
readjustment (including the kind and amount of securities, cash or other property into which each series of the Series B Convertible Preferred Stock is convertible) and showing in detail the facts upon which such adjustment or readjustment is based.
The Corporation shall, as promptly as reasonably practicable after the written request at any time of any Holder specifying one or more series of Series B Convertible Preferred Stock, furnish or cause to be furnished to such Holder a certificate
setting forth (i)&nbsp;the Conversion Price then in effect for each requested series of Series B Convertible Preferred Stock, and (ii)&nbsp;the number of shares of Common Stock and the amount, if any, of other securities, cash or property which then
would be received upon the conversion of a share of each requested series of Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Notice of
Record Date</U>. In the event: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Corporation declares a dividend (or any other distribution) on its Common Stock payable in Common
Stock or declares an Ordinary Dividend; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">that the Corporation effects a Stock Split, Rights Offering or Stock Combination; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of a Reorganization Event; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">of a Liquidation Event; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then the Corporation shall cause to be filed at its principal office or at the office of the Transfer Agent (if the Corporation is not then serving as its own
transfer agent), and shall cause to be mailed to the Holders at their last addresses as shown on the records of the Transfer Agent, at least ten (10)&nbsp;days prior to the date specified in (A)&nbsp;below or twenty (20)&nbsp;days before the date
specified in (B)&nbsp;below, a notice stating </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the record date of such dividend, distribution, Stock Split, Rights Offering or Stock Combination, or, if a
record is not to be taken, the date as of which the holders of Common Stock of record to be entitled to such dividend, distribution, Stock Split, Rights Offering or Stock Combination are to be determined, or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the date on which such Reorganization Event or Liquidation Event, and the date as of which it is expected that
holders of Common Stock of record shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such Reorganization Event or Liquidation Event. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Mandatory Conversion</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Trigger Event</U>. With respect to each series of Series B Convertible Preferred Stock, if, at any time following the third anniversary
of the applicable Initial Issue Date, the closing sale price of the Common Stock on the principal Trading Market exceeds <FONT STYLE="white-space:nowrap">one-hundred</FONT> and fifty percent (150%) of the Conversion Price of such series of Series B
Convertible Preferred Stock for twenty (20)&nbsp;Market Traded Days out of a period of thirty (30)&nbsp;consecutive Market Traded Days ending no later than two (2)&nbsp;Business Days prior to the date of the Mandatory Conversion Notice, then the
Corporation shall have the right to require conversion of all (but not less than all) of the applicable series of Series B Convertible Preferred Stock, at the then effective applicable Conversion Price in accordance with
<U>Section</U><U></U><U>&nbsp;5(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Procedural Requirements</U>. All Holders of the applicable series of Series B Convertible
Preferred Stock shall be sent written notice of the Mandatory Conversion Time and the place designated for mandatory conversion of all such shares of Series B Convertible Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;6</U> (such
notice, the &#147;<B><I>Mandatory Conversion Notice</I></B>&#148;) (including to or through DTC, if applicable). The Corporation shall send such notice at least ten (10)&nbsp;days in advance of the occurrence of the conversion requested pursuant to
<U>Section</U><U></U><U>&nbsp;6(a)</U> (the time of such occurrence, the &#147;<B><I>Mandatory Conversion Time</I></B>&#148;). Prior to the Mandatory Conversion Time specified in the Mandatory Conversion Notice, each Holder shall surrender his, her
or its certificate or certificates (if any) for all such shares (or, if such Holder alleges that any such certificate has been lost, stolen or destroyed, a lost certificate affidavit and bond of indemnity, if requested, in each case reasonably
satisfactory to the Corporation) to the Corporation at the place designated in such notice (or comply with the applicable delivery procedures of DTC and the Transfer Agent, if applicable). If so required by the Corporation, certificates surrendered
for conversion shall be endorsed or accompanied by written instrument or instruments of transfer, in form reasonably satisfactory to the Corporation, duly executed by the Holder or such Holder&#146;s attorney duly authorized in writing. All rights
with respect to the shares of Series B Convertible Preferred Stock converted pursuant to <U>Section</U><U></U><U>&nbsp;6(a)</U>, including the rights to receive notices and vote (other than as a holder of Common Stock), will terminate at the
Mandatory Conversion Time (notwithstanding the failure of the Holder or Holders thereof to surrender the certificates at or prior to such time or comply with the applicable procedures of DTC and the Transfer Agent), except only the rights of the
Holders thereof, upon surrender of their certificate or certificates (or lost certificate affidavit) therefor or compliance with the applicable procedures of DTC and the Transfer Agent, as applicable, to receive the items provided for in the next
sentence of this <U>Section</U><U></U><U>&nbsp;6(b)</U>. As soon as practicable after the Mandatory Conversion Time but no later than the Share Delivery Date, the Corporation shall deliver, or cause to be delivered (in certificated form or through
the facilities of DTC, as applicable), to the Holder, or to his, her or its nominees, the number of full shares of Common Stock being acquired upon the conversion of the Series B Convertible Preferred Stock pursuant to this
<U>Section</U><U></U><U>&nbsp;6</U>, together with cash in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion (as provided in <U>Section</U><U></U><U>&nbsp;5(b)</U>) and the payment of any declared but unpaid
cash dividends on the shares of Series B Convertible Preferred Stock converted (to the extent the amount of any such dividends shall not then be reflected in the applicable Stated Value). Such converted Series B Convertible Preferred Stock shall be
retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need for shareholder action) as may be necessary to reduce the authorized number of shares of the
applicable series of Series B Convertible Preferred Stock accordingly and restore such shares to the status of authorized but unissued shares of Preferred Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Protective Covenants</U>. (i)&nbsp;At any time when shares of Series B Convertible
Preferred Stock are outstanding, the Corporation shall not do any of the following without (in addition to any other vote required by applicable law or the Articles) the written consent or affirmative vote of the Required Holders, given in writing
or by vote at a meeting, consenting or voting (as the case may be) separately as a class: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) alter or change the rights, preferences or
privileges of the Series B Convertible Preferred Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) decrease the number of authorized shares of Series B Convertible Preferred
Stock (except for such decrease as permitted under <U>Sections 5(c)</U>, <U>6(b)</U> or <U>8(f)</U> hereunder); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) issue any shares of
Series B Convertible Preferred Stock, other than pursuant to the terms of the Investment Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) authorize or issue any Senior
Stock or securities convertible into Senior Stock, or amend or alter the Articles to increase the number of authorized shares of Series B Convertible Preferred Stock; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) amend, alter or repeal any provision of the Articles (by operation of law or otherwise) or the Bylaws in a manner that adversely affects
the rights, preferences or privileges of the Series B Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) At any time when shares of Series B Convertible
Preferred Stock are outstanding and the Investor continues to beneficially own at least 5% of the aggregate number of shares of Series B Convertible Preferred Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the
Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), the Corporation shall not without the written consent of the Investor, pay any cash dividend on the Common Stock other than Ordinary Dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) At any time when shares of Series B Convertible Preferred Stock are outstanding and the Investor continues to beneficially own at least
25% of the aggregate number of shares of Series B Convertible Preferred Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), the
Corporation shall not without the written consent of the Investor, redeem, repurchase or otherwise acquire, or make or declare any dividend or other distribution in respect of, any outstanding Junior Stock other than (u)&nbsp;Ordinary Dividends,
(v)&nbsp;dividends or other distributions for which the Conversion Price is adjusted pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, (w) repurchases of Junior Stock totaling up to $100&nbsp;million on an aggregate annual basis, (x)&nbsp;repurchases
of unvested shares at cost following termination of an employee, advisor or consultant of the Corporation or its Subsidiaries, <FONT STYLE="white-space:nowrap">(y)&nbsp;non-cash</FONT> dividends or other distributions paid <I>pro rata </I>to all
holders of Common Stock and, if applicable, holders of the Series B Convertible Preferred Stock in accordance with <U>Section</U><U></U><U>&nbsp;2</U>, or (z)&nbsp;dividends or other distributions on Junior Stock in the form of such Junior Stock or
other Junior Stock or securities convertible into or exchangeable for Junior Stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary in this Statement with
Respect to Shares, nothing herein shall prohibit or restrict or, except as may be required by applicable law, require any vote of the Series B Convertible Preferred Stock with respect to, Permitted Issuances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Redemptions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U><FONT STYLE="white-space:nowrap">Ten-Year</FONT> Redemption</U>. On or at any time after the tenth anniversary of the applicable
Initial Issue Date, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) each Holder shall have the right to require the Corporation to redeem all of such Holder&#146;s Series B
Convertible Preferred Stock, for cash, at a redemption price per share of the applicable series of Series B Convertible Preferred Stock equal to the sum of the applicable Stated Value plus an amount equal to all accrued or declared and unpaid
dividends on such series of Series B Convertible Preferred Stock that have not previously been added to the applicable Stated Value (the &#147;<B><I>Redemption Price</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Corporation shall have the right, with respect to one or more series of Series B Convertible Preferred Stock, to redeem, in whole or
in part, on a pro rata basis from all Holders thereof based on the number of shares of the applicable series of Series B Convertible Preferred Stock then held, the outstanding shares of such series of Series B Convertible Preferred Stock, for cash,
at the applicable Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Exercise of Redemption Right</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) Any Holder may exercise the Holder&#146;s redemption right under <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U> by delivering to
the Corporation in accordance with <U>Section</U><U></U><U>&nbsp;11</U> a written notice stating the Holder&#146;s intention to exercise the Holder&#146;s redemption right and the number of each series of the Holder&#146;s shares of Series B
Convertible Preferred Stock to be redeemed (a &#147;<B><I>Holder Redemption Notice</I></B>&#148;). The Corporation shall be obligated to redeem the total number of shares of Series B Convertible Preferred Stock specified in the Holder Redemption
Notice on or before the 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day following its receipt of such Holder Redemption Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Corporation may exercise its redemption right under <U>Section</U><U></U><U>&nbsp;8(a)(ii)</U> by delivering to the applicable
Holder the notice specified in <U>Section</U><U></U><U>&nbsp;8(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Notice of Redemption</U>. The Corporation shall provide
notice of any redemption requested by the Corporation under <U>Section</U><U></U><U>&nbsp;8(a)(ii)</U>, specifying the time and place of redemption and the applicable Redemption Price (the &#147;<B><I>Corporation Redemption Notice</I></B>&#148;), to
each Holder of record of Series B Convertible Preferred Stock at the address for such Holder last shown on the records of the Transfer Agent therefor, not less than fifteen (15)&nbsp;days prior to each redemption date. In the case of redemptions
requested by a Holder under <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U>, the Corporation shall use its reasonable best efforts, and shall take all reasonable action necessary, to pay the applicable Redemption Price as provided in this
<U>Section</U><U></U><U>&nbsp;8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Insufficient Funds</U>. If the funds of the Corporation legally available for redemption by
the Holder pursuant to <U>Section</U><U></U><U>&nbsp;8(a)(</U><U>i</U><U>)</U> of the Series B Convertible Preferred Stock on any redemption date are insufficient to redeem all shares of the Series B Convertible Preferred Stock being redeemed by the
Corporation on such date, those funds which are legally available will be used first to redeem, on a pro rata basis from the Holders thereof based on the number of shares of Series B Convertible Preferred Stock then held, the maximum possible number
of shares of the Series B Convertible Preferred Stock being redeemed in accordance with the aggregate redemption proceeds payable with respect to the shares of Series B Convertible Preferred Stock to be redeemed. At any time thereafter when
additional funds of the Corporation become legally available for the redemption of the Series B Convertible Preferred Stock, such funds will be used to redeem the balance of the shares of Series B Convertible Preferred Stock which the Corporation
was theretofore obligated to redeem as provided in the immediately preceding sentence. Any shares of Series B Convertible Preferred Stock which are not redeemed as a result of the circumstances described in this
<U>Section</U><U></U><U>&nbsp;8(d)</U> shall remain outstanding until such shares shall have been redeemed and the Redemption Price therefor, as applicable, shall have been paid or set aside for payment in full. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Rights Terminated</U>. Upon (i)&nbsp;surrender of the certificate or certificates
representing the shares of Series B Convertible Preferred Stock being redeemed (or surrender of such shares in compliance with the procedures established by DTC and the Transfer Agent, if applicable) pursuant to this
<U>Section</U><U></U><U>&nbsp;8</U> and delivery of the Redemption Price therefor or (ii)&nbsp;irrevocable deposit in trust by the Corporation for Holders of the Series B Convertible Preferred Stock being redeemed pursuant to this
<U>Section</U><U></U><U>&nbsp;8</U> of an amount in cash equal to the applicable Redemption Price for the shares of Series B Convertible Preferred Stock being redeemed on any redemption date, each Holder will cease to have any rights as a
shareholder of the Corporation by reason of the ownership of such redeemed shares of Series B Convertible Preferred Stock (except for the right to receive the Redemption Price therefor upon the surrender of the certificate or certificates
representing the redeemed shares or compliance with the procedures established by DTC and the Transfer Agent, if such shares have not been so surrendered), and such redeemed shares of Series B Convertible Preferred Stock will not from and after the
date of payment in full of the Redemption Price therefor be deemed to be outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Reacquired Shares</U>. Any shares of Series
B Convertible Preferred Stock converted, redeemed, purchased, or otherwise acquired by the Corporation in any manner whatsoever shall be retired and canceled promptly after the acquisition thereof, and shall not be reissued as shares of such series,
and the Corporation (without the need for shareholder action) may from time to time take such appropriate action as may be necessary to reduce the authorized number of shares of the applicable series of Series B Convertible Preferred Stock
accordingly and restore such shares to the status of authorized but unissued shares of Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Withdrawal Right</U>. Each
Holder shall retain the right to (i)&nbsp;convert shares of Series B Convertible Preferred Stock to be redeemed pursuant to <U>Section</U><U></U><U>&nbsp;8(b)(i)</U> at any time on or prior to the redemption date or (ii)&nbsp;withdraw its Holder
Redemption Notice; <U>provided</U>, <U>however</U>, that, where a Holder of Series B Convertible Preferred Stock exercises its rights under (i)&nbsp;or (ii) above, the applicable shares of Series B Convertible Preferred Stock of such Holder shall
not be redeemed pursuant to this <U>Section</U><U></U><U>&nbsp;8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Fundamental Change</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Offer to Repurchase</U>. In connection with any Fundamental Change, the Corporation shall, or shall cause the Survivor of a Fundamental
Change (such Survivor of a Fundamental Change, the &#147;<B><I>Acquirer</I></B>&#148;) to, make an offer to repurchase, at the option and election of the holder thereof, each share of Series B Convertible Preferred Stock then-outstanding (the
&#147;<B><I>Fundamental Change Repurchase Offer</I></B>&#148;) at a purchase price per share (such amount being the &#147;<B><I>Fundamental Change Repurchase Price</I></B>&#148;) in cash equal to (i)&nbsp;the applicable Stated Value plus an amount
equal to all accrued or declared and unpaid dividends on such share of Series B Convertible Preferred Stock that have not previously been added to the applicable Stated Value as of the Fundamental Change Repurchase Date plus (ii)&nbsp;if prior to
the fifth anniversary of the applicable Initial Issue Date, the aggregate amount of all dividends that would have been paid (excluding any such dividends that would be paid in light of the timing of such Fundamental Change Repurchase Offer and, for
the avoidance of doubt, without duplication of amounts in clause (i)) in respect of an outstanding share of such series of Series B Convertible Preferred Stock from the Fundamental Change Repurchase Date through the fifth anniversary of the
applicable Initial Issue Date. The Fundamental Change Repurchase Offer must be made in the Fundamental Change Notice delivered pursuant to <U>Section</U><U></U><U>&nbsp;9(b)</U> and shall become irrevocable from the date thereof unless otherwise
consented to by (i)&nbsp;with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders and (ii)&nbsp;with respect to the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Required Holders (any such consent, an &#147;<B><I>Offer Consent</I></B>&#148; and the date such consent is effective, the
&#147;<B><I>Offer Consent Effective Date</I></B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Repurchase</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Corporation shall provide notice of any repurchases offered by the Corporation under <U>Section</U><U></U><U>&nbsp;9(a)</U> by
delivering to the applicable Holder (including notice to or through DTC, if applicable) a written notice in accordance with <U>Section</U><U></U><U>&nbsp;9(b)(ii)</U> (the &#147;<B><I>Fundamental Change Notice</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Fundamental Change Notice shall specify (i)&nbsp;the time and place of repurchase and the applicable Fundamental Change Repurchase
Price for each series of Series B Convertible Preferred Stock and (ii)&nbsp;the Holder&#146;s Conversion Rights pursuant to <U>Section</U><U></U><U>&nbsp;5</U> hereof, and shall be delivered to each Holder at the address for such Holder last shown
on the records of the Transfer Agent therefor, not less than fifteen (15)&nbsp;days prior to the Fundamental Change Repurchase Date. The &#147;<B><I>Fundamental Change Repurchase Date</I></B>&#148; shall be the date on which the Fundamental Change
is consummated (provided that in the case of a Fundamental Change described in clause (i)&nbsp;of the definition thereof, the Fundamental Change Repurchase Date shall be a date no later than thirty (30)&nbsp;days following the date of the first
public announcement of such Fundamental Change having occurred (including, for these purposes, the filing of a Schedule 13D pursuant to the Exchange Act)). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Insufficient Funds</U>. If the funds of the Corporation legally available for the Fundamental Change Repurchase Offer by the
Corporation pursuant to <U>Section</U><U></U><U>&nbsp;9(a)</U> on any Fundamental Change Repurchase Date are insufficient to redeem all shares of the Series B Convertible Preferred Stock being repurchased by the Corporation on such date, those funds
which are legally available will be used first to repurchase, on a pro rata basis from the Holders thereof based on the number of shares of Series B Convertible Preferred Stock then held, the maximum possible number of shares of the Series B
Convertible Preferred Stock being repurchased in accordance with the aggregate repurchase proceeds payable with respect to the shares of Series B Convertible Preferred Stock to be repurchased. At any time thereafter when additional funds of the
Corporation or the Acquirer, as applicable, become legally available for the repurchase of the Series B Convertible Preferred Stock, such funds will be used to redeem the balance of the shares of Series B Convertible Preferred Stock which the
Corporation was theretofore obligated to repurchase as provided in the immediately preceding sentence. Any shares of Series B Convertible Preferred Stock which are not repurchased as a result of the circumstances described in this
<U>Section</U><U></U><U>&nbsp;9(c)</U> shall remain outstanding until such shares shall have been redeemed and the Fundamental Change Repurchase Price therefor, as applicable, shall have been paid or set aside for payment in full. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Rights Terminated</U>. Upon (i)&nbsp;surrender of the certificate or certificates representing the shares of Series B Convertible
Preferred Stock being repurchased (or surrender of such shares in compliance with the procedures established by DTC and the Transfer Agent, if applicable) pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> and delivery of the Fundamental Change
Repurchase Price therefor or (ii)&nbsp;irrevocable deposit in trust by the Corporation for Holders being repurchased pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> of an amount in cash equal to the applicable Fundamental Change Repurchase
Price for the shares of Series B Convertible Preferred Stock being repurchased on any Fundamental Change Repurchase Date, each Holder will cease to have any rights as a shareholder of the Corporation by reason of the ownership of such repurchased
shares of Series B Convertible Preferred Stock (except for the right to receive the Fundamental Change Repurchase Price therefor upon the surrender of the certificate or certificates representing the repurchased shares or compliance with the
procedures established by DTC and the Transfer Agent, if such shares have not been so surrendered ), and such repurchased shares of Series B Convertible Preferred Stock will not from and after the date of payment in full of the Fundamental Change
Repurchase Price therefor be deemed to be outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Offer Made by Affiliate</U>. The Corporation shall not be required to make a
Fundamental Change Repurchase Offer if an affiliate in control of the Corporation makes the Fundamental Change Repurchase Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this
<U>Section</U><U></U><U>&nbsp;9</U> and purchases all shares of Series B Convertible Preferred Stock validly tendered and not withdrawn under such Fundamental Change Repurchase Offer; <U>provided</U>, that if an affiliate in control of the
Corporation makes such repurchase, the shares of Series B Convertible Preferred Stock so purchased shall remain outstanding in the hands of such affiliate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Withdrawal Right</U>. Each Holder shall retain the right to (i)&nbsp;convert shares of Series B Convertible Preferred Stock to be
repurchased pursuant to this <U>Section</U><U></U><U>&nbsp;9</U> at any time on or prior to the Fundamental Change Repurchase Date or (ii)&nbsp;withdraw a tender of such shares in the Fundamental Change Repurchase Offer on or prior to the
Fundamental Change Repurchase Date; <U>provided</U>, <U>however</U>, that, where a Holder exercises its rights under (i)&nbsp;or (ii) above, the applicable shares of Series B Convertible Preferred Stock of such Holder shall not be repurchased
pursuant to this <U>Section</U><U></U><U>&nbsp;9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Events of Noncompliance</U>. Notwithstanding anything to the contrary
contained here, if one or more of the following events (each, an &#147;<B><I>Event of Noncompliance</I></B>&#148;) shall occur with respect to any Holder: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Corporation shall fail to pay when due any dividend payment in full pursuant to <U>Section</U><U></U><U>&nbsp;2</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Corporation shall fail to pay when due the applicable Redemption Price pursuant <U>Section</U><U></U><U>&nbsp;8</U>; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Corporation shall fail to pay when due the applicable Fundamental Change Repurchase Price pursuant to
<U>Section</U><U></U><U>&nbsp;9</U>, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, and in each case, unless such Event of Noncompliance is cured within thirty (30)&nbsp;days (the
&#147;<B><I>Cure Period</I></B>&#148;) of such Event of Noncompliance, the Annual Rate (i)&nbsp;shall increase to 8% per annum as of the date of the Event of Noncompliance and (ii)&nbsp;so long as such Event of Noncompliance remains uncured, shall
increase by an additional 2% per annum with respect to each Dividend Period ending subsequent to the Dividend Period in which the Event of Noncompliance occurred; <U>provided</U>, <U>however</U>, that at no time shall the Annual Rate on the Series B
Convertible Preferred Stock exceed 14% per annum; <U>provided</U>, <U>further</U>, the Annual Rate shall be reduced to 5% per annum immediately after all Events of Noncompliance are cured (if any shares of Series B Convertible Preferred Stock remain
outstanding). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Notices</U>. All notices or communications in respect of Series B Convertible Preferred Stock shall be sufficiently
given if given in writing and delivered in person or by first class mail, postage prepaid, or if given in such other manner as may be permitted in this Statement with Respect to Shares, in the Articles or the Bylaws and by applicable law. Any Notice
of Conversion or Holder Redemption Notice shall be given by the Holder to the Corporation (i)&nbsp;in the case of any Series B Convertible Preferred Stock held in certificated form, by transmittal, by overnight carrier (in the case of a Notice of
Conversion for receipt prior to 5:00 p.m., Eastern Time, on the Conversion Date) to the Corporation&#146;s then principal offices, Attention: Chief Financial Officer, of such Notice of Conversion or Holder Redemption Notice, as applicable, executed
by such Holder, together with the applicable stock certificate or certificates duly endorsed (unless delivery of certificates is not required pursuant to <U>Section</U><U></U><U>&nbsp;5(c)(</U><U>i</U><U>)</U>) and any additional instruments
required to be delivered hereunder and (ii)&nbsp;in the case of any Series B Convertible Preferred Stock held through the facilities of DTC, by complying with the applicable procedures established from time to time by DTC and the Transfer Agent.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>No Preemptive Rights</U>. The Holders shall have no preemptive or preferential rights
to purchase or subscribe for any stock, obligations, warrants or other securities of the Corporation of any class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>No Other
Rights</U>. The shares of Series B Convertible Preferred Stock shall not have any rights, preferences, privileges or voting powers or relative, participating, optional or other special rights, or qualifications, limitations or restrictions thereof,
other than as set forth herein or in the Articles or as provided by applicable Pennsylvania law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Book-Entry Form</U>. Shares of
each series of the Series B Convertible Preferred Stock may be issued (or reissued) in the form of one or more global certificates (&#147;<B><I>Global Preferred Shares</I></B>&#148;) to be deposited on behalf of one or more Holders thereof with the
Transfer Agent, as custodian for DTC (or with such other custodian as DTC may direct), and registered in the name of DTC or its nominee. The number of shares of any series of Series B Convertible Preferred Stock represented by Global Preferred
Shares may from time to time be increased or decreased by adjustments made on the records of the Transfer Agent and DTC to reflect such changes as provided for herein. Members of, or participants in, DTC shall have no rights under the terms of the
shares of Series B Convertible Preferred Stock with respect to any Global Preferred Shares held on their behalf by DTC or any custodian of DTC or under such Global Preferred Shares, and DTC may be treated by the Corporation, the Transfer Agent and
any agent of the Corporation or the Transfer Agent as the absolute owner of such Global Preferred Shares for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Corporation, the Transfer Agent or any agent of the
Corporation or the Transfer Agent from giving effect to any written certification, proxy or other authorization furnished by DTC or impair, as between DTC and its members and participants, the operation of customary practices of DTC governing the
exercise of the rights of a holder of a beneficial interest in any Global Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Definitions</U>. The following terms
shall have the following respective meanings: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Acquirer</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>affiliate</I></B>&#148; means, with respect to any Person, any other Person that,
directly or indirectly, through one or more intermediaries, controls, or is controlled by, or is under common control with, such Person. The term &#147;<B><I>control</I></B>&#148; includes, without limitation, the possession, directly or indirectly,
of the power to direct the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Annual Rate</I></B>&#148; means 5% per annum, subject to increase pursuant to <U>Section</U><U></U><U>&nbsp;10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Articles</I></B>&#148; means the Amended and Restated Articles of Incorporation of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Board of Directors</I></B>&#148; means the Board of Directors of the Corporation or an authorized committee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Business Day</I></B>&#148; means any day other than a Saturday or Sunday or any other day on which commercial banks in New York
City are authorized or required by law or executive order to close or be closed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Bylaws</I></B>&#148; means the Amended and Restated Bylaws of the Corporation,
as they may be amended or restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Common Stock</I></B>&#148; means the common stock, no par value, of the
Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Price</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Conversion Rights</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Corporation</I></B>&#148; means <FONT STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Corporation Redemption Notice</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Cure Period</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Dividend Payment Date&#148;</I></B> means, with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible
Preferred Stock and the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, as applicable, January&nbsp;1, April&nbsp;1, July&nbsp;1 and October&nbsp;1 of each year, commencing on, for the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, July&nbsp;1, 2021 and, for the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the first such date that occurs after the Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Issue Date; <U>provided</U>, that if any such Dividend Payment Date would otherwise occur on a day that is not a Business Day, such Dividend Payment Date shall instead be (and any dividend payable on Series B
Convertible Preferred Stock on such Dividend Payment Date shall instead be payable on) the immediately succeeding Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Dividend Period</I></B>&#148; means the period commencing on and including a Dividend Payment Date and shall end on and include
the day immediately preceding the next Dividend Payment Date; <U>provided</U>, that the initial Dividend Period with respect to a series of Series B Convertible Preferred Stock shall commence on and include the applicable Initial Issue Date and
shall end on and include the day immediately preceding the first applicable Dividend Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>DTC</I></B>&#148; means
The Depositary Trust Company or its nominee or any successor appointed by the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Event of
Noncompliance</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;10</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange
Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Exchange Property</I></B>&#148; shall have the meaning set forth in the definition of Fundamental Change hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A &#147;<B><I>Fundamental Change</I></B>&#148; shall be deemed to have occurred, at any time after the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, if any of the following occurs: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any &#147;person&#148; or &#147;group&#148;
(as such terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act, whether or not applicable), other than the Corporation, any of its Wholly-Owned Subsidiaries or any of the Corporation&#146;s or its Wholly-Owned
Subsidiaries&#146; employee benefit plans, has become the &#147;beneficial owner&#148; (as defined in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of
the Common Stock; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the consummation of (A)&nbsp;any recapitalization, reclassification or change of the
Common Stock (other than changes resulting from a subdivision or combination or change in par value) as a result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets (including cash
or a combination thereof); (B) any consolidation, merger or other combination of the Corporation or binding share exchange pursuant to which the Common Stock will be converted into, or exchanged for, stock, other securities or other property or
assets (including cash or a combination thereof); or (C)&nbsp;any sale, lease or other transfer or disposition in one transaction or a series of transactions of all or substantially all of the consolidated assets of the Corporation and its
Subsidiaries taken as a whole, to any person other than one or more of its Wholly-Owned Subsidiaries; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Common Stock (or other
common equity underlying the Series B Convertible Preferred Stock) ceases to be listed or quoted for trading on any of The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, a transaction or transactions described in clause (i)&nbsp;or clause (ii)&nbsp;above shall not constitute a Fundamental Change if at least 90%
of the consideration received or to be received by holders of Common Stock, excluding cash payments for fractional shares or pursuant to statutory appraisal rights, in connection with such transaction or transactions consists of shares of common
stock that are listed or quoted on any of The New York Stock Exchange, the Nasdaq Global Select Market or the Nasdaq Global Market (or any of their respective successors) or shall be so listed or quoted when issued or exchanged in connection with
such transaction or transactions and as a result of such transaction or transactions such consideration (excluding cash payments for fractional shares or pursuant to statutory appraisal rights) becomes the consideration that a Holder would have been
entitled to receive if such Holder had immediately converted its Series B Convertible Preferred Stock prior to such transaction or transactions (such consideration, &#147;<B><I>Exchange Property</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Notice</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Offer</I></B>&#148; shall have meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Fundamental Change Repurchase Price</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Global Preferred Shares</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder</I></B>&#148; means each Person in whose name shares of Series B Convertible Preferred Stock are registered, who shall be
treated by the Corporation as the absolute owner of those shares of Series B Convertible Preferred Stock for the purpose of making payment and settling conversions and for all other purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Holder Redemption Notice</I></B>&#148; has the meaning set forth in <U>Section</U><U></U><U>&nbsp;8(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial Closing</I></B>&#148; shall have the meaning set forth in the definition of Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Initial Issue Date</I></B>&#148; means (i)&nbsp;with respect to the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible
Preferred Stock, the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date and (ii)&nbsp;with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Issue Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Investment Agreement</I></B>&#148; means that certain Amended and Restated
Investment Agreement, dated as of March&nbsp;30, 2021, by and between the Corporation and BCPE Watson (DE) SPV, LP, a Delaware limited partnership (the &#147;<B><I>Investor</I></B>&#148;), the text of which agreement is on file at the
Corporation&#146;s principal place of business at 375 Saxonburg Blvd., Saxonburg, PA 16056 (or at such other address as is the principal place of business of the Corporation from time to time following the Initial Issue Date). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Investor</I></B>&#148; shall have the meaning set forth in the definition of Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Issue Date</I></B>&#148; means, with respect to each share of Series B Convertible Preferred Stock, the date on which such share
of Series B Convertible Preferred Stock was issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Junior Stock</I></B>&#148; means&nbsp;(i) the Common Stock and
(ii)&nbsp;each other class or series of capital stock of the Corporation, the terms of which do not expressly provide that such class or series ranks either (x)&nbsp;senior to the Series B Convertible Preferred Stock as to dividend rights or
distribution rights upon a Liquidation Event or (y)&nbsp;on parity with the Series B Convertible Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liquidation Event</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Liquidation Preference</I></B>&#148; means, with respect to a particular share of Series B Convertible Preferred Stock, the Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Liquidation Preference or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory Conversion Notice</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory Conversion Time</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Mandatory PIK Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Market Traded Days</I></B>&#148; shall have the meaning set forth in the definition of Trading Day hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Notice of Conversion</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Offer Consent</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a).</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Offer Consent Effective Date</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Ordinary Dividends</I></B>&#148; means cash dividends on the Common Stock in the aggregate not exceeding (i)&nbsp;in calendar year
2021, $3.00 per share (the &#147;<B><I>Maximum</I></B>&#148;), and (ii)&nbsp;in each subsequent calendar year, 105% of the prior year&#146;s Maximum. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Parity Stock</I></B>&#148; means (i)&nbsp;the 6% Series A Mandatory Convertible Preferred Stock, no par value per share, of the
Corporation and (ii)&nbsp;any class or series of capital stock of the Corporation established after the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, the terms of which expressly provide that such class or series shall rank on
parity with the Series B Convertible Preferred Stock as to dividend rights and distribution rights upon a Liquidation Event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Permitted Issuances</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Person</I></B>&#148; means any individual, partnership, firm, corporation, limited liability company, business trust, joint stock
company, trust, unincorporated association, joint venture, governmental authority or other entity of whatever nature. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>PIK
Dividend</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2(b)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Preferred Stock</I></B>&#148; shall have the meaning set forth in the Articles.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Pro Rata Amount</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Purchase Price</I></B>&#148; means $10,000 per share of Series B Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Redemption Price</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8(a)(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Reorganization Event</I></B>&#148; means a recapitalization, reclassification, consolidation or merger that is not a Fundamental
Change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Required Holders</I></B>&#148; means the Holders of a majority of the then outstanding shares of Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock and Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, voting together as a single class; <U>provided</U>, that if the relevant action adversely affects
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock in a manner different from the other series of Series B Convertible Preferred
Stock (taking into account such series&#146; relative Initial Issue Dates) (a series of Series B Convertible Preferred Stock so adversely affected, an &#147;<B><I>Affected Series</I></B>&#148;) and provided that there remain outstanding at such time
at least 10% of the shares of such Affected Series issued on the Initial Issue Date for such Affected Series, then Required Holders shall in addition mean the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders if the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock is an Affected Series or the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Required Holders if the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock
is an Affected Series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Rights Offering</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5(h)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Senior Stock</I></B>&#148; means each class or series of capital stock of the
Corporation established after the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue Date, the terms of which expressly provide that such class or series shall rank senior to the Series B Convertible Preferred Stock as to dividend rights or
distribution rights upon a Liquidation Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series B Convertible Preferred Stock</I></B><B>&#148; </B>shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Issue
Date</I></B>&#148; means March&nbsp;31, 2021, the first Issue Date of shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Issue Date</I></B>&#148; means the first Issue Date of shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Liquidation Preference</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Liquidation Preference</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Required Holders</I></B>&#148; means the Holders of a majority of the then
outstanding shares of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Required Holders</I></B>&#148; means the Holders of a majority of the then outstanding shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Stated Value</I></B>&#148; shall have the meaning set forth in the definition
of Stated Value hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Stated Value</I></B>&#148; shall have the meaning
set forth in the definition of Stated Value hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Share Delivery Date</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities</I></B>&#148; shall have
the meaning set forth in the definition of <FONT STYLE="white-space:nowrap">Spin-Off</FONT> Transaction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I><FONT
STYLE="white-space:nowrap">Spin-Off</FONT> Transaction</I></B>&#148;<B><I> </I></B>means a payment by the Corporation of a dividend or other distribution on the Common Stock of shares of capital stock of any class or series, or similar equity
interest, of a Subsidiary of the Corporation, that are, or, when issued, will be, listed or admitted for trading on a U.S. national securities exchange (the securities so dividended or distributed, the
&#147;<B><I><FONT STYLE="white-space:nowrap">Spin-Off</FONT> Securities</I></B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stated Value</I></B>&#148; means,
(i)&nbsp;with respect to each share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock, the sum, subject to appropriate adjustment pursuant to <U>Section</U><U></U><U>&nbsp;5</U>, of (x)&nbsp;the Purchase Price plus
(y)&nbsp;on each Dividend Payment Date (A)&nbsp;on which a dividend is paid in whole in the form of a PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> or (B)&nbsp;on which a dividend is paid in part in the form of a
PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously
added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> less the amount of cash dividends actually paid with the respect to such share on the applicable Dividend Payment Date (the &#147;<B><I>Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Stated Value</I></B>&#148;) and (ii)&nbsp;with respect to each share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock, the sum, subject to appropriate adjustment pursuant to
<U>Section</U><U></U><U>&nbsp;5</U>, of (x)&nbsp;the Purchase Price plus (y)&nbsp;on each Dividend Payment Date (A)&nbsp;on which a dividend is paid in whole in the form of a PIK Dividend, an additional amount equal to the dollar value of any
dividends on a share of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to
<U>Section</U><U></U><U>&nbsp;2(a)</U> or (B)&nbsp;on which a dividend is paid in part in the form of a PIK Dividend, an additional amount equal to the dollar value of any dividends on a share of Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock which have accrued on any Dividend Payment Date and have not been previously added to such Stated Value pursuant to <U>Section</U><U></U><U>&nbsp;2(a)</U> less the amount of cash dividends actually paid with the respect
to such share on the applicable Dividend Payment Date (the &#147;<B><I>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Stated Value</I></B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stock Combination</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Stock Split</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsequent Closing</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsequent Investment Obligation</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(c)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to any Person, any corporation, association, partnership or other business entity of
which more than 50% of the total voting power of shares of capital stock or other interests (including partnership interests) entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers, general
partners or trustees thereof is at the time owned or controlled, directly or indirectly, by (i)&nbsp;such Person; (ii)&nbsp;such Person and one or more Subsidiaries of such Person; or (iii)&nbsp;one or more Subsidiaries of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Survivor of a Fundamental Change</I></B>&#148; means the issuer of the securities received by the holders of Common Stock (or
Exchange Property, to the extent applicable) (in their capacities as such) upon the consummation of a Fundamental Change described in <U>clauses</U> <U>(i)</U>&nbsp;and <U>(ii)</U> of the definition thereof, to the extent the holders of Common Stock
(or Exchange Property, to the extent applicable) receive other securities in exchange, conversion or substitution of their Common Stock (or Exchange Property, to the extent applicable) in the transaction that resulted in such Fundamental Change.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Target Merger Agreement</I></B>&#148; shall have the meaning set forth in the
Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Day</I></B>&#148; means (i)&nbsp;any day on which the Common Stock is listed or quoted and
traded on its primary Trading Market (&#147;<B><I>Market Traded Days</I></B>&#148;) or (ii)&nbsp;if the Common Stock is not then listed or quoted and traded on any Trading Market, then a day on which trading occurs on the Nasdaq Global Market (or
any successor thereto). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Trading Market</I></B>&#148; means the following market(s) or exchange(s) on which the Common Stock
is listed or quoted for trading on the date in question (as applicable): the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the NYSE MKT or any successor markets thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer</I></B>&#148; shall have the meaning set forth in the Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Transfer Agent</I></B>&#148; means such agent or agents of the Corporation as may be designated by the Board of Directors or its
duly authorized designee as the transfer agent, registrar and dividend disbursing agent for one or more series of the Series B Convertible Preferred Stock or, if the Corporation is serving as its own transfer agent, the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Upsize Investment</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Wholly-Owned Subsidiary</I></B>&#148; means, with respect to any Person, any Subsidiary of such Person, except that, solely for
purposes of this definition, the reference to &#147;more than 50%&#148; in the definition of &#147;Subsidiary&#148; shall be deemed to be replaced by a reference to &#147;100%&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of Page Intentionally Left Blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d135490dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><U>EXECUTION VERSION</U> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED INVESTMENT AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and between </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BCPE Watson (DE) SPV, LP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated
as of March&nbsp;30, 2021 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TABLE OF CONTENTS </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE I Definitions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 &nbsp;&nbsp;&nbsp;&nbsp;Definitions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE II Purchase and Sale</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>18</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 &nbsp;&nbsp;&nbsp;&nbsp;Purchase and Sale</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 &nbsp;&nbsp;&nbsp;&nbsp;Initial and Subsequent Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE III Representations and Warranties of the Company</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>20</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 &nbsp;&nbsp;&nbsp;&nbsp;Organization; Standing; Subsidiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 &nbsp;&nbsp;&nbsp;&nbsp;Capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03 &nbsp;&nbsp;&nbsp;&nbsp;Authority; Noncontravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04 &nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05 &nbsp;&nbsp;&nbsp;&nbsp;Company SEC Documents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06 &nbsp;&nbsp;&nbsp;&nbsp;Absence of Certain Changes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07 &nbsp;&nbsp;&nbsp;&nbsp;Internal Controls and Procedures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08 &nbsp;&nbsp;&nbsp;&nbsp;No Undisclosed Liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09 &nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 &nbsp;&nbsp;&nbsp;&nbsp;Compliance with Laws; Permits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 &nbsp;&nbsp;&nbsp;&nbsp;Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 &nbsp;&nbsp;&nbsp;&nbsp;Employee Benefit Plans</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 &nbsp;&nbsp;&nbsp;&nbsp;Labor Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 &nbsp;&nbsp;&nbsp;&nbsp;Environmental Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 &nbsp;&nbsp;&nbsp;&nbsp;Real Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 &nbsp;&nbsp;&nbsp;&nbsp;No Rights Agreement; Anti-Takeover Provisions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 &nbsp;&nbsp;&nbsp;&nbsp;Customers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 &nbsp;&nbsp;&nbsp;&nbsp;Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 &nbsp;&nbsp;&nbsp;&nbsp;Sale of Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 &nbsp;&nbsp;&nbsp;&nbsp;Listing and Maintenance Requirements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 &nbsp;&nbsp;&nbsp;&nbsp;Status of Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 &nbsp;&nbsp;&nbsp;&nbsp;Indebtedness</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 &nbsp;&nbsp;&nbsp;&nbsp;Intellectual Property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 &nbsp;&nbsp;&nbsp;&nbsp;Affiliate Transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 &nbsp;&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE IV Representations and Warranties of the Investor</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>35</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 &nbsp;&nbsp;&nbsp;&nbsp;Organization; Standing; Ownership</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 &nbsp;&nbsp;&nbsp;&nbsp;Authority; Noncontravention</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 &nbsp;&nbsp;&nbsp;&nbsp;Governmental Approvals</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 &nbsp;&nbsp;&nbsp;&nbsp;Financing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 &nbsp;&nbsp;&nbsp;&nbsp;Brokers and Other Advisors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(CONT&#146;D) </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><U>Page</U></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 &nbsp;&nbsp;&nbsp;&nbsp;Securities Act Representations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 &nbsp;&nbsp;&nbsp;&nbsp;No Other Representations or Warranties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE V Additional Agreements</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>39</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 &nbsp;&nbsp;&nbsp;&nbsp;Negative Covenants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 &nbsp;&nbsp;&nbsp;&nbsp;Reasonable Best Efforts; Filings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 &nbsp;&nbsp;&nbsp;&nbsp;Corporate Actions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 &nbsp;&nbsp;&nbsp;&nbsp;Public Announcements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 &nbsp;&nbsp;&nbsp;&nbsp;Confidentiality</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 &nbsp;&nbsp;&nbsp;&nbsp;NASDAQ Listing of Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 &nbsp;&nbsp;&nbsp;&nbsp;Standstill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 &nbsp;&nbsp;&nbsp;&nbsp;Transfer Restrictions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 &nbsp;&nbsp;&nbsp;&nbsp;[RESERVED]</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 &nbsp;&nbsp;&nbsp;&nbsp;Legend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 &nbsp;&nbsp;&nbsp;&nbsp;Board Matters; Election of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 &nbsp;&nbsp;&nbsp;&nbsp;Tax Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 &nbsp;&nbsp;&nbsp;&nbsp;Use of Proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 &nbsp;&nbsp;&nbsp;&nbsp;Back Leverage Cooperation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 &nbsp;&nbsp;&nbsp;&nbsp;State Securities Laws</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 &nbsp;&nbsp;&nbsp;&nbsp;Information Rights</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 &nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;16 Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 &nbsp;&nbsp;&nbsp;&nbsp;VCOC Letters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 &nbsp;&nbsp;&nbsp;&nbsp;Target Acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 &nbsp;&nbsp;&nbsp;&nbsp;Statement With Respect to Shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 &nbsp;&nbsp;&nbsp;&nbsp;Pipeline Financings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VI Conditions to Subsequent Closing</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>58</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Company and the
Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Company</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03 &nbsp;&nbsp;&nbsp;&nbsp;Conditions to the Obligations of the Investor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VII Termination; Survival</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>60</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 &nbsp;&nbsp;&nbsp;&nbsp;Termination Prior to the Subsequent Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02 &nbsp;&nbsp;&nbsp;&nbsp;Effect of Termination Prior to Subsequent
Closing</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03 &nbsp;&nbsp;&nbsp;&nbsp;Survival and Limitation on Liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>ARTICLE VIII Miscellaneous</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>62</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01 &nbsp;&nbsp;&nbsp;&nbsp;Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02 &nbsp;&nbsp;&nbsp;&nbsp;Extension of Time, Waiver, Etc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03 &nbsp;&nbsp;&nbsp;&nbsp;Assignment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TABLE OF CONTENTS </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>(CONT&#146;D) </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><U>Page</U></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04 &nbsp;&nbsp;&nbsp;&nbsp;Counterparts; Electronic Delivery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05 &nbsp;&nbsp;&nbsp;&nbsp;Entire Agreement; No Third-Party Beneficiaries</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06 &nbsp;&nbsp;&nbsp;&nbsp;Governing Law; Jurisdiction</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.07 &nbsp;&nbsp;&nbsp;&nbsp;Specific Enforcement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.08 &nbsp;&nbsp;&nbsp;&nbsp;WAIVER OF JURY TRIAL</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.09 &nbsp;&nbsp;&nbsp;&nbsp;Notices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10 &nbsp;&nbsp;&nbsp;&nbsp;Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11 &nbsp;&nbsp;&nbsp;&nbsp;Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12 &nbsp;&nbsp;&nbsp;&nbsp;Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13
<FONT STYLE="white-space:nowrap">&nbsp;&nbsp;&nbsp;&nbsp;Non-Recourse</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14 &nbsp;&nbsp;&nbsp;&nbsp;Effectiveness of Amendment and Restatement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Exhibits </U></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Equity Commitment Letter</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;B:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Issuer Agreement</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;C:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Registration Rights Agreement</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED INVESTMENT AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIS AMENDED AND RESTATED INVESTMENT AGREEMENT</B>, is made as of March&nbsp;30, 2021 (this &#147;<U>Agreement</U>&#148;), by and between <FONT
STYLE="white-space:nowrap">II-VI</FONT> Incorporated, a Pennsylvania corporation (the &#147;<U>Company</U>&#148;), and BCPE Watson (DE) SPV, LP, a Delaware limited partnership (together with its successors and any Affiliate that becomes a party
hereto pursuant to <U>Section</U><U></U><U>&nbsp;5.08(b)</U> and <U>Section</U><U></U><U>&nbsp;8.03</U>, the &#147;<U>Investor</U>&#148;). Capitalized terms used in this Agreement shall have the meanings ascribed to such terms in <U>Article I</U> or
as otherwise defined elsewhere in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company and the Investor previously entered into an Investment Agreement,
dated as of March&nbsp;25, 2021 (the &#147;<U>Original Investment Agreement</U>&#148;) and, pursuant to Section&nbsp;8.01(i) of the Original Investment Agreement, the parties wish to amend and restate the Original Investment Agreement in its
entirety; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, subject to the terms and conditions set forth herein, the Company desires to issue, sell and deliver to the Investor,
and the Investor desires to purchase and acquire from the Company, subject to the terms and conditions set forth in this Agreement, (i) 75,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-1</FONT> Convertible Preferred
Stock, having no par value per share (the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</U>&#148;), at the Initial Closing, (ii) 105,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT>
Convertible Preferred Stock, having no par value per share (the &#147;<U>Series B</U><U><FONT STYLE="white-space:nowrap">-2</FONT> Preferred Stock</U>&#148; and together with the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock,
the &#147;<U>Series B Preferred Stock</U>&#148;), at the Subsequent Closing, and (iii)&nbsp;up to an additional aggregate number of 35,000 shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">B-2</FONT> Convertible Preferred Stock at
the Subsequent Closing, in each case, having the designation, preferences, rights, privileges, powers, and terms and conditions, as specified in the Statement With Respect to Shares; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution of the Original Investment Agreement, the Company entered into that certain Agreement and Plan of
Merger, dated as of March&nbsp;25, 2021 (as amended, restated, supplemented, waived or otherwise modified from time to time, the &#147;<U>Target Merger Agreement</U>&#148;), by and among the Company, Coherent, Inc., a Delaware corporation (the
&#147;<U>Target</U>&#148;), and Watson Merger Sub Inc., a Delaware corporation and a direct wholly owned Subsidiary of the Company, pursuant to which the Company will acquire all outstanding equity interests of the Target (the &#147;<U>Target
Acquisition</U>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">WHEREAS, concurrently with the execution of the Original Investment Agreement, and as a condition and
inducement to the willingness of the Company to enter into the Original Investment Agreement, the Equity Provider executed and delivered an equity commitment letter attached as Exhibit A to the Original Investment Agreement (the &#147;<U>Original
Equity Commitment Letter</U>&#148;), and, concurrently with the execution of this Agreement, the Equity Provider has executed and delivered an equity commitment letter, a copy of which is attached hereto as <U>Exhibit A</U> (the &#147;<U>Equity
Commitment Letter</U>&#148;), which replaces and supersedes the Original Equity Commitment Letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of
the mutual covenants, representations, warranties and agreements contained in this Agreement, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows: </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Definitions </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01 <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As used in this Agreement (including the recitals hereto), the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>25% Beneficial Ownership Requirement</U>&#148; means that the Investor Parties continue to beneficially own at all times shares of
Series B Preferred Stock and/or shares of Company Common Stock that were issued upon conversion of shares of Series B Preferred Stock that represent, in the aggregate and on an as converted basis, at least 25% of the number of shares of Company
Common Stock issued to the Investor Parties, on an as converted basis, as of the Initial Closing (if the Subsequent Closing has not occurred) or the Subsequent Closing (if the Subsequent Closing has occurred), as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Activist Investor</U>&#148; means, as of any date, any Person identified on the most recently available &#147;SharkWatch 50&#148;
list (or, if &#147;SharkWatch 50&#148; is no longer available, then the prevailing comparable list as reasonably determined by the Company), or any Person who, to the knowledge of the Investor, is an Affiliate of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Affiliate</U>&#148; means, as to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is
under common control with, such Person; <U>provided</U>, that (i)&nbsp;the Company and the Company&#146;s Subsidiaries shall not be considered Affiliates of the Investor or any of the Investor&#146;s Affiliates and (ii)&nbsp;for purposes of the
definitions of &#147;beneficially own&#148;, &#147;beneficial ownership of&#148;, &#147;beneficially owning&#148;, &#147;Bain Group&#148; and &#147;Standstill Period&#148; and <U>Section</U><U></U><U>&nbsp;4.06</U>,
<U>Section</U><U></U><U>&nbsp;5.02</U>, <U>Section</U><U></U><U>&nbsp;5.07</U> and <U>Section</U><U></U><U>&nbsp;5.11</U>, neither any Bain Excluded Entity, nor Bain Capital Investors, LLC, nor any of their respective Affiliates solely to the extent
that any such Person has not received any Confidential Information from any Investor and is not acting at the direction of the Investor or any of its Affiliates that have received Confidential Information, shall be deemed an Affiliate of the
Investor and its other Affiliates; provided that any such Person shall not be deemed to have received Confidential Information merely because any investment professional of the Bain Group is a director or manager of such Person and is not acting at
the direction of the Investor or any of its Affiliates who have received any Confidential Information. For this purpose, &#147;<U>control</U>&#148; (including, with its correlative meanings, &#147;<U>controlled by</U>&#148; and &#147;<U>under common
control with</U>&#148;) shall mean the possession, directly or indirectly, of the power to direct or cause the direction of management or policies of a Person, whether through the ownership of securities or partnership or other ownership interests,
by contract or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>as converted basis</U>&#148; means (i)&nbsp;with respect to the outstanding shares of Company Common
Stock as of any date, all outstanding shares of Company Common Stock calculated on a basis in which all shares of Company Common Stock issuable upon conversion of the outstanding shares of Series B Preferred Stock (at the applicable Conversion Price
in effect on such date as set forth in the Statement With Respect to Shares and without regard to any restrictions on conversion set forth therein) are assumed to be outstanding as of such date and (ii)&nbsp;with respect to any outstanding shares of
Series B Preferred Stock as of any date, the number of shares of Company Common Stock issuable upon conversion of such shares of Series B Preferred Stock on such date (at the applicable Conversion Price in effect on such date as set forth in the
Statement With Respect to Shares and without regard to any restrictions on conversion set forth therein). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Back Leverage</U>&#148; means any (i)<I>&nbsp;bona fide</I> loan or lending
transaction entered into by the Investor (or, after the Restricted Period, a Permitted Transferee thereof) to (a)&nbsp;finance a portion of its purchase of the Series B Preferred Stock, (b)&nbsp;finance a return of capital with respect to its
investment in the Series B Preferred Stock or the Company Common Stock issued upon conversion thereof, or (c)&nbsp;refinance or replace any indebtedness described in this clause (i), and (ii)&nbsp;granting of Liens by the Investor to secure payment
of such indebtedness and related obligations, including on the Series B Preferred Stock and any shares of Company Common Stock held by the Investor Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Affiliate</U>&#148; means any Affiliate of Bain Capital Investors, LLC or Bain Capital Private Equity, LP that serves as general
partner of, or manages or advises, any investment fund affiliated with Bain Capital Investors, LLC that has a direct or indirect investment in the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Excluded Entity</U>&#148; means (i)&nbsp;any leveraged finance investment fund or any other investment fund associated or
affiliated with Bain Capital Investors, LLC, the primary purpose of which is to invest in loans or debt securities, or (ii)&nbsp;any hedge fund associated or affiliated with Bain Capital Investors, LLC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Bain Group</U>&#148; means the Investor, together with its Affiliates, including Bain Affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>beneficially own</U>&#148;, &#147;<U>beneficial ownership of</U>&#148;, or &#147;<U>beneficially owning</U>&#148; any securities
shall have the meaning set forth in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the rules and regulations under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Board</U>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means any day except a Saturday, a Sunday or other day on which banks in the City of New York are authorized
or required by Law to be closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Code</U>&#148; means the United States Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Benefit Plan</U>&#148; means each &#147;employee pension benefit plan&#148; (as defined in Section&nbsp;3(2) of ERISA), each
&#147;employee welfare benefit plan&#148; (as defined in Section&nbsp;3(1) of ERISA) (in each case, whether or not such plan is subject to ERISA) and each other plan, policy, agreement or arrangement (whether written or oral) relating to stock
options, stock purchases, stock awards, deferred compensation, bonus, severance, retention, employment, change of control, fringe benefits, supplemental benefits or other employee benefits, in each case, sponsored, maintained or contributed to, or
required to be sponsored, maintained or contributed to, by the Company or its Subsidiaries, for the benefit of current or former employees, officers, directors or consultants of the Company or its Subsidiaries, or with respect to which the Company
or any of its Subsidiaries has any liability, other than any Multiemployer Plan and other than any such benefit, plan, policy, agreement or arrangement if and to the extent required to be provided, maintained or contributed to under applicable Law.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Charter Documents</U>&#148; means the Company&#146;s articles of
incorporation and bylaws, each as amended, restated, supplemented or otherwise modified to the date of the Original Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Common Stock</U>&#148; means the common stock, having no par value per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company COVID Action</U>&#148; means any reasonable action taken or omitted to be taken after the date of the Original Investment
Agreement that the Company reasonably determines to be necessary or prudent for the Company or its Subsidiaries to take in connection with or in response to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the establishment of any policy,
procedure or protocol, in each case in connection with or in response to: (i)&nbsp;events surrounding any pandemic or public health emergency caused by <FONT STYLE="white-space:nowrap">COVID-19;</FONT> (ii)&nbsp;reinitiating operation of all or a
portion of the Company&#146;s and its Subsidiaries&#146; respective businesses; (iii)&nbsp;mitigating the effects of such events, pandemic or public health emergency on the business of one or more of the Company and its Subsidiaries; or
(iv)&nbsp;protecting the health and safety of customers, employees and other business relationships and ensuring compliance with any legal requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company RSU</U>&#148; means a restricted stock unit covering shares of Company Common Stock including any restricted stock units
subject to performance vesting goals or metrics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Company Stockholder Approval</U>&#148; has the meaning given the term
&#147;Parent Stockholder Approval&#148; in the Target Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Competitor</U>&#148; means any of the Persons listed on
<U>Section</U><U></U><U>&nbsp;1.01(a)</U> of the Disclosure Schedules as a &#147;Competitor&#148; and any Person who, to the knowledge of the Investor, is an Affiliate or successor thereof, including any entity that acquires a controlling interest
in a Competitor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Confidentiality Agreement</U>&#148; means the Confidentiality and
<FONT STYLE="white-space:nowrap">Non-Disclosure</FONT> Agreement by and between the Company, on behalf of itself and its Affiliates, and Bain Capital Private Equity, LP, on behalf of itself and its Affiliates, dated January&nbsp;14, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Conversion Price</U>&#148; has the meaning set forth in the Statement With Respect to Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Convertible Notes</U>&#148; means, collectively, (i)&nbsp;Finisar Convertible Notes and (ii)&nbsp;the Senior Convertible Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</U>&#148; means any legally binding quarantine, &#147;shelter in
place,&#148; &#147;stay at home,&#148; workforce reduction, social distancing, shut down, closure, sequester or any other law, order or directive by any Governmental Entity in connection with or in response to
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the Coronavirus Aid, Relief, and Economic Security (CARES)&nbsp;Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Current Percentage</U>&#148; means the portion, expressed as a percentage, of the outstanding shares of Company Common Stock held by
the Investor immediately as of the Initial Closing (if the Subsequent Closing has not occurred) or the Subsequent Closing (if the Subsequent Closing has occurred), as applicable, in each case assuming the conversion of the Series B Preferred Stock.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Environmental Law</U>&#148; means any Law in effect prior to or as of the date of
the Original Investment Agreement relating to pollution or protection of the environment (including ambient air, soil, surface water or groundwater, or subsurface strata), natural resources, endangered or threatened species, human health or safety
(as it relates to exposure to Hazardous Materials), or that prohibits, regulates or controls any Hazardous Material or any products containing any Hazardous Material, including the Comprehensive Environmental Response, Compensation and Liability
Act, 42 U.S.C. &#167;&nbsp;9601 et seq., the Resource Conservation and Recovery Act, 42 U.S.C. &#167;&nbsp;6901 et seq., the Toxic Substances Control Act, 15 U.S.C. &#167;&nbsp;2601 et seq., the Federal Water Pollution Control Act, 33 U.S.C.
&#167;&nbsp;1251 et seq., the Clean Air Act, 42 U.S.C. &#167;&nbsp;7401 et seq., the Federal Insecticide, Fungicide and Rodenticide Act, 7 U.S.C. &#167;&nbsp;121 et seq., the Safe Drinking Water Act, 42 U.S.C. &#167;&nbsp;300f et seq., the Oil
Pollution Act of 1990, the European Union (&#147;<U>EU</U>&#148;) Directive 2012/19/EU on waste electrical and electronic equipment, the EU Directive 2011/65/EU on the restriction on the use of certain hazardous substances, the Administrative
Measures on the Control of Pollution Caused by Electronic Information Products, and the European Commission Regulation 1907/2006, and analogous foreign, provincial, state and local Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA</U>&#148; means the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>ERISA Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is, or was
at the relevant time, a member of a group described in Section&nbsp;414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes or included the first entity, trade or business, or that is, or was at the relevant
time, a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fall-Away of Investor Board Rights</U>&#148; means the first day on which the 25% Beneficial Ownership Requirement is not
satisfied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finisar</U>&#148; means Finisar Corporation, a Delaware corporation and subsidiary of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Finisar Convertible Notes</U>&#148; means the 0.50% Convertible Senior Notes due 2036 of Finisar. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fraud</U>&#148; means common law fraud under the laws of the State of Delaware; <U>provided</U>, however, that the term
&#147;Fraud&#148; does not include the doctrine of constructive or equitable fraud. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fundamental Change</U>&#148; shall have the
meaning set forth in the Statement With Respect to Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Fundamental Representations</U>&#148; means the representations and warranties set
forth in <U>Section</U><U></U><U>&nbsp;3.01(a)</U> and <U>(c)</U> (<I>Organization; Standing</I>) (other than the second sentence of <U>Section</U><U></U><U>&nbsp;3.01(a)</U>), <U>Section</U><U></U><U>&nbsp;3.02</U> (<I>Capitalization</I>) (other
than <U>Section</U><U></U><U>&nbsp;3.02(a)</U>), <U>Section</U><U></U><U>&nbsp;3.03(a)</U> (<I>Authority; <FONT STYLE="white-space:nowrap">Non-contravention</FONT></I>), <U>Section</U><U></U><U>&nbsp;3.16</U> (<I>No Rights Agreement; Anti-Takeover
Provisions</I>), <U>Section</U><U></U><U>&nbsp;3.18</U> (<I>Brokers and Other Advisors</I>) and <U>Section</U><U></U><U>&nbsp;3.21</U> (<I>Status of Securities</I>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>GAAP</U>&#148; means generally accepted accounting principles in the United States, consistently applied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Governmental Entity</U>&#148; means any United States, state of the United States or local, foreign or multi-national governmental or
regulatory agency, commission, court or authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Hazardous Materials</U>&#148; means any substance, waste, liquid or gaseous
or solid matter for which liability or standards of conduct may be imposed, or which is or is deemed to be hazardous, hazardous waste, solid or liquid waste, toxic, a pollutant, a deleterious substance, a contaminant or a source of pollution or
contamination, in each case regulated by, or otherwise subject to, any Environmental Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>HSR Act</U>&#148; means the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Intellectual Property</U>&#148; means any of the following, as they exist anywhere in the world, whether registered or unregistered:
(i)&nbsp;patents, patentable inventions and other patent rights (including any divisions, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, reexaminations and
interpretations thereof); (ii)&nbsp;trademarks, service marks, trade dress, trade names, taglines, brand names, logos and corporate names and all goodwill related thereto; (iii)&nbsp;copyrights, mask works and designs; (iv)&nbsp;trade secrets, <FONT
STYLE="white-space:nowrap">know-how,</FONT> inventions, processes, procedures, databases, confidential business information and other proprietary information and rights; (v)&nbsp;proprietary rights in computer software programs, including all source
code, object code, specifications, designs and documentation related thereto; and (vi)&nbsp;domain names and internet addresses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Director</U>&#148; means a member of the Board who was elected to the Board as an Investor Director Designee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Director Designee</U>&#148; means an individual designated in writing by the Investor and reasonably acceptable to the Board
to be nominated for election to the Board pursuant to <U>Section</U><U></U><U>&nbsp;5.11(a)</U> or <U>5.11(c)</U>, as applicable; <U>provided</U> that Stephen Pagliuca shall be deemed to be reasonably acceptable to the Board to serve as an Investor
Director, and each of Ken Hanau and Joseph Robbins shall be deemed to be reasonably acceptable to the Board to serve as an Investor Observer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Material Adverse Effect</U>&#148; means any effect, change, event or occurrence that would reasonably be expected to
prevent, impair or materially delay (i)&nbsp;the consummation by the Investor of any of the Transactions on a timely basis or (ii)&nbsp;the compliance by the Investor with its obligations under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Investor Parties</U>&#148; means the Investor and each Affiliate of the Investor to
whom shares of Series B Preferred Stock or Company Common Stock are transferred pursuant to <U>Section</U><U></U><U>&nbsp;5.08(b)(i)</U> or<U> Section</U><U></U><U>&nbsp;5.08(b)(viii)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>IRS</U>&#148; means the United States Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Knowledge</U>&#148; means with respect to Company and its Subsidiaries, the actual knowledge of the individuals listed in
<U>Section</U><U></U><U>&nbsp;1.01(b)</U> of the Disclosure Schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Liens</U>&#148; means liens, encumbrances, mortgages,
charges, claims, restrictions, pledges, security interests, title defects, easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> covenants, encroachments or other adverse claims of any kind with
respect to a property or asset. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Management Services Agreement</U>&#148; means that certain Management Services Agreement, to be
dated as of the Initial Closing Date, providing for expense reimbursement and indemnification for any Investor personnel that provide services to the Company to the extent the Company requests such services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Material Adverse Effect</U>&#148; means an event, state of facts, circumstance, change, effect, development, occurrence or
combination of the foregoing (an &#147;<U>Effect</U>&#148;) that individually or in the aggregate has had, or would reasonably be expected to have, a material adverse effect on the business, financial condition or results of operations of the
Company and its Subsidiaries, taken as a whole; <U>provided</U> that the term Material Adverse Effect will not include any Effect to the extent resulting from or arising out of: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes after the date of the Original Investment Agreement in general business, economic or market conditions
in the United States or elsewhere in the world (including changes generally in prevailing interest rates, credit availability and liquidity, currency exchange rates and price levels or trading volumes in the United States or foreign securities or
credit markets), changes in political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, or any outbreak or escalation of
hostilities, declared or undeclared acts of war or terrorism, in each case generally affecting the industries in which the Company and its Subsidiaries operate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any changes or developments generally in the industries in which the Company or any of its Subsidiaries are
expected to conduct their business from and after the closing under the Target Merger Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the announcement or the existence of, compliance with or performance under, this Agreement, the Target Merger
Agreement or the transactions contemplated hereby or thereby (<U>provided</U>, <U>however</U>, that the exceptions in this clause (C)&nbsp;shall </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
not apply to any representation or warranty contained in <U>Section</U><U></U><U>&nbsp;3.03(a)</U> or <U>Section</U><U></U><U>&nbsp;3.03(c)(1)</U> to the extent that the purpose of such
representation or warranty is to address the consequences resulting from the execution and delivery of this Agreement or the performance of obligations or satisfaction of conditions under this Agreement); </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any taking of any action or failure to take an action at the request of the Target or its Affiliates or which
is required by the terms of the Target Merger Agreement, or at the request of Investor or its Affiliates or which is required by the terms of this Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">changes in applicable Law, GAAP or accounting standards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">floods, hurricanes, tornados, earthquakes, fires or other natural disasters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(G)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">national or international disasters, acts of God, sabotage, calamities, emergencies, or any escalation or
worsening thereof, whether or not occurring or commenced before the date of the Original Investment Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(H)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> and any
political or social conditions, including civil unrest, protests and public demonstrations or any other law, directive, pronouncement or guideline issued by a Governmental Entity, the Centers for Disease Control and Prevention or the World Health
Organization, &#147;sheltering in place,&#148; curfews or other restrictions that relate to, or arise out of, an epidemic, pandemic or disease outbreak (including <FONT STYLE="white-space:nowrap">COVID-19)</FONT> or any change in such law (including
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures), directive, pronouncement or guideline or interpretation thereof, or the action of any third party arising out of or relating to any of the foregoing, in each case, following the date of the
Original Investment Agreement or any material worsening of such conditions threatened or existing as of the date of the Original Investment Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(I)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any actions arising from allegations of breach of fiduciary duty or otherwise relating to this Agreement, the
Target Merger Agreement or the transactions contemplated hereby or thereby; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(J)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">failure by the Company to meet any financial projections or forecasts or estimates of revenues, earnings or
other financial metrics for any period (<U>provided</U> that the exception in this clause&nbsp;(J) shall not prevent or otherwise affect a determination that any event, change, effect, development or occurrence underlying such failure has resulted
in, or contributed to, a Material Adverse Effect); <U>except</U>, in each case with respect to clauses&nbsp;(A), (B), (E), (F), (G)&nbsp;and (H), to the extent disproportionately affecting the Company and its Subsidiaries, taken as a whole, relative
to other similarly situated companies in the industries in which the Company and its Subsidiaries are expected to operate from and after the closing under the Target Merger Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Maximum Percentage</U>&#148; means the Current Percentage <I>plus</I> 3%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Multiemployer Plan</U>&#148; means any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;4001(a)(3) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Multiple Employer Plan</U>&#148; means a plan that has two or more contributing sponsors at least two of whom are not under common
control, within the meaning of Section&nbsp;4063 of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>NASDAQ</U>&#148; means the NASDAQ Global Select Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Ordinary Course of Business</U>&#148; shall describe any action taken by the Company or any of its Subsidiaries if such action is
(i)&nbsp;consistent with such Person&#146;s past practices and/or is taken in the ordinary course of such Person&#146;s normal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations or (ii)&nbsp;a
Company COVID Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Parity Stock</U>&#148; means any class or series of capital stock that ranks on a parity basis with any
series of the Series B Preferred Stock as to dividend rights, rights of redemption and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Company. &#147;<U>Parity
Stock</U>&#148; shall include any rights, options or warrants exercisable or exchangeable for or convertible into Parity Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>PBCL</U>&#148; means the Pennsylvania Business Corporation Law of 1988, as amended, restated, supplemented or otherwise modified from
time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Issuances</U>&#148; means issuances of Parity Stock: (i)&nbsp;in connection with the closing of the
Target Acquisition if the Company shall have made the Upsize Offer contemplated by <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U> and the Investor shall not have made the election contemplated by <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U> of this
Agreement to purchase the full dollar amount of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock offered in the Upsize Offer, provided that such issuance(s) does not exceed (A)&nbsp;the dollar amount of the Upsize Offer, less
(B)&nbsp;the dollar amount, if any, as to which such election has been made to, and the holder(s) of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares do, purchase pursuant to such <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>,
(ii) in the form of a customary convertible preferred security that does not provide for a premium upon liquidation and that is issued on arms-length terms, provided that the amount of Parity Stock under this clause (<U>ii</U>)&nbsp;outstanding at
any time does not exceed $500&nbsp;million, and (iii)&nbsp;in the form of a customary public mandatory convertible preferred, provided that the amount of Parity Stock under this clause (<U>iii</U>)&nbsp;outstanding at any time does not exceed
$1.0&nbsp;billion (including the Company Mandatory Convertible Preferred Stock). Prior to making any Permitted Issuance pursuant to clause (<U>ii</U>)&nbsp;above, the Company shall offer the Investor the opportunity to purchase such securities. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Liens</U>&#148; means (i)&nbsp;any Lien for Taxes not yet due or, if due,
not yet delinquent or which are being contested in good faith by appropriate proceedings and for which adequate reserves have been made, (ii)&nbsp;vendors&#146;, mechanics&#146;, materialmens&#146;, carriers&#146;, workers&#146;, landlords&#146;,
repairmen&#146;s, warehousemen&#146;s, construction and other similar Liens arising or incurred in the Ordinary Course of Business or with respect to liabilities that are not yet due and payable or, if due, are not delinquent or are being contested
in good faith by appropriate proceedings, (iii)&nbsp;Liens imposed or promulgated by applicable Law or any Governmental Entity with respect to Real Property, including zoning, building or similar restrictions, (iv)&nbsp;pledges or deposits in
connection with workers&#146; compensation, unemployment insurance, and other social security legislation, (v)&nbsp;Liens relating to intercompany borrowings among the Investor and its wholly owned (direct or indirect) Subsidiaries or any other
existing indebtedness of the Investor or its Subsidiaries, (vi)&nbsp;Real Property easements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> leases, encroachments, restrictions, rights, servitudes,
encumbrances, conditions or imperfections of title or other matters of a similar nature and other similar Liens, which, individually and in the aggregate, do not materially impair the present use of the Real Property or otherwise materially impair
the present business operations at the Real Property, (vii)&nbsp;purchase money Liens or Liens under capital lease arrangements, (viii)&nbsp;licenses of Intellectual Property, (ix)&nbsp;Liens disclosed in the Investor financial statements or in the
Company financial statements, as applicable, or (x)&nbsp;other <FONT STYLE="white-space:nowrap">non-monetary</FONT> Liens that do not, individually or in the aggregate, materially interfere with the present use, or materially detract from the value
of, the property encumbered thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Permitted Transferee</U>&#148; means, with respect to any Person, (i)&nbsp;any Affiliate of
such Person, so long as it remains such, and that is a U.S. Person or (ii)&nbsp;with respect to any Person that is an investment fund, vehicle or similar entity, any other investment fund, vehicle or similar entity that is controlled by or under
common control with such transferor and that is a U.S. Person; <U>provided</U> that portfolio companies of the Investor or any of its Affiliates shall not be Permitted Transferees of any Investor Party hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means an individual, corporation, limited liability company, partnership, joint venture, association, trust,
unincorporated organization or any other entity, including a Governmental Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Personal Data</U>&#148; shall mean any
information about an identifiable natural person that is defined as &#147;personal data,&#148; &#147;personally identifiable information,&#148; &#147;biometric information,&#148; &#147;nonpublic personal information,&#148; &#147;protected health
information,&#148; &#147;individually identifiable health information,&#148; &#147;protected health information&#148; or &#147;personal information&#148; under any applicable Law relating to privacy, data protection, or information security. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Stock</U>&#148; means the preferred stock, having no par value per share, of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Real Property</U>&#148; means any lands, buildings, structures and other
improvements, together with all fixtures attached or appurtenant to the foregoing, and all easements, covenants, hereditaments and appurtenances that benefit the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Registration Rights Agreement</U>&#148; means that certain Registration Rights Agreement to be entered into by the Company and the
Investor as of the Initial Closing in the form attached hereto as <U>Exhibit C</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Remedies Exceptions</U>&#148; means the
rules governing the availability of specific performance, injunctive relief or other equitable remedies and general principles of equity, regardless of whether considered in a proceeding in equity or at law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Representatives</U>&#148; means, with respect to any Person, its officers, directors, principals, partners, managers, members,
employees, consultants, agents, financial advisors, investment bankers, attorneys, accountants, other advisors and other representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>SEC</U>&#148; means the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Senior Convertible Notes</U>&#148; means the Company&#146;s 0.25% Convertible Senior Notes due 2022 with U.S. Bank National
Association, as trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Standstill Period</U>&#148; means the period from and after the Initial Closing Date and ending on the
six (6)&nbsp;month anniversary of the date on which no Investor Director is serving on the Board (and as of such time the Investor no longer has board nomination rights pursuant to this Agreement to designate an Investor Director Designee or
Investor Observer or otherwise has irrevocably waived in a writing delivered to the Company its rights under <U>Section</U><U></U><U>&nbsp;5.11</U> to nominate an Investor Director Designee and designate an Investor Observer); <U>provided</U> that
the Standstill Period shall (a)&nbsp;in the case of clauses (i)&nbsp;and (iii) below immediately terminate and expire (and the restrictions of <U>Section</U><U></U><U>&nbsp;5.07</U> shall cease to apply and shall be of no further force and effect)
and in the case of clause (ii)&nbsp;below shall be suspended during the pendency of such tender or exchange offer, at the earliest of: (i)&nbsp;the Company entering into a definitive written agreement to consummate a Fundamental Change,
(ii)&nbsp;the commencement of a tender offer or exchange offer for the Company Common Stock (other than by the Company or its Subsidiaries) recommended by or approved by the Board or (iii)&nbsp;the failure of the stockholders of the Company, upon a
vote duly taken thereupon, to elect an Investor Director Designee nominated in accordance with <U>Section</U><U></U><U>&nbsp;5.11</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Statement With Respect to Shares</U>&#148; means the definitive Statement With Respect to Shares to be filed with the Pennsylvania
Department of State in the form agreed as of the date hereof by the Company and the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Subsidiary</U>&#148;, when used
with respect to any Person, means, any corporation, partnership, association, trust or other form of legal entity of which (i)&nbsp;fifty percent (50%) or more of the voting power of the outstanding voting securities are directly or indirectly owned
by such person or (ii)&nbsp;such person or any Subsidiary of such person is a general partner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; means any and all U.S. federal, state,
local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxes, imposts, levies, duties, fees or other similar governmental assessments, including all net income, gross receipts, capital, sales, use, ad valorem, value added, transfer, franchise,
profits, inventory, capital stock, license, withholding, payroll, employment, social security, unemployment, excise, severance, stamp, occupation, property and estimated taxes, escheat, customs duties and other taxes of any kind whatsoever,
including any and all interest, penalties, additions to tax or additional amounts imposed by any Governmental Entity in connection with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Tax Return</U>&#148; means any report, return, refund, claim, election, statement, estimate, disclosure, document, declaration or
information report or return filed or required to be filed with or supplied or required to be supplied to a Taxing Authority (including any amendments thereto and including any attachment, schedule or statement thereto). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Taxing Authority</U>&#148; means any Governmental Entity or any subdivision, agency, commission or entity thereof or any
quasi-governmental or private body having jurisdiction over the assessment, determination, collection or imposition of any Tax (including the IRS). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Top Company Customer</U>&#148; means one of the 10 largest customers and resellers of the Company and its Subsidiaries by revenue for
the fiscal year ended June&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transaction Documents</U>&#148; means this Agreement, the Equity Commitment Letter,
the Registration Rights Agreement, the Statement With Respect to Shares, the Issuer Agreement, the VCOC Letters, the Management Services Agreement and the Closing Certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transactions</U>&#148; means the transactions expressly contemplated by this Agreement and the other Transaction Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Transfer</U>&#148; by any Person means, directly or knowingly indirectly, to sell, transfer, assign, pledge, encumber, hypothecate or
otherwise dispose of or transfer (by the operation of law or otherwise), or to enter into any contract, option or other arrangement, agreement or understanding with respect to the sale, transfer, assignment, pledge, encumbrance, hypothecation or
other disposition or transfer (by the operation of law or otherwise), of any interest in any equity securities beneficially owned by such Person; <U>provided</U>, <U>however</U>, that, notwithstanding anything to the contrary in this Agreement, a
Transfer shall not include (i)&nbsp;the conversion of one or more shares of Series B Preferred Stock into shares of Company Common Stock pursuant to the Statement With Respect to Shares, (ii)&nbsp;the redemption or other acquisition of Company
Common Stock or Series B Preferred Stock by the Company or (iii)&nbsp;the transfer (other than any transfer by the Investor or an Affiliate of the Investor immediately following which such subject equity securities are beneficially owned by any
Person other than a member of the Bain Group) of any limited partnership interests or other equity interests in the Investor (or any direct or indirect parent entity of the Investor) (<U>provided</U> that if any transferor or transferee referred to
in this clause&nbsp;(iii) ceases to be controlled (directly or indirectly) by the Person (directly or indirectly) controlling such Person immediately prior to such transfer, such event shall be deemed to constitute a &#147;Transfer&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S. Person</U>&#148; means any Person that is: (i)&nbsp;a U.S. citizen or lawful
permanent resident; or (ii)&nbsp;organized under the laws of the United States or any jurisdiction within the United States or any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> branch or affiliate thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<U>Warranties</U>&#148; means all obligations to service, repair (including to provide fixes to program errors), replace, credit, refund
and other obligations based upon or arising out of express or implied warranties made or deemed made in connection with the provision, license or sale of products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to the terms defined in <U>Section</U><U></U><U>&nbsp;1.01(a)</U>, the following terms have the meanings assigned thereto in
the Sections set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Acquisition Debt Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.03(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bankruptcy and Equity Exceptions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.03(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Certificate</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;6.03(e)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.03(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Capitalization Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Data Processors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.05(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Mandatory Convertible Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Option</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Owned IP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.23(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company SEC Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.05(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Confidential Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Covered Persons</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Disclosure Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Article III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DOJ</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Commitment Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Financing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Equity Provider</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;4.04(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FTC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">HSR Forms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial HSR Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial HSR Form</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial Investment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial Investment Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor First Extended End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Term</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Location</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor Observer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor Original End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor Second Extended End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investor Third Extended End Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.14</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">IT Systems</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.23(g)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Laws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.10(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Leased Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;8.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Owned Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Original Equity Commitment Letter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Original Investment Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Per Share Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Permitted Purpose</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.05</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Real Property Leases</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Restricted Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.08(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series B Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Series One Preferred Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.02(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Specified Guidelines</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.11(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sublease</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;3.15(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.02(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent HSR Form</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;5.02(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Investment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Investment Provisions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;7.01</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Investment Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Target</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Target Acquisition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Target Merger Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Upsize Offer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Upsize Offer Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Upsize Subsequent Investment Purchase Price</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;2.01(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">VCOC Letters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;5.18</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Purchase and Sale </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01 <U>Purchase and Sale</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Initial Investment</U>. On the terms of this Agreement, at the Initial Closing, the Investor will and hereby does purchase and acquire,
and the Company will and hereby does issue, sell and deliver to the Investor, 75,000 shares of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock (such shares, the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Shares</U>&#148;) for a purchase price per share equal to $10,000.00 (the &#147;<U>Per Share Price</U>&#148;) for an aggregate purchase price of $750,000,000.00 (the &#147;<U>Initial Investment Purchase Price</U>&#148;) (such transaction,
the &#147;<U>Initial Investment</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Subsequent Investment</U>. Subject to <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, on
the terms of this Agreement and the Statement With Respect to Shares and subject to the satisfaction (or, to the extent permitted by applicable Law, waiver by the party entitled to the benefit thereof) of the conditions set forth in <U>Article
VI</U>, at the Subsequent Closing the holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock shall purchase and acquire from the Company an aggregate number of 105,000 shares of Series
<FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock (such shares, the &#147;<U>Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>&#148;), and the Company shall issue, sell and deliver to such holders of the
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Stock, the Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares for a purchase price per share equal to the Per Share Price for an aggregate purchase price of
$1,050,000,000.00 (the &#147;<U>Subsequent Investment Purchase Price</U>&#148;) (such transactions, the &#147;<U>Subsequent Investment</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Following the execution of this Agreement and prior to the thirty <FONT STYLE="white-space:nowrap">(30)-day</FONT>
anniversary thereof, the Company may offer (such offer, the &#147;<U>Upsize Offer</U>&#148;, and the date of such offer, the &#147;<U>Upsize Offer Date</U>&#148;) to the Investor an option to purchase up to an additional 35,000 shares of Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock, at a purchase price per share equal to the Per Share Price, exercisable in the sole discretion of the Investor by delivering an irrevocable written notice to the Company to such effect no later
than the sixty <FONT STYLE="white-space:nowrap">(60)-day</FONT> anniversary of the Upsize Offer Date and specifying the number of offered shares of Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock as to which the Investor is making
such irrevocable election (any such shares elected to be purchased in such notice, the &#147;<U>Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>,&#148; and together with the Committed Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, the &#147;<U>Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares</U>&#148;; the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares together with the Series <FONT
STYLE="white-space:nowrap">B-1</FONT> Preferred Shares, the &#147;<U>Shares</U>&#148;; and the aggregate purchase price for the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, the &#147;<U>Upsize Subsequent Investment
Purchase Price</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.02 <U>Initial and Subsequent Closing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Initial Closing</U>. The closing of the Initial Investment (the &#147;<U>Initial Closing</U>&#148;) shall take place remotely via the
electronic exchange of documents and signatures at 10:00 a.m. Eastern Time on March&nbsp;31, 2021, unless otherwise agreed to in writing by the Company and the Investor. The date on which the Initial Investment is to occur is herein referred to as
the &#147;<U>Initial Closing Date</U>.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) At the Initial Closing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company shall deliver to the Investor (1)&nbsp;the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Shares free and clear of all Liens, except restrictions imposed by the articles of incorporation and bylaws of the Company, the Securities Act or any applicable state or foreign securities Laws, and Liens arising due to actions by or on
behalf of the Investor, including Liens contemplated by the Issuer Agreement, if any, or <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement, and (2)&nbsp;the Registration Rights Agreement, duly executed by the Company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will deliver to the Investor a customary legal opinion of the General Counsel of the Company or
outside corporate counsel to the Company as to the due authorization, valid issuance and <FONT STYLE="white-space:nowrap">non-assessability</FONT> of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Investor shall (1)&nbsp;pay the Initial Investment Purchase Price to the Company, by wire transfer in
immediately available U.S. federal funds, to the account designated by the Company in writing, and (2)&nbsp;deliver to the Company the Registration Rights Agreement, duly executed by the Investor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in each case if requested by the Investor, the Company shall have executed and delivered to the Investor
(1)&nbsp;the Issuer Agreement and (2)&nbsp;a VCOC Letter in a form reasonably acceptable to the Company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(E)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Investor and the Company shall have received the Management Services Agreement duly executed by the other
party; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(F)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will file the Statement With Respect to Shares with the Pennsylvania Department of State.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Subsequent Closing</U>. Subject to the satisfaction or, to the extent permitted by applicable law, waiver by the
party entitled to the benefit thereof of all of the conditions to the Subsequent Closing set forth in <U>Article VI</U>, the closing of the sale of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares contemplated hereby (the
&#147;<U>Subsequent Closing</U>&#148;) shall take place, immediately prior to the consummation of the Target Acquisition, remotely via the electronic exchange of documents and signatures, or such other time and place as the Company and the Investor
may agree in writing. The date on which the Subsequent Closing is to occur is herein referred to as the &#147;<U>Subsequent Closing Date</U>.&#148; The Company shall provide the Investor with at least five (5)&nbsp;Business Days prior written notice
of the expected closing date of the Target Acquisition. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) At the Subsequent Closing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">on the terms of this Agreement and the Statement With Respect to Shares, the Company shall deliver to the
holders of the Series </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares, the Committed Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares and, if an election has been made by the Investor
pursuant to <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares free and clear of all Liens, except restrictions imposed by the articles of incorporation and bylaws of the
Company, the Securities Act or any applicable state or foreign securities Laws, and Liens arising due to actions by or on behalf of the Investor, including Liens contemplated by the Issuer Agreement, if any, or <U>Section</U><U></U><U>&nbsp;5.08</U>
of this Agreement; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company will deliver to the Investor a customary legal opinion of the General Counsel of the Company or
outside corporate counsel to the Company as to the due authorization, valid issuance and <FONT STYLE="white-space:nowrap">non-assessability</FONT> of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="18%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares shall pay the Subsequent
Investment Purchase Price and, if an election has been made by the Investor pursuant to <U>Section</U><U></U><U>&nbsp;2.01(b)(i)</U>, the Upsize Subsequent Investment Purchase Price to the Company, by wire transfer in immediately available U.S.
federal funds, to the account designated by the Company in writing. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties of the Company </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Except (x)&nbsp;as disclosed in the Company SEC Documents filed with or furnished to the SEC prior to the date of the Original Investment
Agreement and after January&nbsp;1, 2019 (excluding any risk factor or forward-looking disclosures contained in such documents under the heading &#147;Risk Factors,&#148; and any disclosure of risks included in any &#147;forward-looking
statements&#148; disclaimer, or other statements that are similarly nonspecific or predictive, cautionary, or forward-looking) or (y)&nbsp;as set forth in the confidential disclosure schedules delivered by the Company to the Investor prior to the
execution of this Agreement (the &#147;<U>Disclosure Schedules</U>&#148;) (each section of which qualifies the correspondingly numbered representation, warranty or covenant if specified therein and such other representations, warranties or covenants
where its relevance as an exception to (or disclosure for purposes of) such other representation, warranty or covenant is reasonably apparent on the face of such disclosure), Company and its Subsidiaries represent and warrant to the Investor as
follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01 <U>Organization</U><U>; Standing; Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company is a corporation duly incorporated and presently subsisting under the Laws of the Commonwealth of Pennsylvania. The
Company&nbsp;has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company&#146;s Subsidiaries is a legal entity duly organized, validly
existing and in good standing under the Laws of its respective jurisdiction of organization (to the extent the &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States) and has all requisite corporate
or similar power and authority to own, lease and operate its properties and assets and to carry on its business as presently conducted, except where the failure to have such power or authority or be in good standing would not reasonably be expected
to have a Material Adverse Effect. The Company is duly qualified or licensed and has all necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property owned, leased or operated by it or the
nature of the business conducted by it makes such approvals, qualification or licensing necessary (to the extent the &#147;qualification to do business&#148; or &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside
the United States), except where the failure to be so duly approved, qualified or licensed and in good standing would not reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has made available to the Investor, prior to the date of the Original Investment Agreement, a true and complete copy of the
Company Charter Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02 <U>Capitalization</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The authorized capital stock of Company consists of 300,000,000 shares of Company Common Stock, and 5,000,000 shares of Preferred Stock,
of which, immediately prior to the filing of the Statement With Respect to Shares, 2,300,000 shares are designated Series A Mandatory Convertible Preferred Stock (&#147;<U>Company Mandatory Convertible Preferred Stock</U>&#148;) and 300,000 shares
are designated Series One Preferred Stock (the &#147;<U>Series One Preferred Stock</U>&#148;). As of February&nbsp;26, 2021 (the &#147;<U>Company Capitalization Date</U>&#148;), (i)&nbsp;104,828,047 shares of Company Common Stock were issued and
outstanding, (ii)&nbsp;13,484,634 shares of Company Common Stock were held in treasury, (iii)&nbsp;2,300,000 shares of Company Mandatory Convertible Preferred Stock were issued or outstanding and (iv)&nbsp;no shares of Series One Preferred Stock
were issued and outstanding. As of the Company Capitalization Date, 13,867,704 shares of Company Common Stock were reserved for issuance under Company equity plans, of which amount (A)&nbsp;2,714,466 shares of Company Common Stock are issuable upon
the exercise of options to purchase or acquire shares of Company Common Stock (each a &#147;<U>Company Option</U>&#148;), (B)&nbsp;3,095,514 shares of Company Common Stock are issuable upon the settlement of outstanding Company RSUs (with respect to
performance-based awards, assuming performance is achieved at &#147;target&#148;), and (C)&nbsp;518,309 shares of Company Common Stock are subject to performance share awards (assuming performance is achieved at &#147;target&#148;). As of the
Company Capitalization Date, (A)&nbsp;up to 8,914,798 shares of Company Common Stock may be issuable upon conversion of the then outstanding shares of Company Mandatory Convertible Preferred Stock, (B)&nbsp;up to 7,330,940 shares of Company Common
Stock may be issuable upon conversion of the Company&#146;s then outstanding Senior Convertible Notes and (C)&nbsp;up to 74,814 shares of Company Common Stock may be issuable upon conversion of the then outstanding Finisar Convertible Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for the Target Merger Agreement, as set forth in <U>Section</U><U></U><U>&nbsp;3.02(a)</U> or as set forth on
<U>Section</U><U></U><U>&nbsp;3.02</U> of the Disclosure Schedules (and other than shares of Company Common Stock issued since the Company Capitalization Date pursuant to the terms of outstanding Company stock awards or in respect of any outstanding
shares of Company Mandatory Convertible Preferred Stock or any Convertible Notes), as of the date of the Original Investment Agreement, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
there are no outstanding shares of capital stock or other equity interests in the Company or subscriptions, options, warrants, calls, convertible securities, exchangeable securities or other
similar rights, agreements or commitments to which the Company or any of its Subsidiaries is a party (i)&nbsp;obligating Company or any of its Subsidiaries to (A)&nbsp;issue, transfer, exchange, sell or register for sale any shares of capital stock
or other equity interests of the Company or any Subsidiary of Company or securities convertible into or exchangeable for such shares or equity interests, (B)&nbsp;grant, extend or enter into any such subscription, option, warrant, call, convertible
securities or other similar right, agreement or arrangement, (C)&nbsp;redeem or otherwise acquire any such shares of capital stock or other equity interests, (D)&nbsp;provide a material amount of funds to, or make any material investment (in the
form of a loan, capital contribution or otherwise) in, any Subsidiary, or (E)&nbsp;make any payment to any person the value of which is derived from or calculated based on the value of Company Common Stock or Preferred Stock, or (ii)&nbsp;granting
any preemptive or antidilutive or similar rights with respect to any security issued by the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.03 <U>Authority</U><U>; Noncontravention</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company has the requisite corporate power and authority to enter into this Agreement and the other Transaction Documents and, subject
to the receipt of the Company Stockholder Approval, to consummate the Transactions. The execution and delivery by the Company of this Agreement and the consummation of the Transactions have been duly and validly authorized by the Board, and except
for the Company Stockholder Approval no other corporate proceedings on the part of the Company or vote of the Company&#146;s securityholders are necessary to authorize the consummation of the Transactions. The Board has unanimously
(i)&nbsp;determined that this Agreement and the transactions contemplated hereby, including the purchase and sale of the Series B Preferred Stock hereunder, are in the best interests of the Company and its stockholders, (ii)&nbsp;approved the
execution, delivery and performance by the Company of this Agreement, and the consummation of the transactions contemplated hereby, including the purchase and sale of the Series B Preferred Stock hereunder, and (iii)&nbsp;resolved to recommend the
approval by the Company&#146;s stockholders of the Share Issuance (as defined in the Target Merger Agreement) and submit the Share Issuance to the stockholders of the Company for approval. This Agreement has been duly and validly executed and
delivered by the Company, and assuming this Agreement constitutes the legal, valid and binding agreement of the Investor, constitutes the legal, valid and binding agreement of Company, enforceable against the Company in accordance with its terms,
except as such enforcement may be subject to general principles of equity, whether considered in a proceeding at law or in equity (the &#147;<U>Bankruptcy and Equity Exceptions</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Other than in connection with or in compliance with (i)&nbsp;the laws of the State of Delaware and the laws of the Commonwealth of
Pennsylvania, (ii)&nbsp;the Exchange Act, and the rules promulgated thereunder, (iii)&nbsp;the Securities Act, and the rules promulgated thereunder, (iv)&nbsp;applicable state securities, takeover and &#147;blue sky&#148; Laws, (v)&nbsp;the rules
and regulations of NASDAQ, (vi)&nbsp;the HSR Act and the antitrust Laws and any Laws with respect to foreign investment set forth on <U>Section</U><U></U><U>&nbsp;3.03(b)</U> of the Disclosure Schedules and (vii)&nbsp;the Company Stockholder
Approval (collectively, the &#147;<U>Company Approvals</U>&#148;), no other consent of, or filing with, any Governmental Entity is necessary, under applicable Law, for the consummation by the Company of the Transactions, except for such consents or
filings as are not required to be obtained or made prior to consummation of the Transactions or that, if not obtained or made, would not materially impede or delay the consummation of the Transactions and which would not reasonably be expected to
have, individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The execution and delivery by the Company of this Agreement does not, and (assuming the
Company Approvals are obtained) the consummation of the Transactions and compliance with the provisions hereof will not (i)&nbsp;result in any loss, or suspension, limitation or impairment of any right of the Company or any of its Subsidiaries to
own or use any assets required for the conduct of their business or result in any violation of, or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation, first offer, first refusal,
modification or acceleration of any material obligation or to the loss of a benefit under any loan, guarantee of indebtedness or credit agreement, note, bond, mortgage, indenture, Real Property Lease, agreement, contract, instrument, permit,
concession, franchise, right or license binding upon the Company or any of its Subsidiaries or by which or to which any of their respective properties, rights or assets are bound or subject, or result in the creation of any Liens other than
Permitted Liens (<U>provided</U> that no Lien shall be deemed created by this Agreement), in each case, upon any of the properties or assets of the Company or any of its Subsidiaries, except for such losses, impairments, suspensions, limitations,
conflicts, violations, defaults, terminations, cancellation, accelerations, or Liens which have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (ii)&nbsp;conflict with or result in
any violation of any provision of the articles of incorporation or bylaws or other equivalent organizational document, in each case, as amended or restated (whether by filing a statement with respect to shares or otherwise), of the Company or any of
its Subsidiaries or (iii)&nbsp;conflict with or violate any applicable Laws, except for such conflict or violation as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.04 <U>[RESERVED]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.05 <U>Company SEC Documents</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and each of its Subsidiaries have filed or furnished all forms, documents and reports required to be filed or furnished prior
to the date of the Original Investment Agreement by it with the SEC since January&nbsp;1, 2018 (all such forms, documents and reports, the &#147;<U>Company SEC Documents</U>&#148;). As of their respective dates or, if amended, as of the date of the
last such amendment, the Company SEC Documents complied in all material respects with the requirements of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act, as the case may be, and the applicable rules and regulations promulgated
thereunder, and none of the Company SEC Documents at the time they were filed or furnished contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not materially misleading. None of Company&#146;s Subsidiaries is, or at any time since January&nbsp;1, 2018 has been, required to file any forms, reports or other documents with the
SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The consolidated financial statements (including all related notes and schedules) of Company included in the Company SEC
Documents (the &#147;<U>Company Financial Statements</U>&#148;) at the time they were filed or furnished (i)&nbsp;fairly present in all material respects the consolidated financial position of Company and its consolidated Subsidiaries, as at the
respective dates thereof, and the consolidated results of their operations and their consolidated cash flows for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the respective periods then ended (except, in the case of unaudited statements, subject to normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments, the absence of notes and to
any other adjustments described therein, including in any notes thereto or with respect to pro forma financial information, subject to the qualifications stated therein), (ii)&nbsp;were prepared in conformity with GAAP applied on a consistent basis
during the periods involved (except as may be indicated therein or in the notes thereto) and (iii)&nbsp;comply in all material respects with the applicable accounting requirements and with the rules and regulations of the SEC, the Exchange Act and
the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date of the Original Investment Agreement, there are no outstanding or unresolved comments in any
comment letters of the staff of the SEC received by Company relating to the Company SEC Documents. As of the date of the Original Investment Agreement, none of the Company SEC Documents is, to the knowledge of Company, the subject of ongoing SEC
review. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Neither Company nor any of its Subsidiaries is a party to, or has a commitment to effect, enter into or create, any joint
venture, or <FONT STYLE="white-space:nowrap">&#147;off-balance</FONT> sheet arrangement&#148; (as defined in Item 303(a) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Exchange Act), where the result, purpose or effect of such
contract is to avoid disclosure of any material transaction involving, or material liabilities of, Company or any of its Subsidiaries in the Company Financial Statements or other Company SEC Documents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.06 <U>Absence</U><U> of Certain Changes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for the entry into the Target Merger Agreement and actions taken in relation to the transactions contemplated by the Target Merger
Agreement, (1)&nbsp;from January&nbsp;1, 2020, through the date of the Original Investment Agreement, the businesses of each of Company and its Subsidiaries, as applicable, have been conducted in all material respects in the Ordinary Course of
Business, and (2)&nbsp;from January&nbsp;1, 2020 through the date of this Agreement, none of Company or any Subsidiary of Company has undertaken any action that, if taken during the period from the date of this Agreement to the Subsequent Closing
Date, would constitute a breach of clauses&nbsp;(i) through (v)&nbsp;or (ix)&nbsp;(solely as it relates to clauses&nbsp;(i) through (v)) of <U>Section</U><U></U><U>&nbsp;5.01(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Since January&nbsp;1, 2020, through the date of the Original Investment Agreement, there has not been any event, change, effect,
development or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.07 <U>Internal Controls and Procedures</U>. The Company has established and maintains disclosure controls and procedures and
internal control over financial reporting (as such terms are defined in paragraphs&nbsp;(e) and (f), respectively, of <FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act) as required by
<FONT STYLE="white-space:nowrap">Rule&nbsp;13a-15</FONT> under the Exchange Act. Company&#146;s disclosure controls and procedures are reasonably designed to ensure that all material information required to be disclosed by Company in the reports
that it files or furnishes under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and that all such material information is accumulated and communicated to
Company&#146;s management as appropriate to allow timely decisions regarding required disclosure and to make the certifications required pursuant to Sections&nbsp;302 and 906 of the Sarbanes-Oxley Act. Company&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
management has completed an assessment of the effectiveness of Company&#146;s internal controls over financial reporting in compliance with the requirements of Section&nbsp;404 of the
Sarbanes-Oxley Act for the year ended December&nbsp;31, 2019, and such assessment concluded that such controls were effective. Based on its most recent evaluation of internal controls over financial reporting prior to the date of the Original
Investment Agreement, management of Company has disclosed to Company&#146;s auditors and the audit committee of the Board (i)&nbsp;any significant deficiencies and material weaknesses in the design or operation of internal controls over financial
reporting that are reasonably likely to adversely affect in any material respect Company&#146;s ability to report financial information and (ii)&nbsp;any fraud, whether or not material, that involves management or other employees who have a
significant role in Company&#146;s internal controls over financial reporting, in each case, that was disclosed to Company&#146;s auditors or the audit committee of the Board in connection with its most recent evaluation of internal controls over
financial reporting prior to the date of the Original Investment Agreement. Company maintains a system of internal accounting controls designed to provide reasonable assurances regarding transactions being executed in accordance with
management&#146;s general or specific authorization, the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and the prevention or timely detection of unauthorized acquisition,
use or disposition of Company&#146;s assets that could have a material effect on its financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.08 <U>No
Undisclosed Liabilities</U>. There are no liabilities or obligations of Company or any of its Subsidiaries, whether accrued, absolute, determined or contingent, except for (i)&nbsp;liabilities or obligations disclosed, reflected or reserved against
in the balance sheets included in the Company Financial Statements (or in the notes thereto) filed and publicly available prior to the date of the Original Investment Agreement, (ii)&nbsp;liabilities or obligations arising under or in accordance
with this Agreement or the Target Merger Agreement, (iii)&nbsp;liabilities or obligations incurred in the Ordinary Course of Business since December&nbsp;31, 2019, and (iv)&nbsp;liabilities or obligations that have not had and would not reasonably
be expected to have, individually or in the aggregate, a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.09 <U>Legal Proceedings</U>. Except as
has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (a)&nbsp;there are no actions, suits, inquiries, investigations, proceedings, subpoenas, civil investigative demands or other
requests for information relating to potential violations of Law pending (or, to the Knowledge of the Company, threatened) against or affecting the Company or any of its Subsidiaries, or any of their respective properties and (b)&nbsp;there are no
orders of, or before, any Governmental Entity against the Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.10 <U>Compliance</U><U> with
Laws; Permits</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its Subsidiaries are in compliance with, and are not in default under or in violation of, any
applicable federal, state, local or foreign law, statute, ordinance, rule, regulation, judgment, order, injunction, decree or agency requirement of any Governmental Entity (collectively, &#147;<U>Laws</U>&#148; and each, a &#147;<U>Law</U>&#148;),
except where such <FONT STYLE="white-space:nowrap">non-compliance,</FONT> default or violation have not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Since January&nbsp;1, 2018,
neither the Company nor any of its Subsidiaries has received any written notice or, to the knowledge of the Company, other communication from any Governmental Entity regarding any violation of, or failure to comply with, any Law, except where such
violation or failure has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and its Subsidiaries are in possession of all material franchises, grants,
authorizations, licenses, permits, easements, variances, exceptions, consents, certificates, approvals, clearances, permissions, qualifications and registrations and orders of all applicable Governmental Entities, and all rights under any Company
material contract with all Governmental Entities, and have filed all tariffs, reports, notices and other documents with all Governmental Entities necessary for the Company and its Subsidiaries to own, lease and operate their properties and assets
and to carry on their businesses as they are now being conducted (the &#147;<U>Company Permits</U>&#148;), except where the failure to possess or file the Company Permits has not had and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, all Company Permits are in all respects valid and in full force and effect and
are not subject to any administrative or judicial proceeding that would reasonably be expected to result in modification, termination or revocation thereof. Company and each of its Subsidiaries are in material compliance with the terms and
requirements of all Company Permits, except where such <FONT STYLE="white-space:nowrap">non-compliance</FONT> has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect:
(i)&nbsp;Company and each of its Subsidiaries are in compliance, and have since January&nbsp;1, 2018 complied, with all applicable Data Privacy Laws; (ii)&nbsp;neither Company nor any of its Subsidiaries has, since January&nbsp;1, 2018, received any
written notice from any applicable Governmental Entity alleging any violation of applicable Data Privacy Laws by Company, any of its Subsidiaries or, to the knowledge of Company, any third-party service providers, outsourcers, processors or other
third parties who process, store or otherwise handle Personal Data for or on behalf of Company or any of its Subsidiaries (&#147;<U>Company Data Processors</U>&#148;), nor has Company or any of its Subsidiaries been threatened in writing to be
charged with any such violation by any Governmental Entity; (iii)&nbsp;Company and each of its Subsidiaries have, since January&nbsp;1, 2018, taken commercially reasonable steps (including, as appropriate, implementing reasonable technical, physical
or administrative safeguards) designed to protect Personal Data in their possession or under their control against loss and unauthorized access, use, modification or disclosure, and, to the knowledge of Company, since January&nbsp;1, 2018, there has
been no incident of the same, or of the same with respect to any Personal Data maintained or otherwise processed for or on behalf of Company or its Subsidiaries; (iv)&nbsp;Company and each of its Subsidiaries have, since January&nbsp;1, 2018, taken
commercially reasonable steps with respect to Company Data Processors to obligate such persons to comply in all material respects with applicable Data Privacy Laws and to take reasonable steps to protect and secure Personal Data from loss or
unauthorized use, access, modification or disclosure; and (v)&nbsp;the execution, delivery and performance of this Agreement complies with all applicable Data Privacy Laws (including the General Data Protection Regulation (EU)&nbsp;2016/679, the
Data Protection Act 2018 (UK), and the California Consumer Protection Act) and Company&#146;s and each of its Subsidiaries&#146; applicable published policies, statements, and notices relating to privacy, data protection or information security
regarding Personal Data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.11 <U>Tax Matters</U>.<U><SUP STYLE="font-size:85%; vertical-align:top">
</SUP></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, (i)&nbsp;Company and each of its Subsidiaries have prepared and timely filed (taking into account any valid extension of time within which to file) all Tax Returns required to be filed by any of them and all such Tax Returns are complete and
accurate, (ii)&nbsp;Company and each of its Subsidiaries have timely paid all Taxes that are required to be paid by any of them or that Company or any of its Subsidiaries are obligated to withhold from amounts owing to any employee, creditor,
stockholders or third party (in each case, whether or not shown on any Tax Return), (iii)&nbsp;as of the date of the Original Investment Agreement there are no effective waivers of any statute of limitations with respect to Taxes or extensions of
time with respect to a Tax assessment or deficiency, (iv)&nbsp;all assessments for Taxes due with respect to completed and settled examinations or any concluded litigation have been fully paid, (v)&nbsp;there are no audits, examinations,
investigations or other proceedings pending or threatened in writing in respect of Taxes or Tax matters of Company or any of its Subsidiaries, (vi)&nbsp;no claim has been made in writing or, to Company&#146;s knowledge, otherwise, by a Taxing
Authority in a jurisdiction where Company or any of its Subsidiaries does not file Tax Returns of a certain type that Company or any of its Subsidiaries is or may be subject to taxation of such type or required to file Tax Returns of such type in
that jurisdiction, (vii)&nbsp;there are no Liens for Taxes on any of the assets of Company or any of its Subsidiaries other than statutory Liens for Taxes not yet due and payable, (viii)&nbsp;neither Company nor any of its Subsidiaries is a party to
any agreement or arrangement relating to the apportionment, sharing, assignment or allocation of any Tax or Tax asset (other than an agreement or arrangement solely among members of a group the common parent of which is Company or commercial
agreements or arrangements not primarily related to Taxes and entered into in the ordinary course of business) or has any liability for Taxes of any person (other than Company or any of its Subsidiaries) under Treasury Regulation <FONT
STYLE="white-space:nowrap">Section&nbsp;1.1502-6</FONT> (or any analogous or similar provision of state, local or foreign Tax Law), as transferee, successor, by contract (other than commercial contracts not primarily related to Taxes and entered
into in the ordinary course of business) or otherwise, (ix)&nbsp;neither Company nor any of its Subsidiaries is bound with respect to any current or any future taxable period by any closing agreement (within the meaning of Section&nbsp;7121 of the
Code), private letter ruling, technical advice or other ruling or written agreement with a Governmental Entity, in each case, that could reasonably be expected to affect the liability for Taxes of Company or any of its Subsidiaries following the
Initial Closing, (x)&nbsp;none of Company or any of its Subsidiaries has been a party to any &#147;listed transaction&#148; within the meaning of Treasury Regulation <FONT STYLE="white-space:nowrap">1.6011-4(b)(2),</FONT> and (xi)&nbsp;none of the
Company or any of its Subsidiaries has, within the two (2)-year period ending on the date of the Original Investment Agreement, been a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (as such terms are used in
Section&nbsp;355 of the Code) in a distribution intended or purported to qualify in whole or in part for tax free treatment under Section&nbsp;355 of the Code (or so much of Section&nbsp;356 of the Code as relates to Section&nbsp;355 of the Code).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provisions of this Agreement to the contrary, the representations and warranties made in this
<U>Section</U><U></U><U>&nbsp;3.11</U>, <U>Section</U><U></U><U>&nbsp;3.05</U>, <U>Section</U><U></U><U>&nbsp;3.06</U> (to the extent relating to Taxes) and <U>Section</U><U></U><U>&nbsp;3.12</U> (to the extent relating to Taxes) are the sole and
exclusive representations and warranties of Company with respect to Taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.12 <U>Employee Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to result in, individually or in the aggregate, a material liability to Company and its
Subsidiaries, (i)&nbsp;each Company Benefit Plan has been established, operated and administered in all respects in accordance with its terms and the requirements of all applicable Laws, including ERISA and the Code, and (ii)&nbsp;all contributions
required to be made to any Company Benefit Plan by applicable Law or by any plan document or other contractual undertaking, and all premiums due or payable with respect to insurance policies funding any Company Benefit Plan, have been timely made or
paid or, to the extent not required to be made or paid on or before the date of the Original Investment Agreement, have been reflected on the books and records of Company in accordance with GAAP. As of the date of the Original Investment Agreement,
there are no pending or threatened material claims (other than routine claims for benefits) by, on behalf of or against any of the Company Benefit Plans, except as would not reasonably be expected to have, individually or in the aggregate, a
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse
Effect, since January&nbsp;1, 2016, no Company Benefit Plan has been an employee benefit plan subject to Section&nbsp;302 or Title IV of ERISA or Section&nbsp;412, 430 or 4971 of the Code and (ii)&nbsp;none of Company or any of its ERISA Affiliates
has incurred or is reasonably expected to incur any Controlled Group Liability that has not been satisfied in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, neither the Company, nor its Subsidiaries nor any of their respective ERISA Affiliates has, at any time since January&nbsp;1, 2016, contributed to, been
obligated to contribute to or had any liability (including any contingent liability) with respect to any Multiemployer Plan or Multiple Employer Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the execution of this
Agreement and the consummation of the Transactions will not, either alone or in combination with another event, (i)&nbsp;entitle any current or former employee, director, consultant or officer of Company or any of its Subsidiaries to any severance
pay or any other similar payment, (ii)&nbsp;accelerate the time of payment or vesting, or increase the amount of compensation due any such employee, director, consultant or officer or (iii)&nbsp;trigger any funding obligation under any Company
Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no
Company Benefit Plan provides for, and neither Company nor any of its Subsidiaries otherwise has any obligation to provide, a <FONT STYLE="white-space:nowrap">gross-up</FONT> or reimbursement of Taxes imposed under Section&nbsp;4999 of the Code,
Section&nbsp;409A(a)(1)(B) of the Code, or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not, either individually or in the aggregate, reasonably be
expected to result in material liability to Company or its Subsidiaries, each Company Benefit Plan that is mandated by applicable Law or by a Governmental Entity outside of the United States or that is subject to the laws of a jurisdiction outside
of the United States (i)&nbsp;has been maintained in accordance with all applicable requirements, (ii)&nbsp;if intended to qualify for special Tax treatment, meets all the requirements for such treatment, and (iii)&nbsp;if required, to any extent,
to be funded, book-reserved or secured by an insurance policy, is fully funded, book-reserved or secured by an insurance policy, as applicable, based on reasonable actuarial assumptions in accordance with applicable accounting principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.13 <U>Labor Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;neither the
Company nor any of its Subsidiaries is party to or bound by any collective bargaining agreement, works council agreement or similar labor-related agreement or arrangement, (ii)&nbsp;no strike, material work slowdown, work stoppage, or unfair labor
practice against Company or any of its Subsidiaries is pending, or to knowledge of Company, threatened and (iii)&nbsp;to the knowledge of Company, no activities or proceedings of any labor union to organize any employees of Company or any of its
Subsidiaries are pending or threatened. As of the date of the Original Investment Agreement, no labor union or works council represents any employees of Company or any of its Subsidiaries in connection with their employment with Company or any of
its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had, and would not reasonably be expected to have, a Material Adverse Effect, Company and each of
its Subsidiaries is in compliance with all applicable Laws respecting hiring, employment and employment practices, terms and conditions of employment, harassment, retaliation, reasonable accommodations, leaves of absence, occupational safety and
health, workers&#146; compensation, employee classification, wages and hours, engagement of independent contractors (including the appropriate classification of the same), payroll taxes, redundancy, &#147;mass layoffs,&#148; &#147;plant
closings&#148; and immigration with respect to all employees, independent contractors, and other service providers of Company and its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date of the Original Investment Agreement, except as has not had, and would not reasonably be expected to have, a Material
Adverse Effect, (i)&nbsp;there are no charges, complaints, audits or investigations pending or scheduled by any Governmental Entity pertaining to the employment practices or actions of Company or any of its Subsidiaries or, to Company&#146;s
knowledge, threatened against Company or any of its Subsidiaries and (ii)&nbsp;to Company&#146;s knowledge, no complaints or charges relating to employment practices or actions of Company or any of its Subsidiaries have been made since
January&nbsp;1, 2018 to any Governmental Entity or submitted to Company or any of its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the knowledge of Company,
neither Company nor any of its Subsidiaries is party to a settlement agreement with any employee of Company or any of its Subsidiaries that involves material allegations of sexual harassment by any employee of Company or any of its Subsidiaries at
the level of Senior Vice President or above. To the knowledge of Company, no material allegations of sexual harassment are pending against any employee of Company or any of its Subsidiaries at the level of Senior Vice President or above in his or
her capacity as such. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.14 <U>Environmental</U><U> Matters</U>. Company and its Subsidiaries are, and since January&nbsp;1,
2018 have been, in compliance with all applicable Environmental Laws (which compliance includes the possession, and the compliance with the terms and conditions, by Company and each of its Subsidiaries of all Company Permits required under
applicable Environmental Laws to conduct their respective business and operations), and there are no investigations, actions, suits or proceedings pending or, to the knowledge of Company, threatened </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
against Company or any of its Subsidiaries, in each case, except as, individually or in the aggregate, has not had a would not reasonably be expected to have a Material Adverse Effect. Neither
Company nor any of its Subsidiaries has received any written notice from a Governmental Entity that alleges that Company or any of its Subsidiaries is violating, or has or may have, violated any Environmental Law, or may have any liability or
obligation arising under, retained or assumed by contract or by operation of law, except for such violations, liabilities and obligations that would not have, individually or in the aggregate, a Material Adverse Effect. To the knowledge of Company,
there has been no release of any Hazardous Materials by Company or any of its Subsidiaries at, to or from any facilities owned or leased by Company or any of its Subsidiaries as of or prior to the date of the Original Investment Agreement or at any
other locations where any Hazardous Materials were generated, manufactured, refined, transferred, stored, produced, imported, used, processed or disposed of by Company or any of its Subsidiaries and, in each case, for which Company or any of its
Subsidiaries would reasonably be expected to be subject to any material liability. Neither Company nor any of its Subsidiaries has, either through contract or by operation of law, assumed or agreed to guarantee, reimburse, pledge, defend, hold
harmless or indemnify any other person with respect to any liabilities arising under Environmental Laws except as, individually or in the aggregate, has not had and would not reasonably be expected to have a Material Adverse Effect. Company has
delivered or made available to the Company all material environmental assessment reports, investigations and audits in its possession or control, which relate to environmental matters for which Company may reasonably be expected to have any material
liability with respect to Company and its Subsidiaries&#146; business and operations. The representations and warranties set forth in this <U>Section</U><U></U><U>&nbsp;3.14</U>, <U>Section</U><U></U><U>&nbsp;3.03</U>,
<U>Section</U><U></U><U>&nbsp;3.05</U>, <U>Section</U><U></U><U>&nbsp;3.06</U> and <U>Section</U><U></U><U>&nbsp;3.08</U> are Company&#146;s sole and exclusive representations and warranties relating to Environmental Laws or liabilities relating to
the release or disposal of Hazardous Materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.15 <U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not reasonably be expected to have a Material Adverse Effect: (i)&nbsp;either Company or a Subsidiary of Company has good
and valid title, subject to Permitted Liens, to each material Real Property owned by Company or any Subsidiary of Company (such owned property collectively, the &#147;<U>Owned Real Property</U>&#148;) and (ii)&nbsp;either Company or a Subsidiary of
Company has a good and valid leasehold interest in each material lease, material sublease and other material agreement under which Company or any of its Subsidiaries uses or occupies or has the right to use or occupy any Real Property (such
property, the &#147;<U>Leased Real Property</U>&#148;) and such leases, subleases and other agreements (collectively, the &#147;<U>Real Property Leases</U>&#148;), in each case, free and clear of all Liens other than any Permitted Liens and any Lien
encumbering the interest of the landlord thereunder. Except as would not reasonably be expected to have a Material Adverse Effect, each Real Property Lease and each Sublease (defined below) is valid, binding and in full force and effect, subject to
the limitation of such enforcement by the Remedies Exceptions. Except as would not reasonably be expected to have a Material Adverse Effect, no uncured default of a material nature on the part of Company or, if applicable, its Subsidiary or, to the
knowledge of Company, the landlord, sublandlord or subtenant thereunder (as applicable), exists under any Real Property Lease or Sublease, and no event has occurred or circumstance exists which, with the giving of notice, the passage of time, or
both, would constitute a material breach or default under a Real Property Lease or Sublease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as would not reasonably be expected to have a Material Adverse Effect,
(i)&nbsp;there are no leases, subleases, licenses, rights or other agreements affecting any portion of the Owned Real Property or the Leased Real Property (each, a &#147;<U>Sublease</U>&#148;) that would reasonably be expected to adversely affect
the existing use of such Owned Real Property or Leased Real Property by Company or its Subsidiaries in the operation of its business thereon; and (ii)&nbsp;there are no outstanding (A)&nbsp;options or (B)&nbsp;rights of first refusal in favor of any
other party to purchase any Owned Real Property or any portion thereof or interest therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.16 <U>No Rights Agreement;
Anti-Takeover Provisions</U>. The Board has taken all action necessary to render inapplicable to this Agreement and the Transactions all applicable state Laws (including Subchapter F of Chapter 25 of PBCL) and any similar provisions in the
Company&#146;s articles of incorporation or bylaws. As of the date of the Original Investment Agreement and as of the date of this Agreement, no &#147;fair price,&#148; &#147;business combination,&#148; &#147;moratorium,&#148; &#147;control share
acquisition&#148; or other anti-takeover statute or similar statute or regulation enacted by any state (including Pennsylvania) will prohibit or impair the Transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.17 <U>Customers</U>. <U>Section</U><U></U><U>&nbsp;3.17</U> of the Disclosure Schedules sets forth a list of the Top Company
Customers. As of the date of the Original Investment Agreement, neither Company nor any of its Subsidiaries has received any written notice from any Top Company Customer that such Top Company Customer shall not continue as a customer of Company and
its Subsidiaries or that such Top Company Customer intends to terminate, not renew or materially amend existing contracts with Company or any of its Subsidiaries or otherwise materially modify its business relationship with Company and its
Subsidiaries, except as would not be material and adverse to Company and its Subsidiaries, taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.18 <U>Brokers
</U><U>and</U><U> Other Advisors</U>. Except for Allen&nbsp;&amp; Company LLC and J.P. Morgan Securities LLC, neither the Company nor any of the Company&#146;s Subsidiaries has employed any investment banker, broker or finder in connection with the
Transactions who would be entitled to any fee or any commission in connection with or upon consummation of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.19 <U>Sale of Securities</U>. Based in part on the representations and warranties set forth in
<U>Section</U><U></U><U>&nbsp;4.06</U>, the sale of the Shares pursuant to this Agreement is exempt from the registration and prospectus delivery requirements of the Securities Act and the rules and regulations promulgated thereunder. Without
limiting the foregoing, neither the Company nor, to the Knowledge of the Company, any other Person authorized by the Company to act on its behalf, has engaged in a general solicitation or general advertising (within the meaning of Regulation D of
the Securities Act) of investors with respect to offers or sales of Series B Preferred Stock, and neither the Company nor, to the Knowledge of the Company, any Person acting on its behalf has made any offers or sales of any security or solicited any
offers to buy any security, under circumstances that would cause the offering or issuance of Series B Preferred Stock under this Agreement to be integrated with prior offerings by the Company for purposes of the Securities Act that would result in
none of Regulation D or any other applicable exemption from registration under the Securities Act to be available, nor will the Company take any action or steps that would cause the offering or issuance of Series B Preferred Stock under this
Agreement to be integrated with other offerings by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.20 <U>Listing and Maintenance Requirements</U>. The Company Common Stock is
registered pursuant to Section&nbsp;12(b) of the Exchange Act and listed on the NASDAQ, and the Company has taken no action designed to, or which to the Knowledge of the Company is reasonably likely to have the effect of, terminating the
registration of the Company Common Stock under the Exchange Act or delisting the Company Common Stock from the NASDAQ, nor has the Company received as of the date of the Original Investment Agreement any notification that the SEC or the NASDAQ is
contemplating terminating such registration or listing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.21 <U>Status of Securities</U>. As a result of the approval by the
Board referred to in <U>Section</U><U></U><U>&nbsp;3.03(a)</U>, the shares of Series B Preferred Stock to be issued pursuant to this Agreement, and the shares of Company Common Stock to be issued upon conversion of the Series B Preferred Stock, have
been duly authorized and reserved for issuance by all necessary action. When issued and sold against receipt of the consideration therefor as provided in this Agreement or the Statement With Respect to Shares, such securities shall be validly
issued, fully paid and nonassessable (whether or not the Subsequent Closing occurs), will not be subject to preemptive rights of any other stockholder of the Company, and will be free and clear of all Liens, except restrictions imposed by the
Securities Act, the articles of incorporation and bylaws of the Company, <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement and any applicable state securities Laws and any Liens arising due to actions by or on behalf of the Investor,
including Liens contemplated by the Issuer Agreement. Upon any conversion of any shares of Series B Preferred Stock into Company Common Stock pursuant to the Statement With Respect to Shares, the shares of Company Common Stock issued upon such
conversion shall be validly issued, fully paid and nonassessable, and will not be subject to preemptive rights of any other stockholder of the Company, and will be free and clear of all liens, except restrictions imposed by the Securities Act, the
articles of incorporation and bylaws of the Company, <U>Section</U><U></U><U>&nbsp;5.08</U> of this Agreement and any applicable state securities Laws and any Liens arising due to actions by or on behalf of the Investor, including Liens contemplated
by the Issuer Agreement. The respective rights, preferences, privileges, and restrictions of the Series B Preferred Stock and the Company Common Stock as of the Initial Closing and Subsequent Closing, as applicable, will be as stated in the articles
of incorporation and bylaws of the Company (including the Statement With Respect to Shares). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.22 <U>Indebtedness</U>. The
Company is not party to any contract, and is not subject to any provision in the Company Charter Documents or other governing documents or resolutions of the Board that, in each case, by its terms restricts, limits, prohibits or prevents the Company
from paying dividends in form and the amounts contemplated by the Statement With Respect to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.23 <U>Intellectual
Property</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect, the Company and its Subsidiaries solely and exclusively own the Intellectual Property owned (or purported to be owned) by the Company and its Subsidiaries (&#147;<U>Company Owned IP</U>&#148;), free and clear of all Liens other than
Permitted Liens. All material issued patents, all registered copyrights and all registered trademarks that are registered or filed in the name of the Company or any of its Subsidiaries are subsisting and, to the knowledge of the Company, valid and
enforceable. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company Owned IP is not subject to any outstanding consent, settlement, Lien (other than Permitted Liens), decree, order, injunction, judgment or ruling restricting the use thereof in a
manner that would reasonably be expected to impair the continued operation of the businesses of the Company and its Subsidiaries as conducted as of the date of the Original Investment Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the
date of the Original Investment Agreement, (i)&nbsp;the conduct of the business of the Company and its Subsidiaries as conducted since January&nbsp;1, 2018 and as presently conducted does not infringe, misappropriate or otherwise violate any
Intellectual Property rights of any third party and (ii)&nbsp;since January&nbsp;1, 2018 through the date of the Original Investment Agreement, the Company has not received any written claim alleging any such infringement, misappropriation or other
violation. Since January&nbsp;1, 2018 through the date of the Original Investment Agreement, there is no and has not been any legal proceeding brought by a third party against the Company or any of its Subsidiaries (or against another person who has
sought indemnification from the Company or any of its Subsidiaries in connection with such legal proceeding) with respect to any material alleged infringement or other material violation by the Company, its Subsidiaries, its or their current
products or services, or other operation of the Company&#146;s or any of its Subsidiaries&#146; businesses, of the Intellectual Property of such third party, that is outstanding and unresolved as of the date of the Original Investment Agreement, or
which, if resolved, has resulted in any material liability or obligation (including ongoing payment), or the resolution of which required granting any license under any Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, as of the
date of the Original Investment Agreement, to the knowledge of the Company, no person or entity is infringing, misappropriating or otherwise violating any Intellectual Property owned by the Company or any of its Subsidiaries. Neither the Company nor
any of its Subsidiaries have, since January&nbsp;1, 2018 through the date of the Original Investment Agreement, brought (or asserted or threatened in writing) any claim against any person alleging that such person is infringing or misappropriating
any material Company Owned IP, that is outstanding and unresolved as of the date of the Original Investment Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Except as has
not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the Company and its Subsidiaries have taken commercially reasonable steps to protect all material trade secrets of the Company or its
Subsidiaries. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;to the knowledge of the Company, there have been no unauthorized uses or disclosures of any such
trade secrets, and (ii)&nbsp;none of the Company or its Subsidiaries has published, provided or disclosed, nor are the Company or its Subsidiaries under any present or contingent obligation to so publish, provide or disclose, any software source
code for Company Owned IP, including through or in connection with any agreement requiring the Company or any of its Subsidiaries to place any software source code in escrow. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as has not had and would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect, none of the Company or its Subsidiaries has received any support, funding, resources or assistance from any Governmental Entity, or from any university, college, other academic institutions, or <FONT
STYLE="white-space:nowrap">non-profit</FONT> research centers in the development of any Intellectual Property owned by the Company or its Subsidiaries, that resulted in, or is reasonably expected to result in, such third-parties being granted any
rights or licenses to, or ownership interest in, any such Intellectual Property. Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, no rights have been granted to any
Governmental Entity with respect to any Company Owned IP other than substantially the same standard commercial rights as are granted by the Company to commercial end users in the Ordinary Course of Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, none of
the Company or its Subsidiaries is a member or promoter of, or a contributor to, or made any commitments or agreements regarding, any patent pool, industry standards body, standard-setting organization or other similar organization, in each case
that requires or obligates the Company or any of its Subsidiaries to grant or offer to any other person any license or other right to any Company Owned IP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, the
information technology systems (&#147;<U>IT Systems</U>&#148;) used by the Company and its Subsidiaries are designed, implemented, operated and maintained in accordance with reasonable and customary industry standards and practices for entities
operating businesses similar to the business of the Company and its Subsidiaries, including with the respect to redundancy, reliability, scalability and security, and constitute all the information and communications technology and other systems
infrastructure reasonably necessary to carry on the business of the Company and its Subsidiaries as conducted in the 12 months prior to the date of the Original Investment Agreement. Without limiting the foregoing, except as has not had and would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries have taken reasonable steps and implemented reasonable procedures to ensure that their IT Systems are free
from viruses, contaminants and other harmful code, (ii)&nbsp;the Company and its Subsidiaries have in effect industry standard disaster recovery plans, procedures and facilities for their businesses and have taken all reasonable steps to safeguard
the security and the integrity of their IT Systems, and (iii)&nbsp;there has been no failure, breakdown, loss or impairment of, or any unauthorized intrusions or breaches of the security with respect to the IT Systems used by the Company or any of
its Subsidiaries that (A)&nbsp;has resulted in a disruption or interruption in the operation of the business of the Company or its Subsidiaries or (B)&nbsp;to the knowledge of the Company, has resulted in loss, unauthorized access to, or
unauthorized modification or disclosure of any confidential information of or maintained by, for or on behalf of the Company or its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, there
exist no facts, and no events have occurred, that would reasonably be expected to form the basis of any present or future claim against the Company or its Subsidiaries, whether or not fully covered by insurance, for liability on account of
negligence or product liability or on account of any breach of Warranties of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.24 <U>Affiliate Transactions</U>. To the knowledge of the Company, no
officer, director or Affiliate of the Company or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate family (a)&nbsp;owns any property or right, tangible or intangible, that is material to the conduct of the
business of the Company or its Subsidiaries, (b)&nbsp;with the exception of liabilities incurred in the Ordinary Course of Business, owes money to, or is owed money by, the Company or its Subsidiaries, or (c)&nbsp;is a party to or the beneficiary of
any contract with the Company or its Subsidiaries, except in each case for compensation and benefits payable under any Company Benefit Plans to officers and employees in their capacity as officers and employees. Except as disclosed in the Company
SEC Documents, there are no contracts between the Company or any of its Subsidiaries, on the one hand, and any officer, director or Affiliate of the Company or its Subsidiaries or any individual in such officer&#146;s or director&#146;s immediate
family, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.25 <U>No Other Representations or Warranties</U>. Except for the representations and warranties
contained in <U>Article IV</U> or in any certificates delivered by the Investor in connection with the Transactions, the Company acknowledges that neither the Investor nor any person on behalf of the Investor makes, and none of the Company or any
person acting on behalf of the Company, has relied or is relying upon, any other express or implied representation or warranty with respect to the Investor or any of their respective Subsidiaries or with respect to any other information provided or
made available to the Company in connection with the Transactions, including the accuracy, completeness or currency thereof. Except as otherwise expressly provided in this Agreement and to the extent any such information is expressly included in a
representation or warranty contained in <U>Article IV</U>, neither the Investor nor any other person will have or be subject to any liability or obligation to the Company or any other person resulting from the distribution or failure to distribute
to the Company, or the Company&#146;s use of, any such information, including any information, documents, projections, estimates, forecasts or other material, made available to the Company or any other person for purposes of, or in expectation of,
the Transactions. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Representations and Warranties of the Investor </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Investor represents and warrants to the Company, as of the date of the Original Investment Agreement (unless expressly stated as of the
date hereof, in which case as of the date hereof) and as of the Subsequent Closing Date: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01 <U>Organization; Standing;
Ownership</U>. The Investor is a limited partnership duly formed, validly existing and in good standing under the Laws of its organization, and is a U.S. Person. The Investor has all requisite power and authority to own, lease and operate its
properties and assets and to carry on its business as presently conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Investor is duly qualified or licensed and has all
necessary governmental approvals, to do business and is in good standing in each jurisdiction in which the property owned, leased or operated by it or the nature of the business conducted by it makes such approvals, qualification or licensing
necessary (to the extent the &#147;qualification to do business&#148; or &#147;good standing&#148; concept is applicable in the case of any jurisdiction outside the United States), except where the failure to be so duly approved, qualified or
licensed and in good standing would not reasonably be expected to have an Investor Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date of the Original Agreement and as of the date hereof, the Investor and its
Affiliates do not beneficially own any shares of Company Common Stock or any securities convertible into or exchangeable for Company Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02 <U>Authority; Noncontravention</U>. The Investor has the requisite corporate power and authority to enter into this
Agreement and the other Transaction Documents and to consummate the Transactions. The execution and delivery by the Investor and the other Transaction Documents of this Agreement and the consummation of the Transactions have been duly and validly
authorized by the board of directors (or equivalent) of the Investor, and no other corporate proceedings on the part of the Investor or vote of the Investor&#146;s equityholders are necessary to authorize the consummation of the Transactions. This
Agreement has been duly and validly executed and delivered by the Investor, and assuming this Agreement constitutes the legal, valid and binding agreement of the Company, constitutes the legal, valid and binding agreement of the Investor,
enforceable against it, in accordance with its terms, except as such enforcement may be subject to the Bankruptcy and Equity Exceptions. Neither the execution and delivery of this Agreement or the other Transaction Documents by the Investor, nor the
consummation of the Transactions by the Investor, nor performance or compliance by the Investor with any of the terms or provisions hereof or thereof, will (i)&nbsp;conflict with or violate any provision of the certificate or articles of
incorporation or bylaws (or other comparable charter or organizational documents) of the Investor or (ii)&nbsp;violate any law, order or judgment applicable to the Investor or violate or constitute a default (or constitute an event which, with
notice or lapse of time or both, would violate or constitute a default) under any of the terms, conditions or provisions of any contract to which the Investor is a party or accelerate the Investor&#146;s obligations under any such contract, except,
in the case of clause&nbsp;(ii), as would not, individually reasonably be expected to have an Investor Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03 <U>Governmental</U><U> Approvals</U>. Except for (a)&nbsp;the filing by the Company of the Statement With Respect to Shares
with the Pennsylvania Department of State and (b)&nbsp;filings required under, and compliance with other applicable requirements of, the HSR Act and the antitrust Laws and any Laws with respect to foreign investment set forth on
<U>Section</U><U></U><U>&nbsp;4.03</U> of the Disclosure Schedules, no consent or approval of, or filing, license, permit or authorization, declaration or registration with, any Governmental Entity is necessary for the execution and delivery of this
Agreement and the other Transaction Documents by the Investor, the performance by the Investor of its obligations hereunder and thereunder and the consummation by the Investor of the Transactions, other than such other consents, approvals, filings,
licenses, permits, authorizations, declarations or registrations that, if not obtained, made or given, would not, individually or in the aggregate, reasonably be expected to have an Investor Material Adverse Effect. The Bain Group does not hold five
percent (5%) or more of the voting securities or <FONT STYLE="white-space:nowrap">non-corporate</FONT> interests (as &#147;hold,&#148; &#147;voting securities,&#148; and <FONT STYLE="white-space:nowrap">&#147;non-corporate</FONT> interests&#148; are
defined under 16 CFR 801) of any entity that competes with the Company or the Target, to the extent that any such holdings would reasonably be expected to prevent or materially delay the expiration or termination of the waiting period or the
obtaining or receiving of any consent or approval under the HSR Act or any other antitrust or foreign investment Law in connection with the Transactions. For purposes of giving the representations and warranties in this
<U>Section</U><U></U><U>&nbsp;4.03</U>, it is acknowledged and agreed that the Investor has relied on the information regarding the Company and its Subsidiaries that has been provided to the Investor&#146;s Representatives by the Company and its
Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.04 <U>Financing</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date hereof, the Investor has delivered to the Company a true and complete copy of the Equity Commitment Letter, pursuant to
which Bain Capital Fund XII, L.P., Bain Capital Fund (DE) XII, L.P. and Bain Capital Fund (Lux) XII, SCSp (collectively, the &#147;<U>Equity Provider</U>&#148;), have committed, subject only to the terms and conditions thereof, to invest the amounts
set forth therein (the &#147;<U>Equity Financing</U>&#148;). The Equity Commitment Letter provides that (A)&nbsp;the Company is an express third party beneficiary thereof; and (B)&nbsp;the Investor and Equity Provider will not oppose the granting of
an injunction, specific performance or other equitable relief seeking to enforce the obligations under the Equity Commitment Letter on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an
appropriate remedy for any reason at law or in equity in connection with the exercise of such third party beneficiary rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
(i)&nbsp;The Equity Commitment Letter and the terms of the Equity Financing have not been amended or modified as of the date hereof and as of the date of the Subsequent Closing; (ii)&nbsp;as of the date hereof no such amendment or modification is
contemplated;&nbsp;and (iii)&nbsp;as of the date hereof the respective commitments contained therein have not been withdrawn, terminated or rescinded in any respect. There are no other contracts, agreements, side letters or arrangements to which the
Investor is a party relating to the funding or investing, as applicable, that would reasonably be expected to adversely affect the availability or conditionality of the Equity Financing, other than as expressly set forth in the Equity Commitment
Letter. Other than as set forth in the Equity Commitment Letter, there are no conditions precedent related to the funding or investing, as applicable, of the full amount of the Equity Financing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The net proceeds of the Equity Financing, when funded in accordance with the Equity Commitment Letter, will be, in the aggregate,
sufficient to pay the Initial Investment Purchase Price at the Initial Closing and the Subsequent Investment Purchase Price at the Subsequent Closing, on the terms and subject to the conditions contemplated in this Agreement. The Company
acknowledges (x)&nbsp;the separate corporate existence of the Investor and (y)&nbsp;that the sole asset of the Investor is cash in a <I>de minimis</I> amount and its rights under this Agreement and the Equity Commitment Letter, in each case in
accordance with, and subject to, the terms and conditions set forth herein and therein and that no additional funds will be contributed to the Investor unless and until the Initial Closing occurs pursuant to the terms and conditions of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, the Equity Commitment Letter (in the form delivered by the Investor to the Company) is in full
force and effect and constitutes the legal, valid and binding obligations of the Investor and Equity Provider, as applicable, enforceable against the Investor and Equity Provider, as applicable, in accordance with their terms, except as such
enforceability (i)&nbsp;may be limited by applicable bankruptcy, insolvency, reorganization, moratorium and other similar laws affecting or relating to creditors&#146; rights generally; and (ii)&nbsp;is subject to general principles of equity.
Assuming the accuracy of the representations and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
warranties set forth in <U>Article III</U> in all respects as of the date of the Original Investment Agreement, no event has occurred that, with notice or lapse of time or both, would, or would
reasonably be expected to, constitute a default or breach on the part of the Investor or Equity Provider pursuant to the Equity Commitment Letter. Subject to the Company&#146;s compliance with this Agreement, as of the date hereof, the Investor has
no reason to believe that it will be unable to satisfy on a timely basis any term or condition of the Equity Financing to be satisfied by it, whether or not such term or condition is contained in the Equity Commitment Letter. As of the date hereof,
the Investor has fully paid, or caused to be fully paid, all commitment or other fees that are due and payable on or prior to the date hereof, in each case pursuant to and in accordance with the terms of the Equity Commitment Letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.05 <U>Brokers and Other Advisors</U>. No broker, investment banker, financial advisor or other Person is entitled to any
broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the Transactions based upon arrangements made by or on behalf of the Investor or
any of its Affilates, except for Persons, if any, whose fees and expenses will be paid by the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.06 <U>Securities
Act Representations</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Investor is an accredited investor (as defined in Rule 501 of the Securities Act), and is aware that the
sale of the Shares is being made in reliance on a private placement exemption from registration under the Securities Act. The Investor is not an underwriter within the meaning of Section&nbsp;2(a)(11) of the Securities Act. The Investor is acquiring
the Shares (and any shares of Company Common Stock issuable upon conversion of the Shares) for its own account, and not with a view toward, or for sale in connection with, any distribution thereof in violation of any federal or state securities or
&#147;blue sky&#148; law, or with any present intention of distributing or selling such Shares (or any shares of Company Common Stock issuable upon conversion of the Shares) and agrees not to reoffer or resell the Shares in violation of the
Securities Act. The Investor has sufficient knowledge and experience in financial and business matters so as to be capable of evaluating the merits and risks of its investment in such Shares (and any shares of Company Common Stock issuable upon
conversion of the Shares) and is capable of bearing the economic risks of such investment. The Investor has been provided a reasonable opportunity to undertake and has undertaken such investigation and has been provided with and has evaluated such
documents and information as it has deemed necessary to enable it to make an informed and intelligent decision with respect to the execution, delivery and performance of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Investor nor any of its Affiliates is acting in concert, and neither the Investor nor any of its Affiliates has any agreement
or understanding, with any Person that is not an Affiliate of the Investor, and is not otherwise a member of a &#147;group&#148; (as such term is used in Section&nbsp;13(d)(3) of the Exchange Act), with respect to the Company or its securities, in
each case, other than with respect to any <I>bona fide</I> loan from one or more financial institutions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.07 <U>No Other
Representations or Warranties</U>. Except for the representations and warranties contained in <U>Article III</U> or in any certificates delivered by the Company in connection with the Transactions, the Investor acknowledges that neither the Company
nor any person on behalf of the Company makes, and none of the Investor or any person acting on behalf of the Investor has relied or is relying upon, any other express or implied representation or warranty with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to the Company or any of its Subsidiaries, or with respect to any other information provided or made available to the Investor in connection with the transactions contemplated hereby or
the transactions contemplated by the Target Merger Agreement, including the accuracy, completeness or currency thereof. Except as otherwise expressly provided in this Agreement and to the extent any such information is expressly included in a
representation or warranty contained in <U>Article III</U>, neither the Company nor any other person will have or be subject to any liability or obligation to the Investor or any other person resulting from the distribution or failure to distribute
to the Investor, or the Investor&#146;s use of, any such information, including any information, documents, projections, estimates, forecasts or other material, made available to the Investor in any electronic data room maintained by the Company for
purposes of, or in expectation of, the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Additional Agreements </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01 <U>Negative Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the date hereof until the earlier of the Subsequent Closing or the Investor End Date (or, if earlier, termination of the
Target Merger Agreement), and except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any stock exchange or regulatory organization applicable to the Company or any of its Subsidiaries, (ii)&nbsp;with the prior
written consent of the Investor (such consent not to be unreasonably conditioned, withheld or delayed), (iii)&nbsp;as may be expressly contemplated, required or permitted by this Agreement (including the Statement With Respect to Shares) or required
by the Target Merger Agreement, (iv)&nbsp;in connection with a Company COVID Action, or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.01</U> of the Disclosure Schedules, the Company covenants and agrees that it shall use commercially
reasonable efforts to conduct the business of the Company and its Subsidiaries in all material respects in the Ordinary Course of Business; <U>provided</U>, <U>however</U>, that no action by the Company or its Subsidiaries with respect to matters
specifically addressed by any provision of <U>Section</U><U></U><U>&nbsp;5.01(b)</U> shall be deemed a breach of this sentence unless such action would constitute a breach of such other provision. Notwithstanding the foregoing, the Company and its
Subsidiaries shall be permitted to take, and nothing in this Agreement shall prohibit the Company or its Subsidiaries from taking, any Company COVID Action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company agrees with the Investor, on behalf of itself and its Subsidiaries, that, from the date hereof and prior to the earlier of the
Subsequent Closing and the Investor End Date (or, if earlier, termination of the Target Merger Agreement), except (i)&nbsp;as may be required by applicable Law or the regulations or requirements of any stock exchange or regulatory organization
applicable to the Company or any of its Subsidiaries or Company Benefit Plan, (ii)&nbsp;with the prior written consent of the Investor (such consent not to be unreasonably conditioned, withheld or delayed), (iii)&nbsp;as may be expressly
contemplated, required or permitted by this Agreement or required by the Target Merger Agreement, (iv)&nbsp;in connection with a Company COVID Action, or (v)&nbsp;as set forth in <U>Section</U><U></U><U>&nbsp;5.01</U> of the Disclosure Schedules,
the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) shall not amend or restate any Company Charter Document; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) shall not, and shall not permit any of such Subsidiaries to split,
combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for any shares of its capital stock, except for any such transaction by a wholly owned (direct or
indirect) Subsidiary of the Company which remains a wholly owned (direct or indirect) Subsidiary following the consummation of such transaction; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) shall not, and shall not permit any of such Subsidiaries that is not wholly owned (directly or indirectly) by the Company
or is not a wholly owned (direct or indirect) Subsidiary of any such Subsidiaries to, authorize or pay any dividends on or make any distribution with respect to its outstanding shares of capital stock (whether in cash, assets, stock or other
securities of the Company or its Subsidiaries), except dividends or distributions by any Subsidiaries only to the Company or to any other wholly owned (direct or indirect) Subsidiary of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) shall not, and shall not permit any of such Subsidiaries to, adopt a plan of complete or partial liquidation, dissolution,
merger, consolidation, restructuring, recapitalization or other reorganization, in each case, that would reasonably be expected to prevent, materially impede or materially delay the consummation of the Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) shall not, and shall not permit any of such Subsidiaries to, acquire (by purchase, merger, joint venture, partnership,
consolidation, dissolution, liquidation, tender offer, exchange offer, recapitalization, reorganization, share exchange, business combination or similar transaction) any business or material amount of assets from any other person except for such
acquisitions for an amount not to exceed $100&nbsp;million in value in the aggregate (for all such transactions), in each case that would not reasonably be expected to (A)&nbsp;impose any material delay in the obtaining of, or materially increase
the risk of not obtaining, any authorization, consent, order, declaration or approval of any Governmental Entity necessary to consummate the transactions contemplated by this Agreement, the other Transaction Documents or the expiration or
termination of any applicable waiting period, (B)&nbsp;materially increase the risk of any Governmental Entity entering an order prohibiting the consummation of the Transactions, (C)&nbsp;materially increase the risk of not being able to remove any
such order on appeal or otherwise, or (D)&nbsp;prevent, materially delay or materially impair the ability of the Company to consummate the transactions contemplated by this Agreement and the other Transaction Documents; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) shall not, and shall not permit any of its Subsidiaries to, issue, sell, pledge, dispose of or encumber, or authorize the
issuance, sale, pledge, disposition or encumbrance of, any shares of its capital stock or other ownership interest in the Company or any of its Subsidiaries or any securities convertible into or exchangeable for any such shares or ownership
interest, or any rights, warrants or options to acquire any such shares of capital stock, ownership interest or convertible or exchangeable securities or take any action to cause to be exercisable any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
otherwise unexercisable option under any existing Company Benefit Plans (except as otherwise provided by the terms of this Agreement, the Statement With Respect to Shares or the express terms of
any unexercisable or unexercised options or warrants outstanding on the date of the Original Investment Agreement), other than (A)&nbsp;issuances of shares of Company Common Stock in respect of the exercise or settlement of any Company stock awards
outstanding on the date of the Original Investment Agreement, (B)&nbsp;the sale of shares of Company Common Stock pursuant to the exercise of options or the settlement of any Company stock awards, if necessary to effectuate an option direction upon
exercise or for withholding of Taxes in accordance with their terms on the date of the Original Investment Agreement, (C)&nbsp;grants of equity awards in the Ordinary Course of Business, in amounts consistent with past practice, pursuant to any
Company Benefit Plan, and (D)&nbsp;the issuance of shares of Company Common Stock or the grant of equity awards in connection with the acquisition of any business or material amount of assets from any other person that is permitted by the terms of
this Agreement or the Statement With Respect to Shares; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) shall not, and shall not permit any of its Subsidiaries to,
incur, assume, guarantee or otherwise become liable for any indebtedness for borrowed money or any guarantee of such indebtedness (other than the Acquisition Debt Financing) except any such incurrence, assumption, guarantee or other liability which
would not be reasonably expected to prevent, materially delay or materially impair the ability of the Company to consummate the Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) shall not and shall not permit any of its Subsidiaries to directly or indirectly, purchase, redeem or otherwise acquire
any shares of the capital stock of the Company or any of its Subsidiaries or any rights, warrants or options to acquire any such shares, except for transactions among the Company and its wholly owned (direct or indirect) Subsidiaries or among the
Company&#146;s wholly owned (direct or indirect) Subsidiaries or in connection with the exercise of any options, or the vesting or settlement of any Company equity awards issued in the Ordinary Course of Business; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) shall not, and shall not permit any of its Subsidiaries to, agree, in writing or otherwise, to take any of the foregoing
actions that are prohibited pursuant to clauses&nbsp;(i) through (viii)&nbsp;of this <U>Section</U><U></U><U>&nbsp;5.01(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02 <U>Reasonable Best Efforts; Filings</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms and conditions of this Agreement, each of the Company and the Investor shall cooperate with each other and use (and
shall cause its Subsidiaries to use) its reasonable best efforts (unless, with respect to any action, another standard of performance is expressly provided for herein) to promptly (i)&nbsp;take, or cause to be taken, all actions, and do, or cause to
be done, and assist and cooperate with each other in doing, all things necessary, proper or advisable to consummate and make effective, in the most expeditious manner reasonably practicable, the Transactions, including preparing and filing promptly
and fully all documentation to effect all necessary filings, notices, petitions, statements, registrations, submissions of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information, applications and other documents, (ii)&nbsp;obtain all approvals, consents, registrations, waivers, permits, authorizations, orders, the expiration or termination of all applicable
waiting periods, and other confirmations from any Governmental Entity or third party necessary, proper or advisable to consummate the Transactions, (iii)&nbsp;execute and deliver any additional instruments necessary to consummate the Transactions
and (iv)&nbsp;defend or contest in good faith any action brought by a third party that could otherwise prevent or impede, interfere with, hinder or delay in any material respect the consummation of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and the Investor agree to make an appropriate filing of a Notification and Report Form (the &#147;<U>Initial HSR
Form</U>&#148;) pursuant to the HSR Act with respect to the transactions contemplated by the Initial Closing (which shall request the early termination of any waiting period applicable to the Transactions under the HSR Act) as promptly as reasonably
practicable following the date of the Original Investment Agreement and in any event no later than ten (10)&nbsp;Business Days (unless the parties mutually agree to a later date), and to supply, as advisable, as promptly as reasonably practicable
any additional information and documentary material that may be requested pursuant to the HSR Act, and the Company and the Investor agree to use reasonable best efforts to promptly take any and all steps necessary to avoid or eliminate each and
every impediment and obtain all consents that may be required pursuant to the HSR Act, so as to enable the parties hereto to consummate the Transactions. The date upon which any applicable waiting periods shall have expired or been terminated, and
any approvals required shall have been obtained, relating to the transactions contemplated by the Initial Closing, the &#147;<U>Initial HSR Approval</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent required by Law, the Company and the Investor agree to make, if necessary, an appropriate filing of a Notification and
Report Form (the &#147;<U>Subsequent HSR Form</U>&#148;, and together with the Initial HSR Form, the &#147;<U>HSR Forms</U>&#148;) pursuant to the HSR Act with respect to the transactions contemplated by the Subsequent Closing (which shall request
the early termination of any waiting period applicable to the Transactions under the HSR Act) in no event later than such time as would permit the Subsequent Closing Date to occur prior to the closing of the Target Merger Agreement, and to supply,
as advisable, as promptly as reasonably practicable any additional information and documentary material that may be requested pursuant to the HSR Act, and the Company and the Investor agree to use reasonable best efforts to promptly take any and all
steps necessary to avoid or eliminate each and every impediment and obtain all consents that may be required pursuant to the HSR Act, so as to enable the parties hereto to consummate the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the Company and the Investor shall (i)&nbsp;cooperate in all respects with the other party in connection with any filing or
submission with a Governmental Entity in connection with the Transactions and in connection with any investigation or other inquiry by or before a Governmental Entity relating to the Transactions, including any proceeding initiated by a private
person, (ii)&nbsp;keep the other party informed in all material respects and on a reasonably timely basis of any material communication received by the Company or the Investor, as the case may be, from or given by the Company or the Investor to, as
the case may be, the Federal Trade Commission (&#147;<U>FTC</U>&#148;), the Department of Justice (&#147;<U>DOJ</U>&#148;) or any other Governmental Entity and of any material communication received or given in connection with any proceeding by a
private Person, in each case regarding the Transactions, (iii)&nbsp;subject to applicable Laws relating to the exchange of information, and to the extent reasonably practicable, consult with the other party with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to information relating to such party and its respective Subsidiaries, as the case may be, that appears in any filing made with, or written materials submitted to, any third Person or any
Governmental Entity in connection with the Transactions, provided that materials furnished pursuant to this <U>Section</U><U></U><U>&nbsp;5.02</U> may be redacted (a)&nbsp;to remove references concerning the valuation of the Company and the
Transactions or other confidential information, (b)&nbsp;as necessary to comply with contractual arrangements, and (c)&nbsp;as necessary to address reasonable privilege concerns, and the parties may reasonably designate any competitively sensitive
or any confidential business material provided to the other under this <U>Section</U><U></U><U>&nbsp;5.02</U> as &#147;counsel only&#148; or, as appropriate, as &#147;outside counsel only&#148;, and (iv)&nbsp;to the extent permitted by the FTC, the
DOJ or such other applicable Governmental Entity or other Person, give the other party the opportunity to attend and participate in such meetings and conferences. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything to the contrary in this Agreement, nothing in this <U>Section</U><U></U><U>&nbsp;5.02</U> or elsewhere in this
Agreement shall require Investor to take any action with respect to any of its Affiliates or its direct or indirect portfolio companies or other investments, including selling, divesting, conveying, holding separate, or otherwise limiting its
freedom of action with respect to any assets, rights, products, licenses, businesses, operations, or interest therein, of any such Affiliates or any direct or indirect portfolio companies or other investments of investment funds advised or managed
by one or more Affiliates of the Investor. The parties understand and agree that all obligations of the Investor related the HSR Act and any other to regulatory approvals shall be governed exclusively by this <U>Section</U><U></U><U>&nbsp;5.02</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each of the Company and the Investor shall not take or agree to take, and shall cause their respective controlled Affiliates not to
take or agree to take, any action that would be reasonably likely to prevent or materially delay the consummation of the Transactions or receipt of any governmental approvals that are conditions to the Subsequent Closing pursuant to <U>Article
VI</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.03 <U>Corporate Actions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At any time that any Series B Preferred Stock is outstanding, the Company shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) from time to time take all lawful action within its control to cause the authorized capital stock of the Company to include
a sufficient number of authorized but unissued shares of Company Common Stock to satisfy the conversion requirements of all shares of the Series B Preferred Stock then outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) take such actions as reasonably requested by the Investor as may be necessary to render inapplicable any control share
acquisition, interested stockholder, business combination or similar anti-takeover provision in the Company Charter Documents or under Chapter 25 of the PBCL or other similar Law that is or could become applicable to the Investor Parties as a result
of the Transactions, including the Company&#146;s issuance of Company Common Stock upon conversion of the Series B Preferred Stock; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) not effect any voluntary deregistration under the Exchange Act or any
voluntary delisting with the NASDAQ (or any other national securities exchange upon which the Company Common Stock may subsequently be principally listed) in respect of the Company Common Stock other than in connection with a Fundamental Change
pursuant to which the Company satisfies in full its obligations under the applicable provisions of the Statement With Respect to Shares, unless the prior written approval of the holders of a majority of the Series B Preferred Stock issued and
outstanding has been obtained; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) so long as the Investor continues to beneficially own at least 5% of the aggregate
number of shares of Series B Preferred Stock issued at the Initial Closing (if the Subsequent Closing has not occurred) or the Initial Closing and the Subsequent Closing (if the Subsequent Closing has occurred), unless the Investor otherwise
consents in writing, not authorize or issue any Parity Stock other than in connection with Permitted Issuances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If any occurrence
since the date of this Agreement until the Subsequent Closing would have resulted in an adjustment to the Conversion Price with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock pursuant to the Statement With Respect
to Shares if such Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock had been issued and outstanding since the date of this Agreement, the Company shall adjust the Conversion Price with respect to such Series <FONT
STYLE="white-space:nowrap">B-2</FONT> Preferred Stock effective as of the Subsequent Closing, in the same manner as would have been required by the Statement With Respect to Shares if such Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred
Stock had been issued and outstanding since the date of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.04 <U>Public Announcements</U>. No press release
or public announcement related to this Agreement or the transactions contemplated herein shall be issued or made by the Investor or its Affiliates without the prior written approval of the Company, unless required by Law (based on the advice of
counsel) in which case the Company shall have the right to review and reasonably comment on such press release, announcement or communication prior to issuance, distribution or publication. Notwithstanding the foregoing (but subject to the terms of
the Confidentiality Agreement and <U>Section</U><U></U><U>&nbsp;5.05</U>), the Investor and its Affiliates shall not be restricted from (a)&nbsp;making any filings and disclosures required under applicable laws (including Sections 13 and 16 of the
Exchange Act) and (b)&nbsp;communicating with their respective investors and potential investors in connection with marketing, informational or reporting activities; provided that in the case of clause (b), the recipient of such information is
subject to a customary obligation to keep such information confidential. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.05 <U>Confidentiality</U>. Until two years after
the Investor no longer owns any Series B Preferred Stock or Company Common Stock issued upon conversion of the Series B Preferred Stock, the Investor will, and will cause its Affiliates and its and their respective Representatives to, keep
confidential any information (including oral, written and electronic information) concerning the Company, its Subsidiaries or its Affiliates that has been or may be furnished to the Investor, its Affiliates or their respective Representatives by or
on behalf of the Company or any of its Representatives pursuant to this Agreement, the Confidentiality Agreement or the Target Merger Agreement (collectively referred to as the &#147;<U>Confidential Information</U>&#148;) and to use the Confidential
Information solely for the purposes of monitoring, administering or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
managing the Investor Parties&#146; investment in the Company made pursuant to this Agreement, including the enforcement of the Investor Parties&#146; rights in respect of such investment and
defending any claim or action made in relation to such investment (a &#147;<U>Permitted Purpose</U>&#148;), provided that the Confidential Information shall not include information that (i)&nbsp;was or becomes available to the public other than as a
result of a disclosure by the Investor, any of its Affiliates or any of their respective Representatives in violation of this <U>Section</U><U></U><U>&nbsp;5.05</U>, (ii) was or becomes available to the Investor, any of its Affiliates or any of
their respective Representatives from a source other than the Company or its Representatives, provided that that such source was not, to the Investor&#146;s knowledge after due inquiry, subject to any legally binding obligation (whether by agreement
or otherwise) to keep such information confidential, (iii)&nbsp;at the time of disclosure is already in the possession of the Investor, any of its Affiliates or any of their respective Representatives, provided that such information is not, to the
Investor&#146;s knowledge after due inquiry, subject to any legally binding obligation (whether by agreement or otherwise) to keep such information confidential, or (iv)&nbsp;was independently developed by the Investor, any of its Affiliates or any
of their respective Representatives without reference to, incorporation of, reliance on or other use of any Confidential Information. The Investor agrees, on behalf of itself and its Affiliates and its and their respective Representatives, that
Confidential Information may be disclosed solely (i)&nbsp;to the Investor&#146;s Affiliates and its and their respective Representatives to the extent required for a Permitted Purpose, and in any event shall not be shared with any such
Representative who, to the knowledge of the Investor, has an employment, director, officer, operating partner or similar relationship with a Competitor, (ii)&nbsp;to its stockholders, limited partners, members or other owners (including any listed
entity that is an investor in an Affiliate of the Investor), who are subject to customary confidentiality obligations, as part of ordinary course reporting or review procedure or in connection with such Person&#146;s ordinary course fundraising,
transactional or reporting activities, as the case may be, and (iii)&nbsp;in the event that the Investor, any of its Affiliates or any of its or their respective Representatives are requested or required by applicable Law, regulation, judgment,
stock exchange rule or other applicable judicial or governmental process (including by deposition, interrogatory, request for documents, subpoena, civil investigative demand or similar process) to disclose any Confidential Information, in each of
which instances the Investor, its Affiliates and its and their respective Representatives, as the case may be, shall, to the extent legally permitted, provide notice to the Company sufficiently in advance of any such disclosure so that the Company
will have a reasonable opportunity to timely seek to limit, condition or quash such disclosure (in which case the Investor shall use reasonable efforts to assist the Company in this respect). The Confidentiality Agreement shall terminate
simultaneously with the Initial Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.06 <U>NASDAQ Listing of Shares</U>. To the extent the Company has not done so
prior to the date of the Original Investment Agreement, the Company shall promptly apply to cause the aggregate number of shares of Company Common Stock issuable upon the conversion of the Series B Preferred Stock issued to the Investor pursuant to
this Agreement and required to be issued to the Investor pursuant to the Statement With Respect to Shares to be approved for listing on the NASDAQ, subject to official notice of issuance, or such other primary exchange as to which the Common Stock
is then admitted for trading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.07 <U>Standstill</U>. The Investor agrees that during the Standstill Period,
without the prior written approval of the Board, the Investor will not, directly or indirectly, and will cause its Affiliates not to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
acquire, offer or seek to acquire, agree to acquire or make a public proposal to acquire, by purchase or otherwise, any securities of the Company, any securities convertible into or exchangeable for any such securities, any options or other
derivative securities or contracts or instruments in any way related to the price of shares of Company Common Stock or any assets or property of the Company or any Subsidiary of the Company that results in the Investor having beneficial ownership of
more than the Maximum Percentage of the shares of the Company Common Stock outstanding at such time (assuming the conversion of the Series B Preferred Stock) (but in any case excluding (i)&nbsp;any issuance by the Company of shares of Company Common
Stock or options, warrants or other rights to acquire Company Common Stock (or the exercise thereof) to any Investor Director as compensation for their membership on the Board, and (ii)&nbsp;the acquisition of the shares of Company Common Stock
issuable upon conversion of the Series B Preferred Stock); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) make or in any way encourage or participate in any
&#147;solicitation&#148; of &#147;proxies&#148; (whether or not relating to the election or removal of directors), as such terms are used in the rules of the SEC, to vote, or knowingly seek to advise or influence any Person with respect to voting
of, any voting securities of the Company or call or seek to call a meeting of the Company&#146;s shareholders or initiate any stockholder proposal for action by the Company&#146;s shareholders, or other than with respect to the Investor Director,
seek election to or to place a representative on the Board or seek the removal of any director from the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) make any public
announcement with respect to, or seek or propose any merger or business combination, tender or exchange offer, recapitalization, reorganization or purchase of a material portion of the assets, properties or securities of the Company, or any other
extraordinary transaction involving the Company, or enter into any discussions, negotiations, arrangements, understandings or agreements with any other Person regarding any of the foregoing; <U>provided</U>, however, that this clause (c)&nbsp;shall
not preclude the tender by the Investor or its Affiliates of any securities of the Company into any tender or exchange offer or the vote by the Investor or its Affiliates of any voting securities of the Company with respect to any Fundamental Change
in accordance with the recommendation of the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) otherwise act, alone or in concert with others, to control or seek to control,
advise or knowingly influence, in any manner, management or the board of directors, or the policies of the Company or any of its Subsidiaries (other than the Investor Director acting in his or her capacity as a member of the Board or voting at a
meeting of the Company&#146;s shareholders); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) acquire, offer or seek to acquire, by purchase or otherwise, any debt securities of the
Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) make any proposal or statement of inquiry or disclose any intention, plan or arrangement inconsistent with any of the
foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) advise, assist, knowingly encourage or direct any Person to do, or to advise, assist, encourage or direct any other Person
to do, any of the foregoing; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) take any action that would or would reasonably be expected to require the Company to
make a public announcement regarding the possibility of a transaction or any of the events described in this <U>Section</U><U></U><U>&nbsp;5.07</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into any discussions, negotiations, communications, arrangements or understandings with any third party (including security holders
of the Company, but excluding, for the avoidance of doubt, the Investor Parties) with respect to any of the foregoing, including, without limitation, forming, joining or in any way participating in a &#147;group&#148; (as defined in
Section&nbsp;13(d)(3) of the Exchange Act) with any third party (excluding, for the avoidance of doubt, the Investor Parties) with respect to the Company or any securities of the Company or otherwise in connection with any of the foregoing; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) request the Company or any of its Representatives, directly or indirectly, to amend or waive any provision of this
<U>Section</U><U></U><U>&nbsp;5.07</U>; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) contest the validity of this <U>Section</U><U></U><U>&nbsp;5.07</U> or make, initiate,
take or participate in any demand, action (legal or otherwise) or proposal to amend, waive or terminate any provision of this <U>Section</U><U></U><U>&nbsp;5.07</U>; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;5.07</U> will limit (1)&nbsp;the Investor Parties&#146;
ability to vote, Transfer (subject to <U>Section</U><U></U><U>&nbsp;5.08</U>), convert (in accordance with the limitations in the Statement With Respect to Shares) or otherwise exercise rights under its Company Common Stock or Series B Preferred
Stock or (2)&nbsp;the ability of any Investor Director to vote or otherwise exercise its fiduciary duties or otherwise act in its capacity as a member of the Board. Notwithstanding anything to the contrary in this
<U>Section</U><U></U><U>&nbsp;5.07</U>, the Investor and its Affiliates may at any time communicate privately with the Company&#146;s directors, officers or advisors or submit to the Board one or more confidential proposals or offers for a
transaction (including a transaction that, if consummated, would result in a Fundamental Change), so long as, in each case, such communications and submissions are not intended to, and would not reasonably be expected to, require any public
disclosure by the Company of such communications or submissions, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.08 <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise permitted in this Agreement or as expressly contemplated by <U>Section</U><U></U><U>&nbsp;5.08(b)</U>, with respect to
the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares until the later of (i)&nbsp;the twelve (12)-month anniversary of the Initial Closing and (ii)&nbsp;the first to occur of (A)&nbsp;the Subsequent Closing and (B)&nbsp;the
termination of the Target Merger Agreement and, with respect to the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, until the twelve (12)-month anniversary of the Subsequent Closing Date (such period, the &#147;<U>Restricted
Period</U>&#148;), the Investor Parties will not Transfer any Series B Preferred Stock or any Company Common Stock issued upon conversion of any Series B Preferred Stock. Following the expiry of the Restricted Period, the Investor Parties will not
at any time knowingly Transfer any shares of Series B Preferred Stock to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Person (other than in underwritten offerings and broadly distributed sales pursuant to Rule 144A and/or similar sales) or
knowingly Transfer any shares of Company Common Stock to (x)&nbsp;any Competitor (including any Activist Investor), or (y)&nbsp;any Person who, upon the occurrence of such Transfer, would beneficially own more than 5% of the outstanding shares of
Company Common Stock (in each case, other than in underwritten offerings and pursuant to Rule 144 under the Securities Act). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding <U>Section</U><U></U><U>&nbsp;5.08(a)</U>, the Investor Parties shall be
permitted to Transfer any portion or all of their Series B Preferred Stock or Company Common Stock issued upon conversion of the Series B Preferred Stock at any time under the following circumstances: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Transfers of (A)&nbsp;Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares following the Restricted Period
or (B)&nbsp;Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares, in the case of each of clauses (A)&nbsp;and (B), to any Permitted Transferees of the Investor, but only if (x)&nbsp;the transferee agrees in writing prior to such
Transfer for the express benefit of the Company (in form and substance reasonably satisfactory to the Company and with a copy thereof to be furnished to the Company) to be bound by the terms of this Agreement and (y)&nbsp;the transferee and the
transferor agree in writing for the express benefit of the Company that the transferee shall Transfer the Series B Preferred Stock or Company Common Stock so Transferred back to the transferor at or before such time as the transferee ceases to be a
Permitted Transferee of the transferor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Transfers to the Company or its Subsidiaries; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Subject to <U>Section</U><U></U><U>&nbsp;5.07</U>, Transfers pursuant to a merger, tender offer, recapitalization,
consolidation or exchange offer or other business combination, acquisition of assets or similar transaction or otherwise, in each case, following an announcement of any Fundamental Change transaction involving the Company or any Subsidiary; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Transfers in connection with, and only after the commencement of, bankruptcy, insolvency or other similar reorganization
proceedings; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Transfers for cash to a Person that is not an affiliate of the Investor to the extent necessary to
satisfy a <I>bona fide</I> prepayment requirement under any Back Leverage; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) Transfers in connection with a mortgage,
hypothecation and/or pledge to a financial institution or other lender or any agent therefor to secure any Back Leverage and the exercise of any rights thereunder by any such financial institution or lender or any agent therefor, including the
foreclosure and subsequent sale of the securities; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) Transfers that have been approved in writing by the Board; and
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) Transfers by the Investor, prior to the end of the Restricted Period, of Series
<FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares to an Affiliate of the Investor that is under common control with the Investor and which is a special purpose vehicle formed for the purpose of holding a portion of the Series B Preferred
Stock; <U>provided</U>, that prior to and as a condition of such Transfer, the Investor shall have delivered to the Company, in each case in form and substance satisfactory to the Company, (A)&nbsp;an amended and restated Equity Commitment Letter,
duly executed by the Equity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
Providers, the Investor and such Affiliate, that, for the express benefit of the Company, provides such Affiliate with a portion of the Subsequent Contribution (as defined in the Equity
Commitment Letter) and continues to provide the remaining portion of the Subsequent Contribution to the Investor, to permit such Affiliate and the Investor to satisfy in full their obligations at the Subsequent Closing and otherwise is consistent
with the terms of the Equity Commitment Letter and (B)&nbsp;a written agreement, duly executed by such Affiliate and the Investor, for the express benefit of the Company, pursuant to which (x)&nbsp;such Affiliate agrees to be bound by the terms of
this Agreement as if it were the Investor (including without limitation <U>Section</U><U></U><U>&nbsp;5.20</U> of this Agreement) and (y)&nbsp;such Affiliate and the Investor agree that such transferee shall not, prior to the Subsequent Closing,
cease to be an Affiliate under common control with the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any attempted Transfer in violation of this
<U>Section</U><U></U><U>&nbsp;5.08</U> shall be null and void <I>ab initio</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.09 <U>[RESERVED]</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>Legend</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All certificates or other instruments representing the Series B Preferred Stock or Company Common Stock issued upon conversion of the
Series B Preferred Stock will bear a legend substantially to the following effect: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED BY THIS INSTRUMENT HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS, OR EXCEPT,
WITH RESPECT TO ANY COMPANY COMMON STOCK, WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS, OR. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN AN AMENDED AND RESTATED INVESTMENT
AGREEMENT, DATED AS OF MARCH&nbsp;30, 2021, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Upon request of the
applicable Investor Party, upon receipt by the Company of an opinion of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state securities laws, the Company
shall promptly cause the first paragraph of the legend to be removed from any certificate for any Series B Preferred Stock or Company Common Stock to be Transferred in accordance with the terms of this Agreement and the second paragraph of the
legend shall be removed upon the expiration of such transfer and other restrictions set forth in this Agreement (and, for the avoidance of doubt, at the request of the holder, in connection with any termination of this Agreement). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Board Matters; Election of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Following the Initial Closing and until the occurrence of the Fall-Away of Investor Board Rights, the Investor shall have the right to
nominate the Investor Director Designee. Effective as of the Initial Closing, the Company and the Board will increase the size of the Board to accommodate the election of such individual (unless there is a vacancy in the Board at such time) and the
Board shall elect Stephen Pagliuca to the Board to serve as the initial Investor Director Designee. The election or appointment of the Investor Director Designee shall be subject to satisfaction of all requirements set forth in the Company&#146;s
corporate governance guidelines, code of business conduct and ethics and insider trading policy in effect from time to time and applicable to other <FONT STYLE="white-space:nowrap">non-executive</FONT> directors (the &#147;<U>Specified
Guidelines</U>&#148;). No Investor Director Designee shall be required to qualify as an independent director under applicable stock exchange rules and federal securities laws and regulations. Following the Initial Closing and until the occurrence of
the Fall-Away of Investor Board Rights, the Investor shall continue to have the right to nominate the Investor Director Designee. The Company will reimburse the Investor Director and any observer appointed pursuant to
<U>Section</U><U></U><U>&nbsp;5.11(b)</U> for their respective reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with travel to or from and
attendance at each meeting of the Board consistent with reimbursement policies of the Company applicable to <FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Board. The Investor Director will receive compensation no less
favorable than such compensation received by other <FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Board. The Investor Director shall have the right to serve on all committees of the Board, subject to applicable legal and
stock exchange requirements. The Investor agrees, upon the Company&#146;s request, to timely provide the Company with accurate and complete information relating to the Investor Director as may be required to be disclosed by the Company under the
Exchange Act and the rules and regulations promulgated thereunder and to make any necessary independence determinations, including for service on Board committees. Upon the occurrence of the Fall-Away of Investor Board Rights, at the written request
of the Board, the Investor Director shall resign, and the Investor shall cause the Investor Director immediately to resign, from the Board effective as of the date of the Fall-Away of Investor Board Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Following the Initial Closing and until the occurrence of the Fall-Away of Investor Board Rights, the Investor shall have the right (in
addition to the rights set forth in <U>Section</U><U></U><U>&nbsp;5.11(a)</U>) to designate a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer of the Board (the &#147;<U>Investor Observer</U>&#148;) reasonably satisfactory to the Board
(it being agreed that Joseph Robbins is satisfactory to the Board). The Investor Observer shall be entitled to (i)&nbsp;attend, strictly as an observer, meetings of each committee of the Board, subject to applicable legal and stock exchange
requirements, other than the Subsidiary Committee of Board and any similar committee that may be formed in the future and (ii)&nbsp;receive notice of and have the right to attend, strictly as an observer, meetings of the Board, and the Company shall
provide the observer with copies of all notices, minutes, consents and other material in connection therewith at the same time as such materials are distributed to members of the Board; provided, that (A)&nbsp;the Investor shall cause the Investor
Observer to agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information provided to the observer pursuant hereto and (B)&nbsp;the Company and the Board shall have the right to withhold any information and
to exclude the Investor Observer from any meeting or portion thereof if doing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
so is, in the opinion of outside counsel to the Company, advisable or necessary to protect the attorney-client privilege between the Company and counsel or work product protection, violate any
Law or violate the terms of any confidentiality agreement or other contract with a third party. In order to be eligible to serve in such capacity, the Investor Observer shall provide a written undertaking to the Company agreeing to be subject to,
bound by and duly comply with a standard confidentiality agreement in a form acceptable to the Company, the code of conduct and other policies of the Company, in each case, to the extent applicable to
<FONT STYLE="white-space:nowrap">non-executive</FONT> directors of the Company. The Investor Observer shall have no right to vote on any matters presented to the Board or any Board committee or be entitled to receive any compensation in his or her
capacity as Investor Observer. Any action taken by the Board at any meeting will not be invalidated by the absence of the Investor Observer at such meeting. All obligations of the Company pursuant to this <U>Section</U><U></U><U>&nbsp;5.11(b)</U>
shall terminate, and, upon request by the Board, the Investor shall cause the Investor Observer to resign promptly from his or position as a <FONT STYLE="white-space:nowrap">non-voting</FONT> observer, in each case upon the Investor ceasing to have
the right to designate the Investor Observer pursuant to this <U>Section</U><U></U><U>&nbsp;5.11</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Following the Initial Closing
and until the occurrence of the Fall-Away of Investor Board Rights, at any annual meeting of the Company&#146;s stockholders at which the term of the Investor Director shall expire, the Investor shall have the right to designate, in accordance with
the articles of incorporation and bylaws of the Company and the PBCL and in accordance with the provisions of this <U>Section</U><U></U><U>&nbsp;5.11</U>, the Investor Director Designee. The Company and the Board shall (i)&nbsp;include each Investor
Director Designee designated by the Investor in accordance with this <U>Section</U><U></U><U>&nbsp;5.11</U> in the Company&#146;s slate of nominees for the applicable meeting of the Company&#146;s stockholders (whether in the Company&#146;s proxy
statement or otherwise), (ii) recommend that the Company&#146;s stockholders vote in favor of such Investor Director Designee, (iii)&nbsp;use its reasonable best efforts to support such nominees with substantially the same level of efforts and
support as is used and/or provided for the other director nominees of the Company with respect to the applicable meeting of stockholders, (iv)&nbsp;cause the Board to have sufficient vacancies to permit such Investor Director Designee to be elected
as a member of the Board and (v)&nbsp;so long as any Investor Director Designee is eligible to be so designated in accordance with this <U>Section</U><U></U><U>&nbsp;5.11</U>, not take any action to remove such person as such a director without
cause without the prior written consent of the Investor. The Investor shall not be required to comply with the advance notice provisions generally applicable to the nomination of directors by the Company so long as the Investor provides reasonable
advance notice to the Company of the Investor Director Designee prior to the mailing of the proxy statement by the Company (provided, that upon the request of the Investor the Company shall provide reasonable advance notice to the Investor of the
expected mailing date). For the avoidance of doubt, failure of the stockholders of the Company to elect any Investor Director Designee to the Board shall not affect the right of the Investor to nominate directors for election pursuant to this
<U>Section</U><U></U><U>&nbsp;5.11</U> in any future election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event of the death, disability, resignation or
removal of the Investor Director as a member of the Board (other than pursuant to <U>Section</U><U></U><U>&nbsp;5.11(c)</U>), the Investor may designate an Investor Director Designee (in accordance with the process set forth in
<U>Section</U><U></U><U>&nbsp;5.11(a)</U>) to replace such director and the Company shall cause such Investor Director Designee to fill such resulting vacancy. In the event of the death, disability, resignation or removal of the Investor Observer,
the Investor may designate an observer designee (in accordance with the process set forth in <U>Section</U><U></U><U>&nbsp;5.11(b)</U>) to replace such observer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees to negotiate in good faith the form of, and agrees to enter into, a
customary director indemnification agreement with the Investor Director no less favorable than with other <FONT STYLE="white-space:nowrap">non-executive</FONT> members of the Board and including customary provisions as agreed by the parties in good
faith, and the Company shall indemnify the Investor Director and provide the Investor Director with director and officer insurance to the same extent as it indemnifies and provides such insurance to other
<FONT STYLE="white-space:nowrap">non-executive</FONT> members of the Board, pursuant to the articles of incorporation and bylaws of the Company, the PBCL or otherwise. The Company acknowledges and agrees that the Company shall be the indemnitor of
first resort with respect to any indemnification, advancement of expenses and/or insurance provided in the Company&#146;s articles of incorporation, bylaws and/or any indemnification agreement entered into between the Company and the Investor
Director (such that the Company&#146;s obligations to such indemnitees are primary), and the Company agrees to include customary &#147;Levy Provisions&#148; with respect to the foregoing in any such indemnification agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the fullest extent permitted by the PBCL and subject to any express agreement that may from time to time be in effect, the Company
agrees that any Investor Director Designee, Investor Observer, the Investor and any other member of the Bain Group or any portfolio company thereof (collectively, &#147;<U>Covered Persons</U>&#148;) may, and shall have no duty not to,
(i)&nbsp;invest in, carry on and conduct, whether directly, or as a partner in any partnership, or as a joint venturer in any joint venture, or as an officer, director, stockholder, equityholder or investor in any person, or as a participant in any
syndicate, pool, trust or association, any business of any kind, nature or description, whether or not such business is competitive with or in the same or similar lines of business as the Company or any of its Subsidiaries, (ii)&nbsp;do business
with any client, customer, vendor or lessor of any of the Company or its Affiliates; and/or (iii)&nbsp;make investments in any kind of property in which the Company may make investments. To the fullest extent permitted by the PBCL, the Company
renounces any interest or expectancy to participate in any business or investments of any Covered Person as currently conducted or as may be conducted in the future, and waives any claim against a Covered Person and shall indemnify a Covered Person
against any claim that such Covered Person is liable to the Company or its stockholders for breach of any fiduciary duty solely by reason of such person&#146;s participation in any such business or investment. The Company shall pay in advance any
expenses incurred in defense of such claim as provided in this provision except to the extent that a Covered Person is determined by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> order of a Delaware court having competent
jurisdiction (or any other judgement which is not appealed in the applicable time) that such Covered Person is not entitled to indemnification under this <U>Section</U><U></U><U>&nbsp;5.11(f)</U>, in which case any such advanced expenses shall be
promptly reimbursed to the Company. The Company agrees that in the event that a Covered Person acquires knowledge of a potential transaction or matter which may constitute a corporate opportunity for both (x)&nbsp;the Covered Person and (y)&nbsp;the
Company or its Subsidiaries, the Covered Person shall not have any duty to offer or communicate information regarding such corporate opportunity to the Company or its Subsidiaries, except for any corporate opportunity which is expressly offered to a
Covered Person in writing stating that such offer is intended for such Covered Person in his or her capacity as a member of the Board. To the fullest extent permitted by the PBCL, the Company hereby renounces any interest or expectancy in any
potential transaction or matter of which the Covered Person acquires knowledge. The Company shall pay in advance any expenses incurred in defense of such claim as provided in this provision, except to the extent that a Covered Person is determined
by a final, <FONT STYLE="white-space:nowrap">non-appealable</FONT> order of a Delaware court having competent jurisdiction (or any other judgment which is not appealed in the applicable time) to have breached this
<U>Section</U><U></U><U>&nbsp;5.11(f)</U> in which case any such advanced expenses shall be promptly reimbursed to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) For so long as an Investor Director Designee is on the Board, (i)&nbsp;such Investor
Director Designee shall be subject to the Specified Guidelines, but the Company shall not implement or maintain any trading policy, equity ownership guidelines (including with respect to the use of Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT>
plans and preclearance or notification to the Company of any trades in the Company&#146;s securities) or similar guideline or policy with respect to the trading of securities of the Company that applies to the Investor or its Affiliates (including a
policy that limits, prohibits or restricts the Investor or its Affiliates from entering into any hedging or derivative arrangements), in each case other than with respect to any Investor Director Designee solely in his or her individual capacity,
except as provided herein, or that imposes confidentiality obligations on any Investor Director Designee that are inconsistent with the Confidentiality Agreement, (ii)&nbsp;any share ownership requirement for any Investor Director Designee serving
on the Board shall be deemed satisfied by the securities owned by the Bain Group and/or its Affiliates and under no circumstances shall any of such policies, procedures, processes, codes, rules, standards and guidelines impose any restrictions on
the Bain Group&#146;s or its Affiliates&#146; transfers of securities pursuant to the terms and conditions of the Registration Rights Agreement and (iii)&nbsp;under no circumstances shall any policy, procedure, code, rule, standard or guideline
applicable to the Board be violated by any Investor Director Designee (A)&nbsp;accepting an invitation to serve on another board of directors of a company that competes (or whose Subsidiaries compete) in any material respect with the business of the
Company or failing to notify an officer or director of the Company prior to doing so (provided, however, that the Investor Director Designee shall be subject to customary recusal requirements of the Board), (B) receiving compensation from the Bain
Group or any of its Affiliates, or (C)&nbsp;failing to offer his or her resignation from the Board of Directors except as otherwise expressly provided in this Agreement or pursuant to any majority voting policy adopted by the Board of Directors,
and, in each case of (i), (ii) and (iii), it is agreed that any such policies in effect from time to time that purport to impose terms inconsistent with this <U>Section</U><U></U><U>&nbsp;5.11</U> shall not apply to the extent inconsistent with this
<U>Section</U><U></U><U>&nbsp;5.11</U>. Notwithstanding the foregoing, the Investor acknowledges and agrees, and will advise each Person who receive any Confidential Information subject to <U>Section</U><U></U><U>&nbsp;5.05</U>, that the
Confidential Information may include material <FONT STYLE="white-space:nowrap">non-public</FONT> information regarding the Company or its Subsidiaries, and the Investor hereby further acknowledges that it is aware, and that it will advise such
Persons, that the United States federal securities laws prohibit persons with material <FONT STYLE="white-space:nowrap">non-public</FONT> information about a company obtained directly or indirectly from such company from purchasing or selling
securities of such company on the basis of such information or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such other person is likely to purchase or sell such securities on
the basis of such information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) At each meeting of the shareholders of the Company involving the election of directors following the
receipt of the Initial HSR Approval and at every postponement or adjournment thereof, the Investor shall, and shall cause the Investor Parties to, take such action as may be required so that all of the voting equity securities of the Company
beneficially owned, directly or indirectly, by the Investor Parties and entitled to vote at such meeting of shareholders are voted in favor of each director nominated or recommended by the Board for election. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company and its paying agent shall be entitled to withhold Taxes on all payments on the Series B Preferred Stock or Company Common
Stock or other securities issued upon conversion of the Series B Preferred Stock in each case to the extent required by applicable Law. The Company shall promptly notify the Investor if it determines that it has such requirement to withhold and give
the Investor a reasonable opportunity to provide any form or certificate to reduce or eliminate such withholding. Within a reasonable amount of time after making such withholding payment, the Company shall furnish the Investor with copies of any tax
certificate, receipt or other documentation reasonably acceptable to the Investor evidencing such payment. On the Initial Closing Date, the Investor shall deliver to the Company or its paying agent a duly executed, valid, accurate and properly
completed IRS Form <FONT STYLE="white-space:nowrap">W-9</FONT> or an appropriate IRS Form <FONT STYLE="white-space:nowrap">W-8,</FONT> as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Absent a change in law or IRS practice, or a contrary determination (as defined in Section&nbsp;1313(a) of the Code), the Investor and the
Company agree not to treat the Series B Preferred Stock (based on their terms as set forth in the Statement With Respect to Shares) as &#147;preferred stock&#148; within the meaning of Section&nbsp;305 of the Code and Treasury Regulations <FONT
STYLE="white-space:nowrap">Section&nbsp;1.305-5,</FONT> for U.S. federal and applicable state and local income Tax and withholding Tax purposes, and shall not take any position inconsistent with such treatment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall pay any and all documentary, stamp and similar issue or transfer Tax due on (i)&nbsp;the issuance of the Series B
Preferred Stock and (ii)&nbsp;the issuance of shares of Company Common Stock upon conversion of the Series B Preferred Stock. However, in the case of conversion of Series B Preferred Stock, the Company shall not be required to pay any Tax or duty
that may be payable in respect of any transfer involved in the issuance and delivery of shares of Company Common Stock or Series B Preferred Stock to a beneficial owner other than the beneficial owner of the Preferred Stock immediately prior to such
conversion, and no such issue or delivery shall be made unless and until the person requesting such issue has paid to the Company the amount of any such Tax or duty, or has established to the satisfaction of the Company that such Tax or duty has
been paid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Use of Proceeds</U>. The Company shall use the proceeds from the issuance and sale of the Shares
(a)&nbsp;to finance the cash consideration payable and to pay for any costs, fees and expenses incurred in connection with the Target Acquisition and/or (b)&nbsp;for general corporate purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Back Leverage Cooperation</U>. If requested by the Investor, the Company will provide the following cooperation in
connection with the Investor obtaining any Back Leverage (i)&nbsp;subject to applicable law, using reasonable best efforts to (A)&nbsp;remove any restrictive legends on certificates representing the Shares (and any shares of Company Common Stock
issued upon conversion of the Shares) and record such Shares (and such shares of Company Common Stock) in book entry form on the books of Company or its transfer agent when eligible to do so or (B)&nbsp;without limiting the generality of clause (A),
if such Shares (or such shares of Company Common Stock issued upon conversion of Shares) are eligible for resale under Rule 144A, and eligible to be so deposited, depositing such pledged Series B Preferred Stock or Company Common Stock in book entry
form on the books of The Depository Trust Company or other depository with customary restrictive legends, (ii)&nbsp;if so requested by any applicable lender, agent or counterparty, as applicable, using commercially reasonable efforts to register the
pledged Series B Preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Stock and/or shares of Company Common Stock to be issued upon conversion of the Series B Preferred Stock, as applicable, in the name of the relevant lender, agent, counterparty, custodian or
similar party to Back Leverage, in certificated or restricted book-entry format on the books and records of the Company&#146;s transfer agent, in each case, with respect to Back Leverage solely as secured party and only to the extent Investor or its
Affiliates continues to beneficially own such pledged Series B Preferred Stock or Company Common Stock, (iii)&nbsp;entering into an issuer agreement (an &#147;<U>Issuer Agreement</U>&#148;) with each lender or agent therefor with respect to such
Back Leverage substantially in the form attached hereto as <U>Exhibit B</U>, and subject to the consent of the Company (which will not be unreasonably withheld, conditioned or delayed), with such changes thereto as are requested by such lender or
agent therefor, (iv)&nbsp;entering into customary triparty agreements with the relevant lender or agent therefor and the Investor relating to the delivery of the Series B Preferred Stock and shares of Company Common Stock, in certificated format or
restricted book-entry format on the books and records of the Company&#146;s transfer agent, as determined by the Investor, to the relevant Back Leverage lender or agent therefor, in each case, subject to applicable transfer restrictions and related
restrictive legends, or, if such Shares (or such shares of Company Common Stock) are eligible for resale under Rule 144A and eligible to be so deposited, the deposit thereof in book entry form on the books of The Depository Trust Company or other
depository for crediting to the relevant collateral accounts upon, funding of the relevant loan and payment of the purchase price of the Investor, including a right for such lender, agent or counterparty as a third party beneficiary with respect to
the Company&#146;s obligation under <U>Article II</U> hereof to issue the Series B Preferred Stock upon payment of the purchase price therefor in accordance with the terms of this Agreement and (v)&nbsp;such other cooperation and assistance as the
Investor may reasonably request that will not unreasonably disrupt the operation of the Company&#146;s business. Anything in the preceding sentence to the contrary notwithstanding, the Company&#146;s obligation to deliver an Issuer Agreement is
conditioned on (A)&nbsp;the Investor delivering to the Company a copy of the applicable loan agreement for the Back Leverage to which the Issuer Agreement relates and (B)&nbsp;the Investor certifying to the Company in writing that (w)&nbsp;the loan
agreement with respect to which the Issuer Agreement is being delivered constitutes Back Leverage being entered into in accordance with this Agreement, the Investor has pledged the Preferred Stock and/or the underlying shares of Company Common Stock
as collateral to the applicable lenders or agents therefor under such Back Leverage and that the execution of such Back Leverage and the terms thereof do not violate the terms of this Agreement or the Statement With Respect to Shares, (x)&nbsp;to
the extent applicable, whether the registration rights under the Registration Rights Agreement are being assigned to the applicable lenders or agents therefor under the Back Leverage, (y)&nbsp;an Exercise of Remedies (as defined in the Issuer
Agreement) constitutes the only circumstance under which the lenders under the Back Leverage may foreclose on the Shares (or shares of Company Common Stock issued upon conversion of Shares) and (z)&nbsp;the Investor acknowledges and agrees that the
Company shall be relying on such certificate when entering into the Issuer Agreement and any material inaccuracy in such certificate shall be deemed a breach of this Agreement; provided, that the Company shall, and shall cause its Affiliates and its
and their respective Representatives to, keep confidential the terms and the existence of any such loan agreement and related documents in connection with Back Leverage (and any amendments or supplements thereto), other than in the case that the
Company, any of its Affiliates or any of its or their respective Representatives are requested or required by applicable Law, regulation, judgment, stock exchange rule or other applicable judicial or governmental process (including by deposition,
interrogatory, request for documents, subpoena, civil investigative demand or similar </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
process) to disclose such information, in each of which instances the Company, its Affiliates and its and their respective Representatives, as the case may be, shall, to the extent legally
permitted, provide notice to the Investor sufficiently in advance of any such disclosure so that the Investor will have a reasonable opportunity to timely seek to limit, condition or quash such disclosure (in which case the Company shall use
reasonable efforts to assist the Investor in this respect). The Investor acknowledges and agrees that the statements and agreements of the Company in an Issuer Agreement are solely for the benefit of the applicable lenders and agents party thereto
and that in any dispute between the Company and the Investor under this Agreement, the Investor shall not be entitled to use the statements and agreements of the Company in an Issuer Agreement against the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>State Securities Laws</U>. During the period from the date of this Agreement until the Subsequent Closing Date (or such
earlier date on which the Subsequent Investment Provisions may be terminated pursuant to <U>Section</U><U></U><U>&nbsp;7.01</U>), the Company shall use its reasonable best efforts to (a)&nbsp;obtain all necessary permits and qualifications, if any,
or secure an exemption therefrom, required by any state or country pursuant to applicable <U>securities</U> laws prior to the offer and sale by the Investor of Company Common Stock and/or Series B Preferred Stock and (b)&nbsp;cause such
authorization, approval, permit or qualification to be effective as of the Subsequent Closing and as of any conversion of Series B Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <U>Information Rights</U>. In order to facilitate (i)&nbsp;the Investor&#146;s compliance with legal and regulatory
requirements applicable to the beneficial ownership by the Investor and its Affiliates of equity securities of the Company, and (ii)&nbsp;oversight of the Investor&#146;s investment in the Company, from the date hereof, and so long as the 25%
Beneficial Ownership Requirement is satisfied by the Investor Parties, the Company agrees promptly to provide the Investor Parties with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) subject to the approval of the Chief Executive Officer of the Company, the right to visit any of the offices and properties of the
Company and its Subsidiaries, in each case upon reasonable notice and at such reasonable times and as often as the Investor may reasonably request, (ii)&nbsp;the right to, as reasonably requested by the Investor, inspect the books and records of the
Company and its Subsidiaries, in each case upon reasonable notice and at such reasonable times and as often as the Investor may reasonably request and (iii)&nbsp;such other information reasonably requested by the Investor in the Company&#146;s
possession related to the business, operations and financial condition of the Company and its Subsidiaries (including any projections or financial analysis prepared by or on behalf of the Company) (it being understood that the Company shall not be
required to create any new projections or analyses or other reports in response to a request pursuant to this clause (iii)); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Subject to the approval of the Chief Executive Officer of the Company, make appropriate officers, advisors and representatives of the Company and its Subsidiaries available periodically and at such times as reasonably requested by the Investor for
consultation with the Investor, its Affiliates and the representatives of the foregoing with respect to matters relating to the business, operations and affairs of the Company and its Subsidiaries; provided that in case of clause (a)&nbsp;and (b)
the Company shall not be obligated to provide materials, documents or information that it reasonably and in good faith considers to be a trade secret or the disclosure of which would reasonably be likely to jeopardize the attorney-client privilege
between the Company and its counsel or violate applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <U>Section 16 Matters</U>. If the Company becomes a party to a
consolidation, merger or other similar transaction that may result in the Investor, its Affiliates and/or the Investor Director being deemed to have made a disposition of equity securities of the Company or derivatives thereof for purposes of
Section&nbsp;16 of the Exchange Act, and if the Investor Director is serving on the Board at such time or has served on the Board during the preceding six months, then (i)&nbsp;the Board will <FONT STYLE="white-space:nowrap">pre-approve</FONT> such
disposition of equity securities or derivatives thereof for the express purpose of exempting the Investor&#146;s, its Affiliates&#146;, the Investor Director&#146;s &#145;interests (to the extent the Investor or its Affiliates may be deemed to be
&#147;directors by deputization&#148;) in such transaction from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> thereunder and (ii)&nbsp;if the transaction involves (A)&nbsp;a merger or
consolidation to which the Company is a party and capital stock is, in whole or in part, converted into or exchanged for equity securities of a different issuer, (B)&nbsp;a potential acquisition by the Investor, the Investor&#146;s Affiliates and/or
the Investor Director of equity securities of such other issuer or derivatives thereof and (C)&nbsp;an Affiliate or other designee of the Investor or its Affiliates will serve on the board of directors (or its equivalent) of such other issuer, then
if the Investor reasonably requires that the other issuer <FONT STYLE="white-space:nowrap">pre-approve</FONT> any acquisition of equity securities or derivatives thereof for the express purpose of exempting the interests of any director or officer
of the Company or any of its Subsidiaries in such transactions from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> thereunder, the Company shall require that such other issuer <FONT
STYLE="white-space:nowrap">pre-approve</FONT> any such acquisitions of equity securities or derivatives thereof for the express purpose of exempting the interests of the Investor&#146;s, its Affiliates&#146; and the Investor Director&#146;s&#146;
(for the Investor and/or its Affiliates, to the extent such persons may be deemed to be &#147;directors by deputization&#148; of such other issuer) in such transactions from Section&nbsp;16(b) of the Exchange Act pursuant to Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <U>VCOC Letters</U>. Upon request by the Investor, the Company
shall deliver to the Investor at the Initial Closing and from time to time any Affiliate of the Investor to whom the Investor&#146;s rights and obligations under this Agreement are assigned in accordance with this Agreement a letter substantially
consistent with the form thereof furnished by the Investor and reasonably acceptable to the Company (the &#147;<U>VCOC Letters</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <U>Target Acquisition</U>. The Company shall at the Investor&#146;s request keep the Investor updated regarding the status
of the Target Acquisition, including progress toward the satisfaction of the closing conditions set forth in the Target Merger Agreement. The Company shall furnish to the Investor information regarding the Target Acquisition as is reasonably
requested by the Investor from time to time, subject to any limitations under the Target Merger Agreement. The Company shall not amend or otherwise modify, waive any term or condition of, or excuse performance under the Target Merger Agreement, in
each case, in a manner that is materially adverse to the Investor without the prior written consent of the Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20
<U>Statement With Respect to Shares</U>(a) . The Investor hereby agrees to perform its obligations pursuant to the Statement With Respect to Shares. In the event the obligations of holders of the Series <FONT STYLE="white-space:nowrap">B-1</FONT>
Preferred Stock to purchase the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Stock terminate pursuant to Section&nbsp;1(e) of the Statement With Respect to Shares, the parties will negotiate in good faith to amend this Agreement to
provide for the purchase of such securities by the Investor, subject to the conditions set forth herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 <U>Pipeline Financings</U>. Following any termination of the Target Merger
Agreement, so long as the Investor continues to beneficially own at least 50% of the shares of Series B Preferred Stock purchased by the Investor, in the event the Company proposes to issue any senior preferred securities for cash to finance any
material acquisition by the Company of a business or another company, the Company shall first offer to the Investor the right to purchase such securities and, in the event the Investor declines, the Company shall be permitted to issue such
securities on terms not more favorable in any material respect to the purchaser than were offered to the Investor. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Conditions to Subsequent Closing </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01 <U>Conditions to the Obligations of the Company and the Investor</U>. The respective obligations of each of the Company and
the Investor to effect the Subsequent Closing shall be subject to the satisfaction (or waiver, if permissible under applicable Law) at the Subsequent Closing of each of the conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.01</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>No Legal Prohibition</U>. No injunction by any court or other tribunal of competent jurisdiction shall have been entered and shall
continue to be in effect and no Law shall have been adopted or be effective, in each case, that prohibits the consummation of the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>HSR Act; Foreign Investment Laws</U>. Any applicable waiting periods shall have expired or been terminated, and any approvals required
shall have been obtained, in each case relating to the Transactions under the HSR Act or under any other antitrust Law or any Laws with respect to foreign investment specified in <U>Section</U><U></U><U>&nbsp;6.01(b)</U> of the Disclosure Schedules.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Target Acquisition</U>. The Target Acquisition shall have been consummated, or will be consummated substantially simultaneously
with the Subsequent Closing, in each case, in accordance with the terms and conditions of the Target Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.02
<U>Conditions to the Obligations of the Company</U>. The obligation of the Company to effect the Subsequent Closing shall be further subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Subsequent Closing
Date of each of the conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.02</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>.
(i)&nbsp;The representations and warranties of the Investor set forth in <U>Article IV</U> shall be true and correct in all respects both when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the extent
expressly made as of an earlier date, in which case as of such date), except where the failure of such representations and warranties to be so true and correct would not have an Investor Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. The Investor shall have complied with or performed in all material
respects its obligations required to be complied with or performed by it pursuant to this Agreement at or prior to the Subsequent Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Closing Certificate</U>. The Company shall have received a certificate, signed on behalf of the Investor by an executive officer
thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> and <U>Section</U><U></U><U>&nbsp;6.02(b)</U> have been satisfied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.03 <U>Conditions to the Obligations of the Investor</U>. The obligation of the Investor to effect the Subsequent Closing shall
be further subject to the satisfaction (or waiver, if permissible under applicable Law) at or prior to the Subsequent Closing of each of the conditions set forth in this <U>Section</U><U></U><U>&nbsp;6.03</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Warranties</U>. (i)&nbsp;The Fundamental Representations shall be true and correct in all material respects both
when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in which case as of such date) and (ii)&nbsp;the representations and warranties of the Company set
forth in <U>Section</U><U></U><U>&nbsp;3.02(a)</U> shall be true and correct in all respects (except for only de minimis inaccuracies) both when made and at and as of the Subsequent Closing Date, as if made at and as of such time (except to the
extent expressly made as of an earlier date, in which case as of such date). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Covenants</U>. The Company shall have complied with
or performed in all material respects its obligations required to be complied with or performed by it pursuant to this Agreement at or prior to the Subsequent Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Material Adverse Effect</U>. Since the date of the Original Investment Agreement, there shall not have been any event, change,
effect, development or occurrence that, individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Debt Financing</U>. The Debt Financing (as defined in the Target Merger Agreement), or such other financing acceptable to the Board
acting reasonably<B> </B>and sufficient (assuming the payment of the Subsequent Investment Purchase Price and the Upsize Subsequent Investment Purchase Price (if any) by the Investor at the Subsequent Closing) to fund the cash portion of the merger
consideration payable under the Target Merger Agreement and transaction fees and expenses (together, the &#147;<U>Acquisition Debt Financing</U>&#148;), shall have been funded, or will be funded simultaneously with the Closing (as defined in the
Target Merger Agreement), in accordance with the Debt Commitment Letter (as defined in the Target Merger Agreement) or the definitive documentation providing for such other financing, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Closing Certificate</U>. The Investor shall have received a certificate, signed on behalf of the Company by an executive officer
thereof, certifying that the conditions set forth in <U>Section</U><U></U><U>&nbsp;6.03(a)</U>, <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and <U>Section</U><U></U><U>&nbsp;6.03(c)</U> have been satisfied (the &#147;<U>Closing Certificate</U>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>NASDAQ Approval</U>. Any shares of Company Common Stock issuable upon conversion of the Series B Preferred Stock (other than any
additional shares of Series B Preferred Stock that may be issued as dividends payable in kind) at the applicable Conversion Price specified in the Statement With Respect to Shares as in effect on the Subsequent Closing Date shall have been approved
for listing on the NASDAQ, subject to official notice of issuance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Termination; Survival </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01 <U>Termination Prior to the Subsequent Closing</U>. The rights and obligations of the parties in respect of the Subsequent
Closing and the provisions of this Agreement specifically related to the Subsequent Investment and the purchase and sale of the Upsize Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares (if any) (collectively, the
&#147;<U>Subsequent Investment Provisions</U>&#148;) may only be terminated at any time prior to the Subsequent Closing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by the
mutual written consent of the Company and the Investor; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) automatically upon the valid termination of the Target Merger Agreement for
any reason in accordance with its terms and conditions, including as set forth in Section&nbsp;7.1 therein; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by either the Company or
the Investor upon valid delivery of written notice to the other, if the Subsequent Closing has not occurred on or prior to 5:00 p.m., Eastern time, on the <FONT STYLE="white-space:nowrap">nine-month</FONT> anniversary of the date of the Target
Merger Agreement (the &#147;<U>Investor Original End Date</U>&#148;); <U>provided</U> that if the Investor Original End Date is extended to the &#147;First Extended End Date&#148; under the Target Merger Agreement pursuant to the terms and
conditions of Section&nbsp;7.1 therein, the Investor Original End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;First Extended End Date&#148; as defined in the Target Merger Agreement
(the &#147;<U>Investor First Extended End Date</U>&#148;); <U>provided</U>, <U>further</U>, that if the &#147;First Executed End Date&#148; is extended to the &#147;Second Extended End Date&#148; in the Target Merger Agreement pursuant to the terms
and conditions of Section&nbsp;7.1 therein, the Investor First Extended End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;Second Extended End Date&#148; as defined in the Target Merger
Agreement (the &#147;<U>Investor Second Extended End Date</U>&#148;); <U>provided</U>, <U>further</U>, that if the Second Executed End Date is extended to the &#147;Third Extended End Date&#148; in the Target Merger Agreement pursuant to the terms
and conditions of Section&nbsp;7.1 therein, the Investor Second Extended End Date shall automatically, without any further action by any Person, be extended to the same date as the &#147;Third Extended End Date&#148; as defined in the Target Merger
Agreement (the &#147;<U>Investor Third Extended End Date</U>&#148;, and the Investor Original End Date, as such date may be extended to the Investor First Extended End Date, the Investor Second Extended End Date and the Investor Third Extended End
Date, as applicable, the &#147;<U>Investor End Date</U>&#148;); <U>provided</U> that (i)&nbsp;the right to terminate the Subsequent Investment Provisions pursuant to this <U>Section</U><U></U><U>&nbsp;7.01(c)</U> shall not be available to a party if
the failure of the Subsequent Closing to occur by such date shall have resulted from a material breach by such party of any representation, warranty, covenant or other agreement of such party set forth in this Agreement and (ii)&nbsp;the Investor
shall not have the right to terminate the Subsequent Investment Provisions pursuant to this <U>Section</U><U></U><U>&nbsp;7.01(c)</U> unless and until the Company has the right to terminate the Target Merger Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;7.1(b)</U> thereof; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by either the Company or the Investor, if an injunction shall have been entered
permanently restraining, enjoining or otherwise prohibiting the consummation of the transactions contemplated by the Subsequent Closing and such injunction shall have become final and nonappealable; <U>provided</U>, that the right to terminate the
Subsequent Investment Provisions under this <U>Section</U><U></U><U>&nbsp;7.01(d)</U> shall not be available to a party if such injunction was primarily due to a material breach by such party of any representation, warranty, covenant or other
agreement of such party set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by the Company, if the Investor shall have breached or failed to perform any of
its or their representations, warranties, covenants or other agreements contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Subsequent Closing Date, would result in a failure of a
condition set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> or <U>Section</U><U></U><U>&nbsp;6.02(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the Investor End Date or, if such breach or failure is capable of being cured by the
Investor End Date, the Investor has not cured such breach or failure within thirty (30)&nbsp;days after receiving written notice from the Company describing such breach or failure in reasonable detail (<U>provided</U> that the Company is not then in
material breach of any representation, warranty, covenant or other agreement contained herein that would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.03(a)</U> or <U>Section</U><U></U><U>&nbsp;6.03(b)</U>); or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Investor, if the Company shall have breached or failed to perform any of its representations, warranties, covenants or other
agreements contained in this Agreement, which breach or failure to perform (i)&nbsp;if it occurred or was continuing to occur on the Subsequent Closing Date, would result in a failure of a condition set forth in
<U>Section</U><U></U><U>&nbsp;6.03(a)</U> or <U>Section</U><U></U><U>&nbsp;6.03(b)</U> and (ii)&nbsp;by its nature, cannot be cured prior to the Investor End Date, if such breach or failure is capable of being cured by the Investor End Date, the
Company has not cured such breach or failure within thirty (30)&nbsp;days after receiving written notice from Investor describing such breach or failure in reasonable detail (<U>provided</U> that Investor is not then in material breach of any
representation, warranty, covenant or other agreement contained herein that would result in a failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;6.02(a)</U> or <U>Section</U><U></U><U>&nbsp;6.02(b)</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02 <U>Effect of Termination Prior to </U><U>Subsequent Closing</U>. In the event of the termination of the Subsequent
Investment Provisions as provided in <U>Section</U><U></U><U>&nbsp;7.01</U>, written notice thereof shall be given to the other party, specifying the provision hereof pursuant to which such termination is made, and the Subsequent Investment
Provisions shall forthwith become null and void (other than <U>Section</U><U></U><U>&nbsp;5.04</U>, <U>Section</U><U></U><U>&nbsp;5.05</U>, this <U>Section</U><U></U><U>&nbsp;7.02</U> and <U>Article VIII</U> (for the avoidance of doubt, all rights,
obligations, terms and conditions of this Agreement which are not the Subsequent Investment Provisions shall survive termination of the Subsequent Investment Provisions)), and there shall be no liability on the part of the Investor or the Company or
their respective directors, officers and Affiliates in connection with the Subsequent Investment Provisions, except that&nbsp;(a) no such termination shall relieve any party from liability for damages for Fraud or willful breach of the Subsequent
Investment Provisions prior to such termination and (b)&nbsp;the parties hereto acknowledge and agree that nothing contained herein shall be deemed to affect their right to specific performance in accordance with this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03 <U>Survival and Limitation on Liability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All of the covenants or other agreements of the parties contained in this Agreement to be performed prior to the Subsequent Closing shall
terminate at the Subsequent Closing. Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;7.02</U>, all of the covenants or other agreements of the parties contained in this Agreement to be performed following the Subsequent Closing shall
survive until fully performed or fulfilled, unless and to the extent that <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such covenants or agreements is waived in writing by the party entitled to such performance. All representations
and warranties contained in this Agreement (including the schedules and the certificates delivered pursuant hereto) will survive (i)&nbsp;with respect to claims in respect of the Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares,
for twelve months following the date of the Original Investment Agreement and (ii)&nbsp;with respect to claims in respect of the Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares will survive for twelve (12)&nbsp;months following
the Subsequent Closing; provided further that nothing herein shall relieve any party of liability for any inaccuracy or breach of such representation or warranty to the extent that any good faith allegation of such inaccuracy or breach is made in
writing prior to such expiration by a Person entitled to make such claim pursuant to the terms and conditions of this Agreement. For the avoidance of doubt, claims may be made with respect to the breach of any representation, warranty or covenant
until the applicable survival period therefor as described above expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any other provision herein to the contrary,
except in the case of Fraud or willful breach in connection with the representations and warranties expressly set forth in <U>Article III</U>, (i)&nbsp;from and after the date of the Original Investment Agreement until the Subsequent Closing (if
any), the maximum liability of the Company under or relating to this Agreement to the extent relating to or arising out of any breach of the representations and warranties of the Company made herein (other than in respect of Fundamental
Representations of the Company) shall in no event exceed 30% of the Initial Investment Purchase Price and (ii)&nbsp;from and after the Subsequent Closing the maximum liability of the Company under or relating to this Agreement to the extent relating
to or arising out of any breach of the representations and warranties of the Company made herein (other than in respect of Fundamental Representations of the Company) shall in no event exceed 30% of the sum of the Initial Investment Purchase Price
and the Subsequent Investment Purchase Price. From and after the date of the Original Investment Agreement, the Investor hereby irrevocably waives any right of rescission it may otherwise have or to which it may become entitled in respect of the
Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares. From and after the Subsequent Closing, the Investor hereby irrevocably waives any right of rescission it may otherwise have or to which it may become entitled in respect of the
Series <FONT STYLE="white-space:nowrap">B-2</FONT> Preferred Shares. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VIII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Miscellaneous </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.01 <U>Amendments</U>. Subject to compliance with applicable Law, (i)&nbsp;this Agreement may be amended or supplemented in any
and all respects only by written agreement signed by each of the parties hereto and (ii)&nbsp;any amendment to or waiver of the provisions, terms and conditions of this Agreement that are addressed in the Statement With Respect to Shares shall be
permitted only as specified in the Statement With Respect to Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.02 <U>Extension of Time, Waiver, Etc.</U> The Company
and the Investor may, subject to applicable Law, (a)&nbsp;waive any inaccuracies in the representations and warranties of the other party contained herein or in any document delivered pursuant hereto, (b)&nbsp;extend the time for the performance of
any of the obligations or acts of the other party or (c)&nbsp;waive compliance by the other party with any of the agreements contained herein applicable to such party or, except as otherwise provided herein, waive any of such party&#146;s
conditions. Notwithstanding the foregoing, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
no failure or delay by the Company or the Investor in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or
further exercise thereof or the exercise of any other right hereunder. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.03 <U>Assignment</U>. Neither this Agreement nor any of the rights, interests or obligations hereunder shall be assigned, in
whole or in part, by operation of Law or otherwise, by any of the parties hereto without the prior written consent of the other party hereto; <U>provided</U>, <U>however</U>, that (a)&nbsp;following the first to occur of the Subsequent Closing and
the termination of the Target Merger Agreement, without the prior written consent of the Company, the Investor or any Investor Party may assign its rights, interests and obligations under this Agreement, in whole or in part, in conjunction with a
permitted transfer of Shares to one or more Permitted Transferees as contemplated in <U>Section</U><U></U><U>&nbsp;5.08</U> so long as the assignee shall agree in writing to be bound by the provisions of this Agreement, including the rights,
interests and obligations so assigned, and (b)&nbsp;following written notice delivered to the Company, without the prior written consent of the Company, the Investor may grant to the lender(s) (or agents) under any such Back Leverage a security
interest in its respective rights (but not its obligations) under this Agreement in connection with any such Back Leverage; it being understood that in no event will the Investor be relieved of its obligations hereunder prior to the Subsequent
Closing. Subject to the immediately preceding sentence, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns. For the avoidance of doubt,
(i)&nbsp;no Transfer by any Investor Party of any Series B Preferred Stock or Company Common Stock to a third party that is not an Investor Party (including as contemplated under <U>Section</U><U></U><U>&nbsp;5.08(b)(iv)</U>) shall result in the
transfer or assignment of any of the Investor Parties&#146; rights hereunder and (ii)&nbsp;each holder of Series <FONT STYLE="white-space:nowrap">B-1</FONT> Preferred Shares prior to the Subsequent Closing shall be subject to the Subsequent
Investment Obligation and the terms and conditions relating to the Upsize Investment (each as defined in the Statement With Respect to Shares). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.04 <U>Counterparts; Electronic Delivery</U>. This Agreement may be executed in multiple counterparts, any one of which need not
contain the signature of more than one party, but all such counterparts taken together shall constitute one and the same instrument. This Agreement and any signed agreement entered into in connection herewith or contemplated hereby, and any
amendments hereto or thereto, to the extent signed and delivered by .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign, shall be treated in all manner and respects as an original contract and shall be considered to have
the same binding legal effects as if it were the original signed version thereof delivered in person. At the request of any party hereto or to any such contract, each other party hereto or thereto shall re&#150;execute original forms thereof and
deliver them to all other parties. No party hereto or to any such contract shall raise the use of a .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign to deliver a signature or the fact that any signature or contract was
transmitted or communicated through the use of .pdf, .tif, .gif, .jpeg or similar attachment to electronic mail or by DocuSign as a defense to the formation of a contract and each such party forever waives any such defense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.05 <U>Entire Agreement; No Third-Party Beneficiaries</U>. This Agreement,
including the Disclosure Schedules, together with the Confidentiality Agreement and the other Transaction Documents, constitutes the entire agreement, and supersedes all other prior agreements and understandings, both written and oral, among the
parties and their Affiliates, or any of them, with respect to the subject matter hereof and thereof, including the Original Investment Agreement. No provision of this Agreement shall confer upon any Person other than the parties hereto and their
permitted assigns any rights or remedies hereunder; provided that (i)<U>&nbsp;Section</U><U></U><U>&nbsp;5.11(e)</U> shall be for the benefit of and fully enforceable by the Investor Director, (ii)<U>&nbsp;Section</U><U></U><U>&nbsp;5.11(f)</U>
shall be for the benefit of and fully enforceable by each of the Covered Persons and (iii)<U>&nbsp;Section</U><U></U><U>&nbsp;8.13</U> shall be for the benefit of and fully enforceable by each of the
<FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.06 <U>Governing Law; Jurisdiction</U>. This Agreement shall
be governed by, and construed in accordance with, the laws of the State of Delaware applicable to contracts executed in and to be performed entirely within that State, regardless of the laws that might otherwise govern under any applicable conflict
of Laws principles. All legal actions or proceedings arising out of or relating to this Agreement shall be heard and determined in the Chancery Court of the State of Delaware (or, if the Chancery Court of the State of Delaware declines to accept
jurisdiction over any legal action or proceeding, any state or federal court within the State of Delaware) and the parties hereto hereby irrevocably submit to the exclusive jurisdiction and venue of such courts in any such legal action or proceeding
and irrevocably waive the defense of an inconvenient forum or lack of jurisdiction to the maintenance of any such legal action or proceeding. The consents to jurisdiction and venue set forth in this <U>Section</U><U></U><U>&nbsp;8.06</U> shall not
constitute general consents to service of process in the State of Delaware and shall have no effect for any purpose except as provided in this paragraph and shall not be deemed to confer rights on any Person other than the parties hereto. Each party
hereto agrees that service of process upon such party in any legal action or proceeding arising out of or relating to this Agreement shall be effective if notice is given by overnight courier at the address set forth in
<U>Section</U><U></U><U>&nbsp;8.09</U> of this Agreement. The parties hereto agree that a final judgment in any such legal action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other
manner provided by applicable Law; provided, however, that nothing in the foregoing shall restrict any party&#146;s rights to seek any post-judgment relief regarding, or any appeal from, a final trial court judgment. Notwithstanding anything in this
<U>Section</U><U></U><U>&nbsp;8.06</U>, the Series B Preferred Stock shall be governed by the laws of the Commonwealth of Pennsylvania, regardless of the laws that might otherwise govern under an applicable conflict of Laws principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.07 <U>Specific Enforcement</U>. The parties hereto agree that irreparable damage for which monetary relief, even if available,
would not be an adequate remedy, would occur in the event that any provision of this Agreement is not performed in accordance with its specific terms or is otherwise breached. Accordingly, subject to <U>Section</U><U></U><U>&nbsp;7.03</U>, the
parties acknowledge and agree that (a)&nbsp;the parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions
hereof (including, for the avoidance of doubt, the right of each party to cause the Subsequent Closing to be consummated on the terms and subject to the conditions set forth in this Agreement) in the courts described in
<U>Section</U><U></U><U>&nbsp;8.06</U> without proof of damages or otherwise (in each case, subject to the terms and conditions of this <U>Section</U><U></U><U>&nbsp;8.07</U>), this being in addition to any other remedy to which they are entitled
under this Agreement and (b)&nbsp;the right of specific enforcement is an integral part of the Transactions and without that right, neither the Company nor the Investor would have entered into this Agreement. The parties hereto agree not to assert
that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, and agree not to assert that a remedy of monetary damages would provide an adequate remedy or that
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the parties otherwise have an adequate remedy at law. The parties hereto acknowledge and agree that any party seeking an injunction or injunctions to prevent breaches of this Agreement and to
enforce specifically the terms and provisions of this Agreement in accordance with this <U>Section</U><U></U><U>&nbsp;8.07</U> shall not be required to provide any bond or other security in connection with any such order or injunction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.08 <U>WAIVER OF JURY TRIAL</U>. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS
LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE IT HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR
INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT AND ANY OF THE AGREEMENTS DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (A)&nbsp;NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (B)&nbsp;IT UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF SUCH WAIVER,
(C)&nbsp;IT MAKES SUCH WAIVER VOLUNTARILY AND (D)&nbsp;IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS <U>Section</U><U></U><U>&nbsp;8.08</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.09 <U>Notices</U>. All notices, requests and other communications to any party hereunder shall be in writing and shall be
deemed given (a)&nbsp;when delivered personally, (b)&nbsp;when transmitted via electronic mail to the <FONT STYLE="white-space:nowrap">e-mail</FONT> address set out below (provided that no error message is generated), (c) the day following the day
(except if not a Business Day, then the next Business Day) on which the same has been delivered prepaid to a reputable national overnight courier or (d)&nbsp;the third Business Day following the day on which the same is sent by certified or
registered mail, postage prepaid to the parties at the following addresses: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Company, to it at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-IV</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Saxonburg,
PA 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Mary Jane Raymond, Chief Financial Officer, Treasurer and Assistant Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">MaryJane.Raymond@II-VI.com</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">II-IV</FONT> Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">375 Saxonburg Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Saxonburg,
PA 16056 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Jo Anne Schwendinger, Chief Legal and Compliance Officer and Secretary </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">JoAnne.Schwendinger@II-VI.com</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Wachtell, Lipton,
Rosen&nbsp;&amp; Katz </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">51West 52nd Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Andrew J. Nussbaum, Karessa L. Cain </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: ajnussbaum@wlrk.com; klcain@wlrk.com </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If to the Investor or any Investor Party, to the Investor at: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">c/o Bain Capital Private Equity, LP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">200 Clarendon Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Boston,
MA 02116 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: Stephen Pagliuca, Ken Hanau, Joseph Robbins, David Hutchins </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: spagliuca@baincapital.com; khanau@baincapital.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">jrobbins@baincapital.com; dhutchins@baincapital.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue, 53rd Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention:
Sarkis Jebejian, P.C., Joshua N. Korff, P.C., Christopher M. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Thomas, P.C. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: sarkis.jebejian@kirkland.com; jkorff@kirkland.com; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">christopher.thomas@kirkland.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or such other
address as such party may hereafter specify by like notice to the other parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.10 <U>Severability</U>. If any
term, condition or other provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or incapable of being enforced by any rule of Law or public policy, all other terms, provisions and conditions of this
Agreement shall nevertheless remain in full force and effect. Upon such determination that any term, condition or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in good faith to modify this
Agreement so as to effect the original intent of the parties as closely as possible to the fullest extent permitted by applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.11 <U>Expenses</U>. Except as otherwise expressly provided herein, all costs and expenses, including fees and disbursements of
counsel, financial advisors and accountants, incurred in connection with this Agreement and the Transactions shall be paid by the party incurring such costs and expenses, whether or not the Subsequent Closing shall have occurred; <U>provided</U>
that the Company shall, upon the Initial Closing, reimburse the Investor for up to $2.0&nbsp;million of its and its Affiliates&#146; reasonable and documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with the Initial Investment (including the reasonable and documented fees and expenses of third-party
consultants, legal counsel, accountants and financing advisors in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection therewith); <U>provided</U>, <U>further</U>, that in the event that the reimbursement pursuant to the immediately preceding proviso clause was in an amount less than $2.0&nbsp;million,
then the Company shall, upon the Subsequent Closing, reimburse the Investor for all such reasonable and documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in
connection with the Subsequent Investment by it and its Affiliates up to $2.0&nbsp;million in the aggregate. For the avoidance of doubt, the Company&#146;s aggregate reimbursement obligations set forth in this <U>Section</U><U></U><U>&nbsp;8.11</U>
shall in no event exceed $2.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.12 <U>Interpretation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) When a reference is made in this Agreement to an Article, a Section, Exhibit or Schedule, such reference shall be to an Article of, a
Section of, or an Exhibit or Schedule to, this Agreement unless otherwise indicated. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this
Agreement. Whenever the words &#147;<U>include</U>&#148;, &#147;<U>includes</U>&#148; or &#147;<U>including</U>&#148; are used in this Agreement, they shall be deemed to be followed by the words &#147;<U>without limitation</U>&#148;. The words
&#147;<U>hereof</U>&#148;, &#147;<U>herein</U>&#148; and &#147;<U>hereunder</U>&#148; and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement unless the
context requires otherwise. The words &#147;<U>date hereof</U>&#148; when used in this Agreement shall refer to the date of this Agreement. The terms &#147;<U>or</U>&#148;, &#147;<U>any</U>&#148; and &#147;<U>either</U>&#148; are not exclusive. The
word &#147;<U>extent</U>&#148; in the phrase &#147;<U>to the extent</U>&#148; shall mean the degree to which a subject or other thing extends, and such phrase shall not mean simply &#147;<U>if</U>&#148;. The word &#147;<U>will</U>&#148; shall be
construed to have the same meaning and effect as the word &#147;<U>shall</U>.&#148; The words &#147;<U>made available to the Investor</U>&#148; and words of similar import refer to documents (A)&nbsp;posted to the Datasite LLC&#146;s data room for
Project Watson by or on behalf of the Company or (B)&nbsp;delivered in Person or electronically to the Investor or its respective Representatives, in each case no later than one Business Day prior to the date of the Original Investment Agreement.
All accounting terms used and not defined herein shall have the respective meanings given to them under GAAP. All terms defined in this Agreement shall have the defined meanings when used in any document made or delivered pursuant hereto unless
otherwise defined therein. The definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such term. In the event that the
Company Common Stock is principally listed on a national securities exchange other than the NASDAQ, all references herein to NASDAQ shall be deemed to be references to such other national securities exchange. Any agreement, instrument or statute
defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, modified or supplemented, including (in the case of agreements or instruments) by
waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. Unless otherwise specifically indicated, all references to
&#147;<U>dollars</U>&#148; or &#147;<U>$</U>&#148; shall refer to the lawful money of the United States. References to a Person are also to its permitted assigns and successors. When calculating the period of time between which, within which or
following which any act is to be done or step taken pursuant to this Agreement, the date that is the reference date in calculating such period shall be excluded (unless, otherwise required by Law, if the last day of such period is not a Business
Day, the period in question shall end on the next succeeding Business Day). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The parties hereto have participated jointly in the negotiation and drafting of this
Agreement and, in the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as jointly drafted by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party
hereto by virtue of the authorship of any provision of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.13
<U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT></U>. This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement, or the Transactions may only be brought against the
entities that are expressly named as parties hereto and their respective successors and assigns. Except as set forth in the immediately preceding sentence, no past, present or future director, officer, employee, incorporator, member, partners,
stockholder, Affiliate, agent, attorney, advisor or representative of any party hereto (collectively, the &#147;<U><FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Parties</U>&#148;) shall have any liability for any obligations or liabilities of
any party hereto under this Agreement or for any claim based on, in respect of, or by reason of, the Transactions (whether in contract, in tort, in law or in equity or provided by statute, whether by or through attempted piercing of the corporate,
limited partnership or limited liability company veil or otherwise), except to the extent expressly set forth in the other Transaction Documents. For the avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;8.13</U> is intended to benefit and may
be enforced by each <FONT STYLE="white-space:nowrap">Non-Recourse</FONT> Party (and each such Person shall be a third-party beneficiary of this <U>Section</U><U></U><U>&nbsp;8.13</U>) and shall be binding on all respective successors and permitted
assigns thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.14 <U>Effectiveness of Amendment and Restatement</U>. This Agreement amends and restates the Original
Investment Agreement in its entirety. All amendments to the Original Investment Agreement effected by this Agreement, and all other covenants, agreements, terms and provisions of this Agreement, shall have effect as of the date of this Agreement
unless expressly stated otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="white-space:nowrap">II-VI</FONT> INCORPORATED</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page &#151; Investment Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3">BCPE WATSON (DE) SPV, LP</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Signature Page &#151; Investment Agreement </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EQUITY COMMITMENT LETTER </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See attached. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF ISSUER AGREEMENT </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See attached. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXHIBIT C </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>FORM OF REGISTRATION RIGHTS AGREEMENT </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See attached. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>iivi-20210330.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 4/1/2021 12:24:29 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:iivi="http://www.ii-vi.com/20210330"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.ii-vi.com/20210330"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" namespace="http://fasb.org/us-gaap/2019-01-31" />
    <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" namespace="http://fasb.org/us-types/2019-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iivi-20210330_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iivi-20210330_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="iivi-20210330_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="iivi_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="iivi_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="iivi_SeriesAMandatoryConvertiblePreferredStockMember" name="SeriesAMandatoryConvertiblePreferredStockMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>iivi-20210330_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 4/1/2021 12:24:32 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="iivi-20210330.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="iivi-20210330.xsd#iivi_SeriesAMandatoryConvertiblePreferredStockMember" xlink:type="locator" xlink:label="iivi_SeriesAMandatoryConvertiblePreferredStockMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="iivi_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="iivi_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iivi_SeriesAMandatoryConvertiblePreferredStockMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="31.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>iivi-20210330_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 4/1/2021 12:24:29 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="iivi_DocumentAndEntityInformationTable" xlink:to="iivi_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="iivi_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="iivi_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="iivi_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="iivi_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="iivi_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="iivi-20210330.xsd#iivi_SeriesAMandatoryConvertiblePreferredStockMember" xlink:type="locator" xlink:label="iivi_SeriesAMandatoryConvertiblePreferredStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="iivi_SeriesAMandatoryConvertiblePreferredStockMember" xlink:to="iivi_SeriesAMandatoryConvertiblePreferredStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="iivi_SeriesAMandatoryConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Series A Mandatory Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="iivi_SeriesAMandatoryConvertiblePreferredStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Mandatory Convertible Preferred Stock [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>iivi-20210330_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 4/1/2021 12:24:30 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="iivi-20210330.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="iivi_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="iivi-20210330.xsd#iivi_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="iivi_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationTable" xlink:to="iivi_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="iivi-20210330.xsd#iivi_SeriesAMandatoryConvertiblePreferredStockMember" xlink:type="locator" xlink:label="iivi_SeriesAMandatoryConvertiblePreferredStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="iivi_SeriesAMandatoryConvertiblePreferredStockMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:type="locator" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_CurrentFiscalYearEndDate" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="iivi_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g135490g0330234154664.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g135490g0330234154664.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  A )H# 2(  A$! Q$!_\0
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M6T[^*]:989"IU'3R"%." >: /.['_D;?B!_U[3?^ABMK3/\ DXJQ_P"N2?\
MHH5FV5C=_P#"5>/6^RS8>VF"GRS\WSCI6SIME=#]H.RF-O,(A$F7V''^J'>@
M#>\3?\CEK/\ V&-+_E7GEG_R,7Q'_P"O2?\ ]'+7H_B2VG?QAK#+#(5;5],(
M(4X('4UP%I87@\0?$0FUFQ):SA#Y9^;]ZO2@#UKQ9_Q_>"O^N5U_Z3&O!M+_
M .22>)_^PE:_R>O??%4$KWW@PK&Y"17.["DX_P!'[UX7IFGWJ_"CQ+&;2<.V
MHVQ53&<D8>@#U7X5_P#(9\-?]BPW_I17L]>.?"ZVGBUCPX9(9$"^&F5BRD8/
MVCI]:]CH CF_U+_2HS]V'_/:BB@"JO\ JI:D7_5K_N&BB@!(/NI_OU))_K7_
M  HHH C'^ME^AI8.D?\ O444 ++_ ,?8H_@_X":** $7_C['TJ1_]8WU%%%
M$(_UDOTIZ_\ 'V*** 'O_K6_WEJ$??F^E%% %B3K'^/\JJC_ (]W_P!X444
..6+?[R_[G]:LT44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d135490d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iivi="http://www.ii-vi.com/20210330"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="iivi-20210330.xsd" xlink:type="simple"/>
    <context id="duration_2021-03-30_to_2021-03-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
        </entity>
        <period>
            <startDate>2021-03-30</startDate>
            <endDate>2021-03-30</endDate>
        </period>
    </context>
    <context id="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-30</startDate>
            <endDate>2021-03-30</endDate>
        </period>
    </context>
    <context id="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000820318</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">iivi:SeriesAMandatoryConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-30</startDate>
            <endDate>2021-03-30</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2021-03-30_to_2021-03-30"
      id="Hidden_dei_EntityRegistrantName">II-VI INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="duration_2021-03-30_to_2021-03-30"
      id="Hidden_dei_EntityIncorporationStateCountryCode">PA</dei:EntityIncorporationStateCountryCode>
    <dei:AmendmentFlag contextRef="duration_2021-03-30_to_2021-03-30">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-03-30_to_2021-03-30"
      id="Hidden_dei_EntityCentralIndexKey">0000820318</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="duration_2021-03-30_to_2021-03-30"
      id="Hidden_dei_CurrentFiscalYearEndDate_duration_2021-03-30_to_2021-03-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="duration_2021-03-30_to_2021-03-30">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-03-30_to_2021-03-30">2021-03-30</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="duration_2021-03-30_to_2021-03-30">001-39375</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-03-30_to_2021-03-30">25-1214948</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-03-30_to_2021-03-30">375 Saxonburg Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-03-30_to_2021-03-30">Saxonburg</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-03-30_to_2021-03-30">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-03-30_to_2021-03-30">16056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-03-30_to_2021-03-30">(724)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-03-30_to_2021-03-30">352-4455</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-03-30_to_2021-03-30">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-03-30_to_2021-03-30">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-03-30_to_2021-03-30">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-03-30_to_2021-03-30">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">IIVI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">Series A Mandatory Convertible Preferred Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">IIVIP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-03-30_to_2021-03-30_us-gaap-StatementClassOfStockAxis_iivi-SeriesAMandatoryConvertiblePreferredStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-03-30_to_2021-03-30">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139888223519656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iivi_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">II-VI INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000820318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">25-1214948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">375 Saxonburg Boulevard<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Saxonburg<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">16056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(724)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">352-4455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iivi_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IIVI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=iivi_SeriesAMandatoryConvertiblePreferredStockMember', window );">Series A Mandatory Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_iivi_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Series A Mandatory Convertible Preferred Stock, no par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IIVIP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_iivi_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">iivi_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>iivi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=iivi_SeriesAMandatoryConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=iivi_SeriesAMandatoryConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ XH-_4F60>9(9 0  SP,  !,
M  !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !
M8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB
M'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G
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M+GAM;%!+ 0(4 Q0    ( .*#?U(V6Z$)[0   "L"   1              "
M :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( .*#?U*97)PC$ 8
M )PG   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L!
M A0#%     @ XH-_4E;?*Y*U!   @A0  !@              ("!# @  'AL
M+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( .*#?U*?H!OPL0(
M .(,   -              "  ?<,  !X;"]S='EL97,N>&UL4$L! A0#%
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K  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  %<4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d135490d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d135490d8k.htm">d135490d8k.htm</File>
    <File>d135490dex101.htm</File>
    <File>d135490dex31.htm</File>
    <File>iivi-20210330.xsd</File>
    <File>iivi-20210330_def.xml</File>
    <File>iivi-20210330_lab.xml</File>
    <File>iivi-20210330_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d135490d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "iivi-20210330_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "d135490d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "iivi-20210330_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "iivi-20210330_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "iivi-20210330.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 5
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 1,
   "memberStandard": 1,
   "nsprefix": "iivi",
   "nsuri": "http://www.ii-vi.com/20210330",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d135490d8k.htm",
      "contextRef": "duration_2021-03-30_to_2021-03-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d135490d8k.htm",
      "contextRef": "duration_2021-03-30_to_2021-03-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "iivi_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://www.ii-vi.com/20210330",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "iivi_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://www.ii-vi.com/20210330",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "iivi_SeriesAMandatoryConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Mandatory Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Mandatory Convertible Preferred Stock [Member]"
       }
      }
     },
     "localname": "SeriesAMandatoryConvertiblePreferredStockMember",
     "nsuri": "http://www.ii-vi.com/20210330",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.ii-vi.com//20210330/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001193125-21-102324-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-102324-xbrl.zip
M4$L#!!0    ( .*#?U*O=1 N.R<  +/G   .    9#$S-30Y,&0X:RYH=&WM
M/6USVS:3WV_F_@/&??J,<Z-WVTELI[Y19*714\?V24[:WI<.1$(6GE"D2I"V
M=;_^=A< "4J4)3E^B5MWIK$D@L "6.S[+M[]]\TD8%<B5C(*?]IJUAI;3(1>
MY,OP\J>M-!E5WVZQ_S[ZS_]X-TZ@(30.U8$OY$];XR29'M3K-\,XJ"GAU2ZC
MJSH\J+<:S?UJHUG=:6Z9YJFJ)K.I4-D[(ZZ&M2B^K-LG)2^%41BFD^R5Z^OK
M&@V%K_E)7,?WZM"H"JU$+#W[WDT@PZ^%UZYWZ*7F_OY^G9[:I@LMLP%:C<9.
M'1\/N1*VN917LM!<RNJ5K'G1!-JWFHV=G48&A))E($"WS?IOGTX&WEA,>%6&
M*N&AEPV0)O%2</;K\#2#1$6[K>:;6V W+;(7;I:U;4+;$&8J?GO?/\F;)^7M
M\Z;U).:A&D7QA"> .=C37K71JK9>.YU4 2\*'5D\6=7/6P<1E/3*D0T>8/-F
M$6^PB;QM9>86'9_Z<^AL&K^NZX<.'E]R/BU%8WRPB,7+\1!/TQ8=*\%]_)O(
M)!!';ZN_O*OKC_#;1"2<80]5\6<JKW[:ZD1A(L*D>@'(O\4\_>VGK43<)'7J
MD=7QO;KIE#'V;ACY,_SXSI=73"6S0/RTY4LU#?@,SYC8.F+OY,T!OB%B\UGZ
MO@CU9VARJ@\8D_Y/6Q_IT1]PSO_HA@#GK"\NI<(]3$[Y!& *X5\80,B#\N<$
M\TW2%R-HE<:TZ7_@\:DV=JH[C3^2R/FV==3K5;_T6.^T\ZY> &8]X'I R.)I
MI$<9)#P1G2@-DWC6B?P26%<TWQ#T\_8JF//QVQ,1^O!_\B'@EQN/-.*!$G=:
MH X,&?.@%_KBYA<Q6UR2A08;@M: _]ZV&CO-MQO"UTGC&-=#*H\'OPL>=T/_
M&';DC]6#.I-8ULO&\ZA6&Z_AP^(DZG/G)18C 4-Z0L%WY" 'BH@]#,2(^1P@
MX_II2\G)-$ B1+^-8X0#&4S5LI+:C?+M8QY[<80'=VU>]0!<\.A=O3@?,_O"
MC.F[BM)8?R5B?&#6FK9XC;6VKPG"P.RK]/&'D10Q(Q!$*6?I]'XI8MW\RPAU
M:?]3V-'(S[X"EX@3Q)6C'#;[9OXLA]5?TM8^R8;-QJD75N=NJ_6'83U5(E=(
M03H!5^IL-$@B[VO[1JJL12>:3)"LP>^?Q&0HXD=8:;-<XA(A,]]]&.]F&DA/
M)AH.YDMXK.5/ ^S!TNEL'=DF"_-Y5R_M/E_I'(Z_%P8071G H$*U/_'0YTF$
M/"T$J3^1PT"<TQ&.A?_\D0.G>K#A5/\">%.?H[MU5Z*K@^1W5)#_\*TJ#^1E
M>.#!7/1N.\^OI9^,#][6]F1XZ+0-Q"@YG/#X4H95_'S >)I$]I=87H[-3]C=
MU':&DGYU+.@IJ)?3K(LDFAXX7X=1DD03^F48Q0"Z_:4YO6$J"J3/?FC0?UM'
M__RA^;IQ^*X^73;0SNJ!6G<>R.EV%SIABQ-@(]B:JI+_)PZ:;[/O(SZ1P>S@
M C!:L5-QS?K1A(>'].Q:PSV, O^P9'L^G_8NNL=L<-&^Z Z6@]-X)' &W<[G
M?N^BUQVP]NDQZ_[6^=@^_;G+.F>?/O4&@][9Z3?!V+H/&'_E:BS#RR0**^RX
MUJFQ5F-O=W\.+F?0YAJ8642(52>J%#-?WPDS:PUH5D3.0WU*6\T?%V>_YBG-
M)V.)1-F&T<H\!E9]..M_6JXC'4=>BF38T7W7E]])KR[*[B^8\""8<"]G%ZA+
MOWMZP?K=\[/^Q=/3DO,T5BD/$Y9$;" \1#;6W&%1S)I[V_ZKIP<P&K%D+!"V
M-)8)2#^L>^.->7@I6-M+&#QN[N_L+H?ST786)1H$IR^F49RP;?L==/, P$Z8
MN(*6+*;'PG]UP#Z!]CMF.\T*PP/-ME<2B',2D^ZHZ3-MB@1E_"8Y\%'.A-?'
M/I_- $(1;AT9<!H:G'FB,H\*+U3E7JA*:_<^<(^]4U,>6@@86J>K\J:JS3<'
MJTR;1X6WK\<R$57XQ1.P_]<QGQICY;LZ-CMBN3%1^/:W;Z(3C?M8@NWN#0=Z
M@!/2I]!.D7'%!E/AH7+F,QFRSA@T%1&_(/2:"/TM"X/F?P[:*?-$$"!.D?,-
MB!%^GW+?M]_-6&:N7A0$?*K$@?UP.WXXR(3BFEZ-9J/QHUF[@X8!\Z!AM3@$
M+-9__*)RN+/[(UH$$W_N*2G:'@_,ZNH)E[8T_;0VZ,?"7/[*?(?PCX$]MDVF
M_%)4A['@7]'Y)GUQP*\BP)"U%ZY)6U<<ESG8Q KH=$"(Q.;F C@Q1TSF3^[&
MI.IVS\71>??T=/#[R9?V::^=TR+ZN_X66GQ=:/\0\U_*Y/5\/\A P#.T4VWN
MD6A6=_9WWNPMZ@//>$$N^$W/V-8\6H$[KDYKK]IL-7?W=Q?\->[R/,3)>GM/
M!^NN_/5>--AM.GNH%YR!.!ZS?X$TKGQ)"L-&S+_Y , !OR_0B5>:CST-NC_M
M-J'O0"KU/>P*DC*F3^O?>$-ZM7YM4&/=R32(9FB2?^)=*1+3A?TA @C_H-#V
M#1KUO8CT*SA#V_=CH93Y<P*"=7-CK@#<D@WX310.T_B2O8_20%SQV)]G$97E
MQKL"+!WX>!9?1-?AQI!D4-QU;"+09_%Y'%U)B@*ZNWD A3)TZ"1B"KWA>&@?
M.!=AJ&;!%0\E7S\ I #C>02]!O\KIW>*.P&BL/=ZA;'S"4ZXF1MJG><Q++V<
M\H!U;X27)O)*L+,1'#:A7K%MF#?#B=]B57OZLX4HW 9IYTX[M/VFM?MJ?=PX
MB8!4GX^C\*XB[\Y>J[J[NU<B\3XU4N3VAW_^\+;5?'.H@'<%8HJ392'-ML(
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M<K]5%6#0><_$^[/^<;=?[9R=G+3/!]T#^^'[]DPTFZ5^!T8? 9?(H+Z"H?>
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MVF&%^308I[!EPB--<5I[%IE ,,'AAB*Y!JF<>N]8H15^Q^]V.3>=#6@$*-'
M?-@_=AH-/3)@>8#8)D,/:"V*)^AFE/I=(V?8 7'N^'TSA#<Z]\J7WE=;]I5;
M='*V[<CN%-,(Z*32X;]16P%D0O@ MR9ZUT"F]:5VERJ1H'P&(IF9Q=H+5[LE
MSUH7,?A6HN*6@\@G8!V?Z\)Y, _G/08L/$^Q8&]UP,+.&H(#D8_7R_LH%SY*
M1GY0 6+-/5B0%Z+0I42V+L:F;$UBY 8P-)"X-:KZ(@!A(]8!Q04J\F:O M(X
M4V-@,(3EG#2D]>E$<QTZ84Y/QZI^8WZ%>I9KT4.U38.Q(;/=G+2M W+.'E&/
M_$>S0<N4P^BRONZ?*6CR(#S$;$ /ST&[%K:'C$5? FVX1!8-NB3HB@I9%;3#
MQ?G'FST:@ 8I<FN@F" QYB3&=GM(_3YFG-0+V?G+DIV'Y=F;DB^.+Q*I(D(&
M= S0P:5C"U1L&R. T"IS)4#L(UN/?CY_>BIL\=PNGJV#EW.U6LM?(P#Q/@Y6
MZUD?K&;C6_GK6G+X]\5?UP'9'#6M1T67VFV0'=R'4FK6X?P52QYPFS<#9&UY
M@L_+ /GFB#]3H%B&P)5+%FM)%,U*(Y<I*DQ.)L)' P'01V@49334"R*%N.)*
M'1W]6R;!&/0:IO KIOF"5CJ4H;:,T)YUHC&6"0?RV@N]6L%HX5I1MC,3B&Z>
M+\IT3NERU'Z8ZWG *;7MDX@O,6ET7<6=3R*860[<AFP(>C F&3TP&Z3#VR=(
M@[+K,7"C&8NN42T&U@JD5/*8$O V@\#=$P/"@AGE10Y\X5?WQZ^6D@E#$BC5
MV/KBAK,%DY@1W<P3*Y]56#IEVKB(FXM'!6C<SCQK?%)3UD.0Y0F_D9-T4D:>
M=W+BO)GE_WZ,7+U\)TJ([_J"O<3\S3 T#M%;!>_-=K=HE,YJ&=(P?719*(='
M..,:A4#[;9&OD1LXA1\G2()CMY]8]P-S  2<"B^SL=XKYZ=EO"N2>SH44U%'
MJ T1(4ZGD5;!/!H64[CQ:RRBT>/;1S? EL(6H5>?'/VX"]A9&$U0J(#S$0K0
M]!10)2&,@&B^VZ?14(G8403?1SSV<76/90S[&,5W6&J7V2[VE\E"B$\J8@%*
M%F8&V90F'- 5_D>KOLKJ;08"M%+L# 4"[;4Q>)9CQ?UB7!3?'\)!IX1N9:AV
MX4P^J_$AS=DO[. :&W8M0<D?"IB"F(Y%R,[Y92!3C]/[_XH4_ HH. 3!4U7L
M@25]OP@'X14/8(L,+S+6BE(O#$#CP2*BOTQ?529B<B[%NJJ;MH%0-(A*$+R\
M8D+-!A<XL0ODP?];!S \6OG;U;[J+%I/<X>^H? 8OJ./QLBX9>_WZ#V.X[M7
MSG:%KKB4UP'9@#;/>1XRA[HKX8UD@)VQE6OKTM*L<49",W@+[O9C@7YMZ^K4
MM18[CF[U/H4CDN(@.)%A()7NQ'(&$F4,2\?Y3O.[JQZ$KVNRDR_%4'B8.R-&
M(TV8EJSHPS/HBP?D+-SSXA367&)4'+GC$[97 ZI#HC+'6ST+'F#KR4:U83,H
M?#'B:0![B1%]?*;Q(BMTHS02Q3GFW?O^5FRLH;CQD(^  IE/LL8^A\ 13$&=
M-*;@PA!MT\IH^J;LCZD@I64WK,SD9S7QO3%36H>Y[VVJN!L$Z@FLGU;@HP 5
MNY7C /9]E:%OPZY8>Y28H-[%N2X;RTBHSA+HR58091RBDLD-T50?850IN!JO
MH3 8,)TP&V3]!>L4K"R<H_$S/W2QE?3U<]*)[D7 X\J4@U(O\0H+!J/&:H-1
MN;'G[^0YY E%52?P'N.63,@XHW?9<2>CD2.:C$&*0UNNIH-D1;GW@S/A,]0H
MS-FQUH3[.3D)49I,)\HM.V^1'[J1 IG1.VM<B \X) 8SQ54R2_7P%K&U@C:L
M0@:JE$M]HA!82+;5^=TNL+*1YZ4QPKTM7VG\Q189ZX,'WXFQ+S.@9&;-;>F"
MC YPAX7@3_/V=V0W\)+[EO%.S]#\N=GTYOW9$65.1%AT!9_%(K,@/K5W+%\Z
MVFR2K[5;\T,:^ABC"?H7WB^"J1#;Q=2>Q)677QP7+WSH'OG04$!W(1I\DS&<
M4(8W.BF'3#ERJ)7 7;KT -I#"=];K_=*9@-_MJQQ;L7G69_-\;J*@G0BC%T'
M+0O0"HY&SDR_ 0JMM2G6W /E=%$?6P )S4&M!IH!R6W@\QFL0YIH4CQC.PU<
M*V4K6KO-GL)_<_&=B0G&Z!L04H70.L)$NAK[D!6;U?:IJ8SG"M7^F4KLZYKK
MFHDF>2^OFO61QTEUX,%"5?L1K'G$VI@X&:<@<O0F:) E=N)DA[YY72%%4-N^
MM 7+6+(?2D.C-1@#^C(]<6.'JMBO&*H0"ETPZ*Y1+BYVD[F.KY&6PE4U.^*V
MHR%74A6L-#:Q1 NBN7G[(3&X#1.:9I:2W(R&0L$&22% &WF2 *'4 2'=F[$<
M8DK(3JU)KS<;M6;175#1TI94K$/R2V*O*X0EI5+,*Q>5[AO-8T00!NDD$C%T
MCX"X,T1WHS%!:F,A&O<O(Z(;0GFQG+I'X:Y+X$>PL&BJ AF1Y@'3(\H^F08B
MT>X7F"SZK[/[WPI),RZ<5A*](S +:..@Q,9YKG\1\>U>LR%W:HW6\\V&_!PZ
M108'/-"DV$13Y%GYCYX*J?FI+Q4&PZ6Q<&*=^1 8C&%'N T,\U&S2@#W0$&H
MVKM#/ JGD80R&HG&IMUG#VEJ-'QR[; .S?20^@R%""M96IP3YF- S8(7EO2]
M$(Q]!TY@#/9#47&K6>:RQ&>\AJB\H(0K,A3=5X7F><0B18T$4BL0H76_331)
M'\71I!AKDA42&,YL_0!]HG>W^:OM5A9C61QN?K/O+7C$L5P5K#+W[Q"U5J0<
ML[)ERTP)MRT<O%!8+ZRYL+V_=+U>^,]#\Y^=Y\M_L@3\3Z!)9/=_8<E>[39&
MO[,I&,0^DGWZJ7B1#'5)%X2OD'CS/?"@G9?@EY?J'>O1B[UG+:_JD)14V]^<
MT,*8=4S4F+[9+%:'K.O8^;*FAWB)%"A\65C+XGOH!A>ATO7OVG&,AG-MT"AI
M_@34J)O%LY0F)KL!XZ."L<<FEF1U"\IS\4HB ;E>,Q(AYF(!T4:)@83:TS^A
M2FIVA,6>:NQ3;&HQ93V0/*+[,"X);96!]WPG%A&E4LJ"))L57<L4FOB=Q3XQ
MY-#*P [T%/$^,S4<$B'4JI@U<U!T[TMGQ7BR44=(NS=[ 7#@X0U "\L((OBE
M8*]?5ZA>'%:%Y%0WS$Y\OK0)&FZOT):O50=;+N52U\R;FH="ZQ4C&4_6""D!
M/4,#U8FJG3&'EWAHM\-RR_GR*F8:'P7!39&G.?#GNE:+]G6M&MV+JA0CG$6T
M6!0 $1Z&% '01X7VNZ\BP?)N("Z#( W;*PP,BZCY[XB\;PBS*4?&)]/#+*(/
M9M+<?]O2BMLH2G4M-3JNN0!BYJ 6UC0-=9FUPJ[H+O<M(#:)! '!!<&VE;)S
M&<5?M0V/P_$,\2U3D8T;71 /5:R=LIB*P6]TC#4@L"(!B9T+3D42KR7H'9]D
MXHV!+2Z9M59T,)(YP.C>I>M'J&BNV_-=1$S)'?P+3@E%1?BK;/;;QTY;?V3;
M'R.E5\6-9(37VU2!CX,>^8N,;B3/^G ;5MC_I!+#S.#@7&!X<C;Y0J-?>8P8
MUAG+ ,WD[/RDD^GAO\*28&:EF7F.JMIWF^"%<D@+E=5AAQ'5O2M00X3W!A;B
M/0^_ L(G/LSQ9XT39IXXW!>)](!]B69PC!_!@%P2 [NP?5EP&7?8\-(0](I-
M>5=H.G#S2LKS :!GNXYD;B4V3FF +AM?>>I'&#R/4(=16!7ZDF2A?\GV(/,)
M+F%H0W0TRDO2P"E@P!/DIBJ)L[/%#2F0$7 )@^WFP _1%8#?T4$C)\,T5J:L
MUZJYW,]D]?=I'%5)']%?X<U,D#11$^1 PJ0+/Y<"YJ>+/!NHOP+!DIS"9?R;
MB/9MZV@('B9\8IBCHA)<RT;,%KBPJ/>+!@#"-15%4',[A)&E>NL>X0B6("-%
M?)A4G84\0)UDM\Y1O'M.6@TK<6(XE8;$B^701I]\F[)<<= .O4YD;]1I(]QD
MB]A"826BC0V:"05(BZ&?6TJSG'W;@NBU;D,18==1&F!U+5/-3-OP,GNT,2(V
M=DTITKZX3(,U,6Y0_277S5[,9@^K!C]CLQF=/<W,X#2V$3SCNLGK)Y)< Y+@
M+.#7J-7J # X=A\TZ?V=2.^3V](P,3?VK8KJ>#G5YF:VE><+28O>?R ?^@-H
M8M;FMJ[!;2\SN)6O4VOW ?*K2N]+=^=+SWWAF;T_((J$98)IVL@GJT$4?<65
MSE99K<Z.NJ_H&*F*-[1106W*S!S-0:=RZ&*!E!-Q(P+=ANP^XHJ>6(G(2TSV
M"5%F9 %#*M.( QA3#5<JU<Z,K((2]@D[2YY-$P:P# 3L<L)]L<#_%!\AYXB'
M-KF9LA"M"$*.+:L..RZ1$_AC;H;NHW5UHGU86I\U]77W]_=6@F799W%-97@5
M!5>8P:N^ZLFFH5F&A#(]])T]'C$PCV/-;N"4*'/&0F%N3P7#?>APDA<-],28
M\D@PWU=2\*N]0A6M2^@:2L:1HC@BO/<\CRJ]!703C*$+9MK:H(ZO]Q'$I LG
MA6X(XJ5 ?4MC$.KPRV$G3"A?>_*[<H;)5: 1(KLU83W#-#$2B@>GE:*Q""=C
M6F,:=8+&B2PECV16%[DK&L@1&3H!U_XM;#*LVFCE2:#6&X[54'1LN,9>D06I
MQ"CPU=@'KL4^@F\YPJS$#-S7=#/, $(<I+[0*V>]R#8B*HD.BL'L(RX#8Q"F
M.]5#PMM)%&=AI"X!,'*J#B( V$OF?C@7>NY47+,5>G0DCQ,J5%J(QY%$BT5Y
M"N[LB[Q5H4#AG-/>*#PR%["!16G3C5XORT))0YIF89)9/!\YG76.ARG92W(I
M&KE! 8!E )TK%X(U!3$)$+B/SBH0&FGK*D-=2MD@)DY9)[#_@,]H $'=@H[4
MX7Q@_ERH.L!)=+W"3,E^-.F0V.W)V$LGJ,!YHH",EU+3.6'+F%B1B*C68K;
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MHG=VFC^JL(ON*< !8'R ?YW?H8_!>;=S\9G@KI]!$^BZSX[/.I^QQ8!]Z)W
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M8A!JQ4%9S;!GB(Y'[V<'#]?YVAR[B3]IFIO_=$-.()_]T*#_-N2B=54'I3#
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MS<M2=P9NSWMUK=+!AK*/E;+M3J^W690/--S#F^ TX5^BSG42Y_#'VF0E/-^
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MS:X/'_\,@RL\+.\^7IS210H40W^A2!Z4X&1Y3LH)S+ROVVVBB/8: J-LUNV
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MEQ\[!>[#NF3[8B<;[H PK5J53E\96%F>@21A;X2!<8CD;N=5Z?OR<RR@D.C
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MR#.21 5'\;D,#N/WTO>$>RFQ)X<Z#U,1Z)A'Y")0W7JJV[$_+V? VQ.F148
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M\W?QA2OG=OLI=C6C:G]8\&<-6U67TQZ3MM$GZF48W*D+6)(.%7@!5%+'Z+K
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M]=)-H@LYH#4DW1;<V@106*!'C4U?DE^SQB%A.Q>7=T_R4U:40'79XMKXME.
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M@RBF:6V323&AXMH)=)&*B]XJ9C$?'=>)WV.^';EI[. A)M.XL7N;1NC"T.N
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M62_J<[<0;EQP<FDKI6\_9F?TH>U\W[1=V]#'L*OX8"3@HXI+1VIXN]B2%0.
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MN&[D4R&FMHNE>O*-&!WDSI%-1JPS%2O_<25 >YQ\2;'S+ 'V0S,@)C& )PJ
M0)BLS-FR$9%&84H-X+OPC[$?FYO8[11Y=TA:M/T7RY+7FKOOUM?B*L4L/_'3
MOMCFCWPA,W6_165*7ZEQ$L8$^=<X<JFQO":EL]N-=.WUEN.%GIME"H=><<-H
M!?#\ 7!/B3@NIT8PAMBA1]"$427WJS/<)2-!_<&)6(!N,E&=YGX7U51@LMB'
MG<3[WH\RC]\$C]Q*4!&Z+Z;SU/(?V*3V;0?<7.MK6+I7]S*'[A>S&O+<J/R%
M$RHMRC4U=T)\N:B<2S23%*HS>/6"BNB'!Y?H%A&VME[HE^"()Q$[5N/E==(1
MIHPA]!8[.;"KC<DG<DL]45VN2N(R2?)1[&(>^PHF]M[SBH@J%[ZX?;'B-JH\
MD^GZW<6NZPR&#073#-5R3KQL9B[MA(=+85TBC QA/[F)0NC?\:1W^R70C.CO
M<DO#"X>S+A75??13-,:W]UD3/]&F<X]YEE72.:A2F$.4X"DX8BUW!M'9*M?B
M, 5^XM;<_^F<*>X:J1:+BJB( >NB)+S:,)>-\$)NWN)C#XQ: !0V:WT[5ZYV
MJ;M%7K=DO?7E:8V+,IRG3YGGT6:HEE.X14D1 T"*LMKR 6D.(2)YXLB-Z>0Z
MI$^&/2KK8WL*I2Q#KLY;U#<H];*5FU.(I S[C'O?,'['=_2Q<<A$D_M>_L38
M97;H^MX676M*,="8:3ZGST/J AE&KP8^!#4XX]TXT'<^7(W\2S?0NPGY+:(!
MQ*QV27!$+7%2?/J:;Y8RK+2^HJ6$VHJT\*5H&)[I]YIGS<ULF>JOP6 /]R$3
MPLDYA1<Y0C>=04:<"MI>W.,4+)1+][J3DNJB013BO'H.0W)$J\97J&1_TB4:
M#ECR7;&&/ZB3^NVW2"/=A0I9?5MY0O,8$,?0<ZB:)_7,Y5[) ;Z_8HJ16D_$
MSE7G<7R5>%=L&?"/'#]MR#FV%J>:ERF2_$-5@%)=S$;!(LDWWRX^YX?'WU,=
M6RW*+?$Z'FJR6=I%0HO8<(ZJ\D5:PVU4)M KBEGAZ--T''5/U5U5/7.T$BT.
M7XRZ5:*G;_P'D(%=:4;;;U036W(;WN NPG$ S?3.$=M# DKO &C;#(W@A)DP
M!E(YZ_5"FX)LTI),)%+:@&3Y/5XB#SF#I/UCQW/'+8B6YL8,,UYQT$L0)V2
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M+0\/^-L83J<LJ_M\3)Q8?C0G,)H"O&-IQFX[F _88?US&1<<>F:LC(@J$]T
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M?OCA&'[SGP;7BE\=8^_DSE?M(X@;_6$J_1XZ'@.^CQ'6[':CP6_#MV[,KZ6
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M3+3X>EH*.CBQP#_^AK$>?_Z>5OA\GN<3\#P)<OP+! 5-^R([44*+N:*]]PE
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MB.-;Z<[VOE+\);!E_'.]H&^SBR[HUJ:;SV[E528\R)E N@+B >*PQ)R#%3^
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MHBE[]%V;(-$U*Y^V/IL<K$&K#4EGP^&!.\=X&]<L3EG*+KL@@E2PP]2$R5N
M:;I@RWC44@MUS7DID?(@]M8+,-S-N3O0CHW&KF!G)Y)!AX(+=1(;=)18]J]
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M 1$W=[  $K_"7%!0X_-+USGI7EC>KE0T5>#C6^P:/X%?__*P/4]&!!PU-,(
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M>#"'C_GJ5U &?HZ--HA/.O,X4W?&<=G^]::1"I_;;1508TJ5WLL&!NZZ1U!
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MKOM%TK/HHEJN['D6\01RS7:G__72<+4G*">TS>!VUWPJQV_GD@(U"$8@= 9
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MX<MV&TYWQ>I[QS ZU^D'8N+<@*F#==F^R$Z UZ2IE]4T>\V,#L('DTKFE-+
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MNV6-@J,&GO<%&>MU0(":'@L#B-)V%SG.D\%1:PWI#8PXB>\@@&YSWY%.8-S
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M&S4(OR63X3P]48WQQ6C9R?7/H<%\'];PGJLVWKY\\_;>B7 Q>@7UWZ;:15_
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M'T^/=_<./__RTZ/M1_3S\>[^OOKYC\/]LU]_>K2SO?W#H^##T<G^P0G]7L;
MOWD,\O=Q]_CTX(WZQ]Q5J"Z9%H\!R2N*(@@C#O'DO?QC7PWDQ<X/L(A/SO;-
M7WZ7;_-4S9#5!]T'/'^E?@__=V*]2DUI&EW$C\_S./KR.$F+9!B_B:ZR9!BT
MGM)K7.O*V&!7*FOV9F?Z-2BR,3SY;]OTO[?!-!H.D_3B,1[(-Z_H,;[M?FD)
M8K-@VOO=<++6)=$HG/_UM]<_/G_^5GZ"_P0G<3G+TV"8#683V-C@_ ;>E8R#
M,GLS5YI;3&_'G9Z]S55I.#GZ ^0;?O%<;X#(\>./!S^?^;9!_GQV=#SGKQ^.
MSLZ./M4_H,:E1E<?V209#L>Q=V2MWGQR^,NO\\;=-#(C7Z2&WSR=DM9?43)>
MM]7YZE"?EE$9DR!<)^4E2$<QC0<E2$-P>AGE<?'NP\G[_0R>42:#X,.L2-*X
M*(*]+)]F>50F68H?>/?S$2AL=9==)F7\N)A&@_A-FEWGT?31^_W3O0]O=EX\
MWGGQ].F[)_CI]T$OCZ^V@A^?/-W>>=&O'@<SHV=ME*A[9UH:M7$9/<_PJ#L8
MTN&G7X+3D[V?'EWL/'OQ_/7VQ?:S9]M/GSW?>?'\Y<OG6_^<7N WSWYZ]/'H
MER/:N66NJIU;;A\OZ+&E.M>L-NDFN .]N6Y]]SF:Q,TW\:O5E)>^B_X35W1W
M.(3S7S2?S%NMZG^HF.XEY4U .C?XWV0*>G08SUG@ITN;%*LJGA9#)U/BY5OP
M;MY[;(A8&1&XGEGQ?[Z,+V"2Q=8@FRBSPCY2\!\T=!O&NQ[?XB2.AG QC ,0
MJ3*?#?"V*H)IGF0YWF\PLNDX+F'KMX*SRZ2 A^43>.E-<!X'Q>Q\DI1E/ RR
M= QW7A"5P6593HLW3YY<7U_#M/0%6&Q-HZV+[.K)5G#G[M+/<?PF^/N/VT'S
M7J_G18<IKT\2I8.838/R,@[R^%^S)"=[H0BR4;#S(CB.MO:V3K>ZG?_ZV\[+
M'\7 PFNI=]['.WX<X1+C@A>NJ9$;4Z,@4Z,?TCMFZ3#."[C.8?&M90Z#85PD
MN?TL^CC^]B*ECP11.@RN,GH?&5-%"-L=C^(\AEG #^,$-I4W+:0/XPB2:*P_
MG8S@US<A3BT*!N,(3!T0EB+.DYCFF\"T>;!A< F//;_I=F@H!8PE*M]4]^46
MSN"[87(%T[P9Q[B]7Q]SB  ]/O4]4ECPH]ILMA_A%^=9#DOXAO4<:+RWY]'@
MRT6>P<H^'F3C+'_S]JW2>C@6')KZ60;S; 4KU'ZD_1D:Y\X/2TK@#I[*.$CA
M7L>5QZVVI"%(BC<K';?*/&\_SH6V[^'AX]\/E=%[F*I)@'2S4H1]GJ?_O\M,
M^[UX"BKX\/W>93SX0L=;5#P(4*J%:)2-Q]DUO!/<W</W:SRP)GJSWBB,%=ZI
MAH&J82([+*0L+!*'X*>@R<9Z5(W$_/#(-:#DW^Q:P>7O.M*>$(/]'\O1MI_C
MO,%>_XJU$]SV)GL;U">  SNCRPRD?<87!UQ+0[I:X/>[.?BZ8W@*W436'1?P
M%1=X;S<X>DE!%@9(7K<S!+'+)PE?3 5:2/CH\RS*AW#/%7&)Y@;<@DD:C&;C
M,5P]\,5"I%-TFS&8/.;2;=3$7TSG_$5.'H9&Z_&IML=2'\67_XE'$4Y/[4SA
M?U5"8[?;B<HR&ES"M8N&&QQ8O" FT1!,>[B%\I)^G8TV>/)>/;R3U_ZV9X-L
MO=?],S81HXN+/$9O,TAGDW,0$[CIV4BG?\T&ES53/@:C_7R<%"@.* ?*B8 ?
M05/WHCZO,GW7R&;8[8"L\9_0KV174KLUEO\P2L;PJ'E"BX,!4Q"=H(SE?9IG
MZ@:!8?.SQ]%UQ5EBX67OI3=0@TEO@@S_9!ZBS!U]@N"$/-UY$6YO;VL/9@#O
M2@JZP.#3/]I_Q%^<\EJQ@=OMS#%Q/SS>40;N7I9>Q?#.<U!]Q^1[Y; 2IV4V
M^,*#WGF^/>\]<]_RM,5;MERS^LG^X>_PD^1<*:N$2G!J#H[Q&>))3<?AKRSU
M?1Z#A@'U/;Z.;@H2_U]/@M/#_X41/WND'DEIWS=_>TW_J^3J1 'N'7P^.SBY
M14[XP68*^8:\TTS?&F.!WN3,'88'G[-&LZ[#:S *HV$V%=6$1_H#&I%X</:3
M''1"EI-FBU*XXF;E99;#N\CUH0!6S"H#%4+Z9KZS<V\BC6 8;#][\O3UDZ?;
M3W?JT<-O)BZN5%>.S((TY>W3@7-E<!^ON]ZG3T_V]Y_\"?_K+PBN_J>8&7<0
M5'AA@@I\@^$E/X6+%JYHW 459 @711G^&E[*?$=$>2#WSMFHJ%6P/L" .X^#
M>#0"'9I<Q<$,##'>NV0L)E&):8%%86MT,_!K^S&Z$?3!; 3F$GYMZTZ]B?\<
MB7K^$"6JVX$KUXZ6W<7_1^5=OR%H$N(&K?QR@59>6^2]=@<&OV:S/.BQ$]:W
M_(#_>'C>]FWA>:\W9K3/A9%]2^B8;QQUK^);HL3NT!$Y_!R<'9R>'7XZ^OQG
MM_/'KP<G!T<_S\W/!I?@J0RB60&_KMR;<%5B2IV_ DY,% QG8_B/\5:RT2@9
MQ+GX*GSQW@V:YP&*[9H$\ZY$[U9>Y%U#8'][_VR[O'SWY#<*-0?#Z ;M.O[+
MIR@?Z#^%\DMV.?EW6[<2P95GNK3#7+T)<"8K9Z4WYV_?_LBLZT1\4UU;W;W/
M@GBP,;:W@HCMS '(/L1=OM>*$<[>D^))\$<TALT,3K:"#Q%X!M?!X:%.PGU?
M[H=@ M6 \I0@FN5KP&LNCU9?1TCU&)Q5D*RT?,@:_O;".#>HNU;9/$O*<>R-
MR_YU\U+?[#ABL>+__'KXX?",]WLW.#M:5+)X1^.@*D4J6?SC\.S7X.3@]/A@
M[PS'<_KK+ORTH6'MPI P(A&<_?HM:BB;1G"PCR64W0XL!*X3_'1R=KCW$9;E
MZ.?@\+-5:XF_V,@XES26]9AA,AN2N(.30UC #\'>T>??#V ],2AU?'+P\\')
M"0SJ].QH[[]7KM\MXZ\E*'Z\*=X\7QH-^^']YZ,_4.1@-$<G!\&'@^#P#,_$
MT<??#_;9TT*H=#"=Y<4LXNC :4S@?!<[+IF4XSA-BYOQ590FD;< +?@(YA5B
MT5^_>A4BAHX01/$P['8P6^,\^T5O3S]XES]&*9V3F*(50P.7@ \9KPC?TL/O
M_-??=I[_^!;<1/4Y=!7QEZ_>TG-7=[M@Y.Y4F]_M. ;Z]2$'3X*DZ'88FFZC
M6G"2#NC% K5/-8"B0 "%6A][B4$8,@(SXE>+P Q'L!L?YB$R>("<.Z/(D"^!
M77^G3&*4?(T+ >DPI#+F 5A@G]G@LMN1; Q\,L3RC7]*D@8_ZD)K"-73+!:R
MLZ$4/"#"\RJ6"@$:AU52H!^G7EZ!H7%,83=-XZ\JJ,"_<G^2*\SZ)9U>QOKH
MLI+O)L/M;Z3/GP_^1QD,F]'=/9#)$YTVTI)?/Q-P;%[LO*4@%8_XZ>LPP/!4
MWQ[Y=Z&X'>?%;U69^.W.22]J0O%;&Q-R[KB:<FZW'];G_=V3?; MCGX_/!7*
MB]_F6&AW8U7L;,&\?WO_2YS&>30./D4EC)#NWJU5*N'LL;Q>=BR]J!\<1$KE
M6_C%N7<@8P?2#*'&P54TGL&E!)<7/\.^WN%@'[Y73^QVYCP2@24,^F;S0R>@
MR<E/!A$!H/%W EDH\#J,X7$*++K4#,(@_CJ(IV7]C@,YB:6X<J<WZ..VA/C;
MG=[0_B$FR?GMO?G=,_D-+"G^BPLGX.<7UB^DQF^4I(G6EP,88I2D_&M,-X%9
M4)"]D*0$H(-9Z=7H)0HD:YD\K;;,-I\*U]YI@55M@XCEK2/9Z':6%(XU#:$J
M180K3NYNS1;@B-L@?*U56_9$K0EC7%DTJ52L@L])9$$*;[H=1%J723DK56%#
MJ\74,BS [>40VW>,UX:3ND[ ]C=5X>!=GK7<A+"*^NIVL-(+7CRT?((G61X,
M86/RY)S10/(GPI1%P<?D7[-DR&[-P16,F?W4Z70,:AI>&LI6YU'ZQ2BL(DZE
M5#V./#4,L!/_F-$G9*#FV,)KX%0@U0 -ONGKQ_P9\W7U_7_.O&\&'\O2!N;5
MHC2N:M^NN'1X7%Z^+> B$1G&[XUF&%0/<"_/06V0=X^_YRMJG$3GR1C.$;RU
MEZ2#\8QK@W(LW)E&-[AZ17^UROO;R=! S(!?L_&0CWU4NU#7=!!9.D+D("#=
M,3LOXG_-$%FQ-\X*6(]N9SH#-R$JXF"49Y.:*[VS]?S.ZBW0!%"G QX>^TRC
M=:W#93PF  D[_+SR(0Z Q13F']IQ):GQU[& D*PA<;C8:. JX728.,[8(0RA
M8"CG[D4>,XJE?J>8?;"^<'0.KHP$9RJWQ($VH"@@@<$G&+L;B=C:?C5O%*&.
M<]R1E,&-6N*5 R<L+>3/T0ASF4F!ZSI  %")5!\PP@+F68PB&C_HAYJNM&,C
M86 5Q*HI+EI">S?)-)3%$L-1_B-QPU[<9Y?@C+@"]*9.P:&.AP)$PK>RX!2L
MCA:/P>B=4+#?6FWCTWZ;HLZPOMM7)"+747+%>WP-BA;UEE1P+'&#ZIT[8>J-
MH1K]XFEZ-&]F9D4,*&DQFTP4DT9=KRR<B/6*K6 WO:G7G_F$N-LQ:Z@&NV@7
M\)AK[>];]5 -5L*_>-71'7*=@%J<9,-DE"R:@W8X5CA9]?WY]G?2L \+0A.(
MKT@0+N7*L.>8C>!8%VK=>0$S@MX%V10^5<+U#58!_%U?*IC;Q.^"2[E:>6#;
MBR0:#+)\:#AG'-WX=&M[!TPWL(_F:DB]B7IJ\5AYOTO,J-5\YCKH:YL0_ 7D
M/_ZFUL;JQD8/IRW+JZ1,UCA79X01H>HY^DY7T[-S0XN4_@!_[H/CZJW^7:^M
MT^W !**QFM5QG@4G41D%NY-L1F4?SBQJ!D--9WG]R-JG9$.RP6"6-V^+7K2U
M6CTTI&XGL_6PU#C;Q^G.C$M;$KQJ'XX5S$[[UUC-CP596<IU.*WNEBUGE]2N
M=CN\K>XF!9,X0O:HJJ6#)=C*(-6BJ*6E]U5\HTKBJK9L7&80O)LVA+]K5T9@
MWQ&O5BS1O'6L^/'.8S7V[SF)Y9'*:XNEN/<>(O+I[O-HW,;T>]M+:3(;EPE8
M<:2]NYW>C0X9TCT0JAQM##]F).TP+5".22U[>U?^C.TM*IUL(LJ2T)X[M&Q6
M%F7$] QWQXN@!XIZVK$>OVE0+.X'G[,2]9J>LR^TKZ/T)KQ/IJ/Q+%048%VV
M2DW&K8MGA>MFSA6SV,4T:[#F5R^T<WBQ@QZ^FO@^G 6O&F'P0/378P[XH3F7
MRD$H8C C** F*:-N1SGF4@-K94S.) K@XAQ46!/U\@"L#XS?->H3C&B@/KF:
MKU!PH';>H>'-"U^37/7Q4?XAJ!%T.WY;YUOG-9&O[K?W^Q)/MA*:W]9MC/KV
M,-#X0<:\5N%Q'O+/R@\X))FCPDQGW\) !<T+Y5X,!OF,7H/?,_$ *9P>!K]3
M2J<IHC@_<2)&\FZ:HOUU0H78>I7QG2L\TQGV,(*59/>'SB,%R.8OP/E,&?)D
MG\XPQ(V'"$S$'+Z-6:+SJ$C,\/1^'$<W)*A<[YILQ5LAYKV:5Y1#Y^;OLW2L
MHNHF=C=*\J)L>,D(M0:.O?HDM"BF48$&!%X4&<[)_[DKBK#$,68B$IHJ?7 (
MC^^#]7P9TS?@/6E6@EL5Y2F';(:@46"]ANS%N)\3A!ON&GX!WD )C6F>C1)D
M7P)%-!W/"AWY"48SVF^X]F'(I1=E-HXO,$471%>PI120&DDP9"HK E_2$[/%
MB((KI),X#:%DN94T4:P)MMR__CKQIQX-VDX, X'?W>"1@450+V7D7AY?)$7)
M2K,6]DD%T(8!"=H'L\UJ?J$80OK]9"K11Q,0<=C,WLX+4=%#L,8-F;)[B/UB
M]0WXD<WNJ)6KJX*E]LE-;N E:J8&W\^&];W"\ <\(<KYQ*F_8Q)X,ITQI323
M0?)Q1_-HH1'Q[.7V8UAQ94C<X-:[R>#R.AY?Q2V>Y#QH JMY*;'D2$<QAFM;
M1E3G1MY9EARAP96D):BL*Y]_=18MT9*L>OWS>B.^Q3JW\-A\"\VSB@8EKB*=
MH'@<35&=9E?HG:RT?9LP&<[)9#@V*K)BQ/S6ZIXQ]^8HFR&<*$K3!!:BB/(;
MI<.LK3^4K;<NV23M=FK9Q^4@*[4PW2?8(W0,;X+CP_^FU]1 ,B!H&@4@]T11
MO=UQI\\ITLSN=V4RKIDS[\X/JQE#LF -)@IG*D@;ZYD2KG( 6E[/XH7X%6X0
M#&<N@ZE%*7]6Y$;5.=57KF[XN9J2]SZ?P!Q"];,G;U5D:!D.DV*0QQQDYHN*
MHAN2':IEH<VM5KT+,5,TB;[ M8F</3!,-  *C7=83H#Z")WHTQ#A,8.HN,08
M*2,\V(1);:J#!21N-U5N!+HW'"JW4:B5Y]<2A62*_ELI#''6=HRCZ]#UJV20
M46#OK_I,8K%)PCO/K5PMSHIF8W^/;PVU!0U>*.PU\CTHN98!P&[1(^'%"=\,
MGA=R_8;]1K:8%]A,Q.D*"Y' %EUEO!)@/":#N)+_)5,Y=Z\CVSSR)K,;+)LS
M9T.\>;=A!I*$5BRMV+RU@2U?N#BUW5C?;.KG1:_M$#UETF9@X<=V<!'GXMB2
M:CIX#"IB\V"CW$^_1[G7#*'"VVB1R7,ZA;<>C4;*Z*'0$(-.Q-JH);V[G08=
MRY(L3J9]^"J&_F)#;,ZH0D?+&&(PL(G*L;%+E8/I]\7P4"&B XN/Z \F+-TB
M\EP=W:F.^EDHV=;AE"*XSF;C(=_=B9Z "8FSPIA,,&HD?A,,G^]H*_@KE5<M
M7NF+W0]D# 2GQ6]6TACS[9P7'*NVEY)S(KJLC"#+,IFJF\PY@PJ"Z5+=(R-W
M\GJCK2W$!RPM4]:N*;/O-G*Y@:3"D/T$O)005%)W%$Y-I9Z=;7A:K0EXJBL+
MR$;21F7/,B;9]C(!;A,(0K9.$)B;/FZQX(2L?6^VR?1G.2K%]7]R!.AFCJ9)
MB2 2QM :C)(C$ ;/ZB)V&3\!BT87-OX7(VH<:.AV.'KE#U"1&(L"^?9QZV<4
MM[91S2>$=]YL /OW;#Q+2W(=<\PQZ!^M@7KN"XGK7-G?3JQOC\VW,>W/F;'9
M-&#(M^9_5)D%!PJ#[@3B 6S7J@8&K_A7[$Y4,FAW O&Q[R1+5:%\^0+DR^$5
M%Q06J&C3.LI;[!4]UL6Y5:?=@>Y<@-$E@=+>CH7-6"FWZ[CR%($V\]-O-2%Z
M)\XM47G2*4:KJ7#Y74&\R$$A$QX=DBDX2DDV*\8W%+$'O\N.63BS(Z3_4VO!
M9)K&J-#& CU>,@!:15LVEFM!-%D/=[H,G/!/M4&1$*@W*HK9A,H3$#>U& )P
M^W%<8UK#&#4T?7=!)N!V)1RHT!X>+4U-FWA0AXO2VA(!4AD=;*:1#R4@HC(P
MQ0PI&A.!H_DVC39?7U)RD37$<^QX"'P0+D4,Z2D" IV!F<$7"TX",JFNA)QX
MJ6R8\;HQ&=5"N)75<2O4SDKJ>'W(VS7IXZ<;UL=/[Z4^;@G;^JOKXW8(\+O7
MQZW&\5T??TM]W&9+^M4R+\$SDBMFIK9LGM^IV43,E.KO*JY]*"DJM]!IU*9:
M,;O&V'US*<X YI:0CXG?MT()M<I*#@V2DZ(Q"96A)P6'O3$P:YYD.YN;3!+F
ME+63$+-X8*-P3G&L460F UV-7VN46B4'Y;]\:"<L?&7E>L=G6'Z>1?%CRDE,
M>AR.\VPR&VMBI>IU4<6W6* 6A./C"8N_ZI(R"V/Q-1X:[]ZS+AGS.;AUNY62
M-#SV=(G@D#"7P.TEJW/'GRU1T?! ^]EBE["VIXL3#Q 6/D?()'6CTA..*,Y1
M,GPXDY3",5EN%8@DN=I:M'C\.R'C%K%PK ?_AIA*[<(T!= 7&8-H<F-S;2 Z
M-N@'NSH%KLZV4TR@EI/Z&1H););Y;L<(O3$=W<H4G56MWI\+*N'M8"R+AI@L
M7.Y.+>W&43)14]"QU$F4I'2!-ZGG!YP3>O8])[3F@/'G."'E209IA#IM'"/6
M.T5I_CJXC-(+LD'('$1E>8X6(5-MJ%JGNOH!*UJD+P<-+#2"^,@H^'F6#K%J
M% .Y>_+XO$F+3>+\@C4[XH*0!%8:DJ.1"+^E>\HT9#P&!8N!0T\*%<$A'GNQ
MYQHZF:Q%E%*(.TM3R;?3BRH75]C&XI(8YN/95!E>WE"F/?G^9NH1SKQY:*E0
MMXL)D9 H0JIB%37'C'2>E=(RT[Y<_/9!Q6Z=JPB_?;S]^1;'M]'@9OO)4 GH
M&N=N1V.$F J))-T#".%+>T(D6GB_%J@-M'MIF[\^0UJ< ;BQ==T_(^2&L2JB
M+OD%<:PP<XN>&3%\@2]F&5CMXY9K8S"5=L#D*D/L@AVI\<952J?$![]4L2;,
M'Z]A$(U.<8_ZV%G/C/%CI?VEONTYN_[UREE0>(#C'S<!>U5Z2SO*:D&K2Z:#
M&[+P/>HX^<]9@4)1SU 9S)Z-S#.(O*4SLF@.MW1U;?*+>^?KS@>)O<7%4 =4
ME4W!29D76%Q';1F5QXK&K.V\J0;0U< NMYM31O.2*P/G5O%@WQ_RE1."\)<B
M^],L24M'C.]LKK"]H#2)_X[B9[59;\U!9L!'!"HF/E&3$B.6V;BNA ./#C9_
MU%<6G&G2Q5AR1CM19A<L[/I6;P(7$)X*"[YA 8B8Z=M?1R_H.MK3!\&PKK@K
M2]Z!=5X47Q;88MP?LZB'F\U3=4[9"1N_F3/;)A;,=227:3 !Q0%) .4:7KJ.
MB%28PJG;04XV5+*I;8'I@G*^45G_IBMH9:FF$2UK>YLHYX8+P[W(!19A>)94
MD-/<D.B7WG"L =^0PE/ RBX*>K]6UI@5=T48](2+OR!7'4]:4US'#7M;=H&6
M%[I^L'U[TO (Z[/'.1YRM+1)N3<_D.6Z04+I*15^ -Y>B_OO/+9X ))^\/=7
M+[:0RZ\:T*J%36^O$%60:TWO;!.H?4O![::+[FXI2^2:<\\52>7=(RE<4W08
MCQ,NZ/BLKQ-+;MS$BUTER#>R.<U@4XX3M"K1N20"$,R0V6P2=2:0,-#%^/@!
M#^W6&>A(N.8_L2MKW=YUPAJ,B!O2D-Z_K0?+)$'$"3'I\:)/8EVH?82L0PU&
MD$;^H\=+ .<Q]A'$MX5VPLFG.8/A+%>FV90KLC0KS5#*,"F3.C5KW6*DEFG$
M6Y [.T!(GSP>QU=HZ7J>IX/&1OOP<T$*"@.T5EPJ'H$XM06"@/^2BJBOQR";
M(/0\S@<)*UZ7-05T[0)#7,!VTGR>*G-*4PI8\5CF<QX)8*Z2/&LPV_6&6GS]
M['J0.%;*7BQ\("7(B"G8HA@6_C?^]\CZ]T4_5%_H79H"?OQ1UB&QN8F_09UB
M%8!F'R?&'U]%V%[(&*.PPO%$&P<4KE_.EUR"YN 5YQ\-F#%2^O/$C$(IMMSQ
MY&L?Z(?56Y7-NDK&V>(-1@_,FBW+B*$H$$,)>0=H870L3_S@2BK%/"GL=J00
MNM5[51X%?T41.Y! BL+;[U&'U?J>M6Q@BUQSP\EA#,YD4K+%A/$I5'@YR'F#
MNQS(?KP2F>;T)Y](4I+^-<4I4,;&:DDA' ]P(,&1F2F?SVE:D<>U63[@@/SS
M[P'Y=6FF%=0,"A/'MO/8X7>K1&.(1:YEH.BUH9E96H_8%&5+Z9'Y1@)?WY8^
ML2[ZN=_$_!RY'H6=I=6:19,DK$>/>%=3[LPE=$I-GP0^=3)5$[,GM3G<P<\Y
M!ZAA%\B6$G3ZYPP,1/V718:)Q 8)JK!LY$]JWPEN#A;D3%W<]=<[,6*Y:AFT
M96)'5IBJJ4 /?/IJ::@6E#K^A6S*$;+V4CVA]E%I+]4879HO3D5'28Y[]@4\
MB"M%TF**?%Q?W\LH,8X*O%<1 @"/'0A_(:;Z1(:<![H[DZ55.>4Z<%\-$J/)
M8.T+!0Q WG *YR'PY$Q^^,1SP95H>(QPC\ Z9YZGA131LL(9(/H7&3HB$7I0
MC<4E6\$?+DRD+ABZ[(K(EW'72!)IBRQQM)*+>A!5\@-R!3/427.HU^;K=DLZ
MX9FL0+L=BC\ICPR6LXZ6T\[0Q04&^$L_^UMET66^2B#EO;[I;P2X03;TIQBS
MT<F@</W[M32FV7FV]*B2?B4 *\$MLU0%2B/[5,IIMM4(YZZ)(!FTA^5]6++6
MB[H=.QSF"W!4H;[BVO#1J$88%M 34#=V)<WJR.[C=9C:D%2E-;&]'5?R\]RK
M1V5>P-E#]2 A7IXD!3KVJL<.W?9D=%-)'1JY7H63@BTH[42'51.C%LDT(/$U
MO,@SBTH$E[\FEV,UJ+B6<2B=L:X5S:Y1*18F6";WI"4:4<DSXC!(T]2;:N$)
M6<TK8D:OPHZYA0B9$B($KQ++6%6EJ)5'4F0GDER0A+(ROD9LFTSY?9*T+$(K
MGMUHX%:OT)Y#'4!?(X%?\+W0=V/:EY5K-BW!M2;A7 OQ'3)2WP+0.'\<R3JK
MW"WN@B<CI?!JL$S3[)I0ODY+QQR1%,E5 B837L$^W@37Q#&6^A5!-/3C)>%%
MQ1P%K 5C!9">'C=SI+"8]L>XYL.M<=5EK#;0TMH/>RR@WZ^2O&2K#.4&Q],J
M0XTD%MV.Y\I8WE! H!+^;03J2ERQ26BB2,TPGAD\A%:'1- \HE?TT6!DK(JZ
MN9:U7FI0;$V,AP&26@5$JX?J0<5#-JC/&51:9+8R<_VL.HQ2I0LJLW:G;!_X
MUD&_/)M,2Z0J="A[S!'N=O;%&1;5M^=NO/BW46K9CP:&>HO%PG5RYJJP+K8+
ME*@C2QX-2R8."D^MFHM=$-+6LE4@6>MZJ&%JY7[Q07!P[/6"HLIM9;O,CC!@
M]I/?EL'!3U)5/5Z5=RY"03MI/!:'(TLIX#K!<H 4#+_:]XH@)J4Q4*N#G]*#
MLN$S_MFVW<EK[C2,EYTGIP._N(0M@F];^;]$V>UP! I[ES%C@$J LEQ>XAQU
M.FSVGHKTU$]*"UA)FJ6/]<:H9-]R,NV?_0C)S)S9B^,\GN4::E@A2E*SY 0[
M;-N##<"^^!Z O147O"W7YJJ,6/T1U,^)?,IYH.OS?)*42,S,\N=//GL-FG:Q
MW93O,ETL(J589A F&UXQ97EH<DL:Q:<4)<J[/6TY,0QQ(>U1RB,*B4_-F2&Q
M<=7L&/=6P"FTAV#"G,^S[,MC$)+\AOGJEJ_JVWG.^D!9I!,,VR);X/C&H+XL
ME0Q:91 /9SA@NW-['?L#U]'^V9[V.31S]NZ%)@>Y3?QUE4!$0ESRP3@J%79]
M9_O-]C;<F4$//_AGEG\)]JC-$'RYKPF%8L0A.EX^)[W)X_/$_*P,EO*@3*2A
MVZEN6GF99[.+2]'& UVJ-Z(%%/ ^!J[1!N\IIML/R@':1\).$Y'M2<209AG6
MXA,&Q"&'@\F3K7@_"J'="4MM7!GIEO<S)FJO5V53<'1?(S \H8NF*+$L$?E2
M \)95)>NMW"=&@Q\NZ=E/W1=;+J9E:YJ<.P=+_(\IM3S0-P#\B4K'CN:-+<S
M9%S<)07"$W^T?FY06LO$_#AMKQ'1X(=EG'.BALLE78P,DB/>>-5?6/44:DAI
M+DE4N\UE*S"R(06F3:#?6E5C^%+:PQ$^*PHP#W;/K(>8RG*CBQZW; 7=RE%"
M&R?)E0E2.XOW1A4%Y%^@4+QUL*"'U?VS'#E%->=-PRBG*X_+69Y6[58,!*G[
MKQUYLGTS.OM6?7\E[#1W.([Y>=E<^L\QODH8OMJ6218,/NB_D#=R!R5-!40H
M)I@+IN\0/^MR[9B=H!.Z'?D5!YN^Q/&T5H?0[:#T-54=5 C$[JC\P.6]@R_B
MD"I$LXT:0P7//)9';/,0F* [Y87<D2[D;KC;DJM5!.BJ'^R./?T!%^"[[82G
MB0SKT)8@$^RXL^I=;^X&9?8'XRQ%B&:U;M!>257-+5[!W!:L;@]-%::T.KJI
M "0K9S9"=&F50)LM[HL!%6821U\-6<%:>.3H3ZF8R-+QC1F!Z\@4'$?#WUD$
MF$V\)*8@U*2SK>\IE'N;.[WE'1X9RF\ZW&0SF%BMYI'A4V[39;9D(Z\P"3O$
M Y;C=5ECUM99:HJJCH2;-ZEV6'&0]'UNV[ID(*_(; Y.K1>1FUM1Z'#@2GZH
M!'Q%]45V!;KT)L*7F_2)PZ5G5R^DL6)*,$4Y4H_(W7?KNJHDOF]\"RQ%GDWS
MA&25Y<"P0J8@.07QSY,8#6<#CC[:A-P^T_5V9BB;.UC4(P0+U, M=@P559\)
MNS=C'[:ID$T/RJM%O_$]?-5T"Q/[=7JC]1?WJS)D*D4"3XR4-T11 -DC/W\1
M/DOWJ*8\D<'3\I)(_M92()X$U>JPVE90:X.S]A8VAX%$3L-J;D0M%RR'+I1=
ML!K*H00+!/DLKXPVT.M$3F9MH7R*-@K2:!+;Y>@JK+MR>:L=%^>0LFI@HW*H
MJ=Q?WGW5>H>H;WQ-CKH=+K]7\64='-;/TSYY@U7LT;VX :JYHHG+:&^W2A54
M>:K$@_63\#&Z3=(#1MV^_![T73]O\JZIA1AI2JA3N&1*%G3^Q9[I#J#XT.L9
M!N7Y<-R ;;-\;B&AV\JLWL)Q@<.A"NLP;HN6BNVR^!T!M[K>)<VUINX-<\VO
M\M-I;=MVE=  A[_-XXU:,2Q%_ 4P[?*8X,Q%9K(Z[:%LM:N&<2P^0KV6CBB8
M\S*B&JD2/A;U/G] 6X'M$7C6'LT5J.";R).TP(A;BD^WXY4?ZZ2L($5!LQ"Q
M9VZ:=#3*D-FQNY$AJ[S8B*M7./3?;RL;Z#]815LSP6^TJ#J3EJ9N&1M'.ZY:
M%OJ07\4[SJ=7JTEKK^79A7GX9NALZAI]#\0]@O4W?>M0K>_;,!]OAXM**<42
MI]!/VK'"@>1=HRY*F!# 9X4*0ZU+)A5PQ.[?1F\=4LQXE'R%]Z[6:T$%1SV4
MN:'=V,,+GG*:]9GR]Z:[R#)ZK2</XV( #VP7RM<U%^BAAR:;P>W1Z$#*YDJ9
MZ1R-I&M(YJDDZY$>E6#P@2I,4[6S=<)!GD&>L[-7*KRLR6I-M(OJ[Q:B$*5T
M3C^1T&M2<'!3;R^F"D^-4N;5M-:!4$4JNG-;JHC5$-BBSZMMSYT"B&8<OB_V
M3N$U^\[SLL_.V\MEMH J8[]]L%56SNW+[@935UV\X!NM'5--+W>?)ZG-Q,%&
MFZVZ;*7U=I5]66H;6B*Y1O6I5\/=7( ;J1R::;/$Q306;0A>'F;F+J>M^2BY
M^/4*7ROHN\!\LX*4NC^H$W5;3E6I$*6JRF_]>LVLY=1CMS*78BE=KZENZ2=:
M$:2@28XV8/R,/,9/MW,2$X$1IS8I-G(@T7P")R"S!=SM,ZMOB[<\RX[6KYXB
ML]@E: C"7, A';:K\.X?$4Z\]!YQ:@B$,Q(F5&3"H4^H2CB&&IS?8-: TWYY
MG.4749K\6Q8@KRV)0R#E6B*6UQIZK%X,C],O3:M2E5\:,8:CK<2=9U>\)5%M
MP$R'&;IDF/19JN?#52':38N=<$1Y^7%V+=80G25%>FE;0E8!Q6V=98TBYHR3
M?7)U$-)^NM[[+XFT<O6AG@M=WB8A:]-ZBBYMU79*#%,F:#99I?:;'ZAC 09.
MA1AQ\5VS@+Q__O)-:+V,8K>(/9HX\)$9I<7$U)28L$#S?RAD7P,/"&=*'W"@
M],?O@=)UWBP7/K?ZD^;H/:E(8EP.[*M$D^@PLP^U77._HILX8 +%5S/I)$!<
MMQ&S<I*4;5>"@S9/A3G'XCR6C*?6,:'NH>LVN:O<$J5I  @/9^P0J!&+3:?;
M<7AT7F@B'7@T_3QRG5=33**3(KY%"_V<7VUO8>M#<[7QXO50?2A-&1WEAMI;
MZ;XTX?*JM+EIB%?DJEU;?+V![.PCIY3,9K_5>&V#U>YVG.2W.36(3%R^@KU?
MR<&Y6 ,[ T;ZFZN*Z$/M$J5>OCK%(DE& ^8*B[*P+_0JFB3CW::6JBK@:@W'
MX3MM/3"+G<-Z5G6X?&X+QLPK(\&LN@\X4/4<U!);$SR/W88/!5$/LP^#X9TL
MI>8,G!X.,0D OQ[K0A,ZLW-Z9-JODESK.NSK31"!7/HN!^$U(3HVS:?=E. (
M%V8XB.%B'#=PY<PG2R/M88,)M9MFP%G,"$K[=!WE<+QA[#T[M>&E254=KKS\
M^//[ULHE-^%R6D6J!Y_%JVS"V0ZX6(KD*UXU+[<%)3]$<+RBWD,3T/C*QB%U
MN^W8W#Q>**YSW=5NA-"^'#D[DCLT>!08<*_DVCBJW3EKTN$N*TB#6Q)ILY=0
MW3 X^Q5ENC0;'W/4]7VD!^X= K> !O-Q('DZ.P?% ,*8POTXB%4\ #]0F9GX
M7K=*>[&U7WFP)]9A0A9*'NC?GK8Q)R+U<P/!]5$N#@,W*)[-QH&+V03_TMNU
M6#672;XMD!"41UM$JHD6MCVJ8D%1S-X':TB]G3[>#L,90XL<^M$EHK$JX.D1
M1B87M5E+Y1PK1J "+&$*O0Q#"6>0$>NTOO,=Q<P3,;K38_5VLP%T++RS(^@^
MJ5M*PA9E8=NMHB_%YQ<\GTPMS-"!C:/DJUJ94-N>S<?0*P#?:&X'/[=6IVKO
MUY5OEAM#+?XZ37(="ZPD5/V'?XDPNM;N&CI74\J1\F)*@24;%7T9"2>490TS
MCD^-WN1@1AYCJ-O1UA!Y1W:"P.&\LM&-&G>^\ AP2)U /[+V+2J]$S=)KV!^
M\RPYM<7(!J-MOWE\/RKW*_";"T0/V%<MUP=X]X-50=.&)*/6=P1M'HZ:HB;Y
MBJW3EJ2E- QK. (52T>K>][ZBM-,4VLR>Q=;HO/-/D5:=P?72K=CCF92,11N
MP74GY4">23@7A9^G3\^6GN%4O.(E_J&_*HN>/:9NQS>H.1$*<@9L]1A14>IL
M'!%C!DA+-A1O2$6:-7_W !P,6.2(FB$)I .?Z ]Z/.#8\ZOOL>=UAA<27WCA
M"#/*6#^B,5V+$5PNF(JMF1J:ZG9P*<?%KZ*ETOJHUP)4:NM#\A-]V,6P":ED
M.N%N!*CD]NA3!=,F*(U?J*WI)D)@_R09W;.Y-2@F:J16Y/,WM=%RJ8OE1;.T
M L5$JFS_O#""J;6R=$-N%V&MLQ<0"TB!1FV<*C[G4'*#7.#LQC^GY/_SF# 3
M(\0E+"6IRTY17F?&E[2N-">PW..D.4F)-*K !(M9BR4H]E_T+B3'4AF)2SW1
M,)1^& B(1<2]>7\\A)MTEJBEAQ1:4DNA69XFQ:7F;_2R+!5Q234T'"^OOQK#
M?G92P2TW72UY8Z6O*[R/K9$=B1,[[$M)(F>P$N27*B/I]8%U.P7K/"MC/F]Y
M"_0VP +N=LX:XL>M!-2@B!0]@J+$<N+/([LUL!"/LHUGB,&6*ST,]<Y7Z$#D
MU_7:?T<D0&<[,N%T;UH4IM.DI3)71,4O.?AZ&^_%KIW3S]M4/Z-_6$%Q&*&L
MY!)Q(N"!*G9FN4F;2$IL;/6MYKL!Y-87NC\TJP.!MO :9,*9JF%3@]R:E[TT
M=G&CF>R8Q:!"SW8_?#Q0C_IP=+)_</(8;,B/N\>G!V_4/^;.H#K=1P$_YJ='
MVX^"O8./'X]W]_<//_^B?SX]WMU3/]OV*8_GA"W9X*?@D67[)M0T[4UTE25#
M^>"^_O*S'\RLSO8K?WT!AN_O8OG"JF@KF*U9.$SV=^R_.=^R%SQPUSBXK1/Q
M-J@,JH&BCZK>"QL>WW-8;^U@/V4V\"YWSJ4%R7<1_E3SJ9[O,54YID<K!?]W
M@O^'<O-=#-<FA@]&#OEB*:K82$^0M :7;)(BVUS_+D:W$Z/[*$=T/?L .&\)
M_O1=)NY6)J[NJTC8?>)%'A8+P]KCWCI'7X\6.<9Z0E0K["%/0<<-DBG1:XZD
M1YMJ+RN_&*E0M<44"79T'03CA&WCG!"02&",V*5KN*$U9V&$C^B'%MV+/;Y)
ME%C=UQ4TBP>5Y!QHCH9#N.$1,D_$,/!XM[5YX1]VR,%Y? *Z3;T=!Y#BE/AP
M,(B\IH1#R#J@3GATRI)=PS,QL>P\QBKS';+7XSSE@_T41)0(MQURM>"*?3>*
M7:7P>I[&>#Y?8^S>0X5139Q5*W#""N1H:>-$QX(CC:Q2)Y/S?=&7. V-D',\
MT^"2F\+!F>XHP<^QP\/KG8'#T:JR..'W*_;.S\N'>WI>^* X<38O#!HDI'85
M&X:PFK0G%)/#(/& V::1\F2Q^/LI2RUNN21OBB>YH'Q/!+,&HEUNLEM-[NU#
MS$"^_IZ!;([./5\V.O=R"X-SG^ P(-SKQ@JXKM['^';APHC"A6=Y<H$%."2_
M/)0_;M\D"B] %X_M=C4I+Y,<$PPIGC:D\---76S2BS1!)+1%?A$V CJ:L8/&
MQ*XT$42"RWC8HKU\EL:/+V<IF+RZ\P2E89(1: S0&P.RR'=>;/_0-P.IA--U
M&4IM&>?#SD<^.U<F@/.)AT)U/F/F,PL#CFN,7WNFOH9UGZ#\B+'%\XA8&K-D
MC=DVEUV];J_+Y'U"+F3#!LF,TZZZ2=7*STRQZE5C]/!97;%EP#[P:[T!*_,[
MAIH3%0=J4=S,3YHO28)MVKA_\RP!=UP]EHX%<"Q.>(VM_#)2Z?[JEJZV7L]Z
MOQY]7Q=4*E5K6-@H,F=$AR/6PW0,1[+:,WBBOU87D)5Z,"T'_W_)]46,[DR-
M@#M5"G-.0[5BP4["9LQGP>3^^V=[[%(8ROXF8LHB5D0.LL+S7&ZBU+E2R,TZ
MHJ"2'C.YL"72YR]%U+DQ@@,,,2]KN6PH$;6NC\>V'FH6)"<,L%!-V8EU65C=
M\ P$(\1\/-Q9.857[+P[IF;M)D\]SEGV=>,_6RY56PHG9SOF9G84-#<LPG;[
M+<5#"?<@X@/+;!RGG'H!OR^[(90,_=%MU#(:@;%ZA5UG0$3.L7L'; 3JD0E<
MM#<T$+W#+FS&2H4CVD]8,S-FWJW$H?I>MOO2?XA5Q:/(:H_8MAO;K&A\L-5O
M)1O-Z:A2/S2'(X0T:K+6>K/ST-T^BPN\VZF0@5N.R##+D:H)MWB $P!G@9^N
MU!VXC&4^4[@$\Q,K6!DT+3IU/[&@!PN6.V1N^/@KWNQQM2V;0@7SCWAD7K[%
M8!X\+(UO:K3R6""-OA%QQ6F>\F['5]NYI&HUM=+MVY\KU>$G0V_B0$<"=+>N
MNG *BFTCL1]RY[HJ(WJWTZQ(>O R7!!==\%H%*=AF%E^#U-Z8^M$"K,2@L&N
M.%;EC.WZ#\T]#_T&6G=US7<[E>%J"@PU8OY<DL_7>?"+9O73YX?C85*S2ES$
MTPHSJW2T<9CEJ4*AC"<6-<7(X,-2L*80&@..H[[U%M_\TN\%C@GV#,Q2Q@[Y
M0$+-@L06K&-M7\[IV+)2>R!?]Q_+LN">/+6^08W]@5@\Z(78+DPNPD#N0:IF
MBA&+XZ)[J(/2;5H'M<>/52VXA=:)*O1Y +V%C"ULV*.H^VR]CT&MUT%6[1RS
MI-)NU^M@36T.3LUZX:^7(J/ H'NUM8'J;8!E]K?K;(!/L&"F<QL5M.^"L$Q+
M R]HCE3WPVAI\"!#H3O;WV.A:XR%_K@E(8A2@BM[V56<1CK^H)&INU8 D9H_
MS==?]=A#C;7!?Y%2Y2;3;<AE8\*5ZA3W+/Y9Q<W!1B89G+9+89W$<72MB"EW
M89"#,;8(M+'#%)1CKP MI'P2T8K0,U5]F7JT&&=A< $?22UKG3Q1;">>L04;
M!9,X+FG"\GS)]4G3<[R -#:>54\?E,8TRKG>@RQFX@&[+3'K2F'I:%RR46%R
M.J8-?'/[]R7LA)5JBV\==],TWJYYY.WKU:[=7$_,>5W^J5^!)@8Z-=3(E8F^
M+1JIX$5O8%BDE#4K)%*OA$2*:@[HJ_T-K->@K]O,6&PM,/%605S+_:N6F7,]
MA0C+(3Q#Z@-V+_*8HJ ;F.RP;Z1 <W1+Y]LT03G7^-HY+"OR88N2)9H(J2@?
M*5L-X7+HG@.W%DAUK 0D\&TS65@G,B'D@]8<>3R-(V[;JDF?U)[K%>B!RL3$
MKR[%$VVM[?B^TMT?;N!/'"_%H'/*LH5 *+3I264RG)4=*K^R"E;35;?.$2Q]
M/Q-#Q;KO7FU/\Y'C4!K<1C,6Q?,XC;$[(57R(Z!,QZU?_*"3$'/;'K2L+V*K
MOY2A<(9Q3S**"E:'=+88"06MH/Z$05>[CEZ)1K=3?8B:I^<A"YZOGSW/3K&]
MBIH1,7)6.-2=J!QO4#F#==^5%6:]+/;VZ>E59'!Y(5S$VK6J#'8[3^^W%-:>
ML2XA]*5IEY9">!K<K/A?3=[@4"5+](=N+-6E0H(:'."8WR#"Z:86LF%N[?D_
M9N92M,6\-Q,OHR[O8;?3NU*),A-#\;V](-O+IA6M)H<++Y%XN\+:WG7?6C42
M,&<Z1+^#DYQ-\9E_!X^0OP^':DR76DJ%KUIDX>Y"_G&B70D-/93U#D)BS&CO
MS/T/DCK @*Z%XG"+V.$E\60ZSFYB+%(?PH6KPKMI,1LCIYV!1AAYDK@A2F(R
M3"*.NRS$8VCRJ31+'Z-F4ZB,A5M%+/;O#I$;)H A1 $F$YE^KQEYQM2<(R>Z
M7"%V;G?HZ^6]\V7@J69V[?V[K3#"J!T!D5@;AWTEP.4>"$QCTH,JOYYK:%;9
M_/ ,V-_OWSW-S.=*%@:.?7DIJ7,)()<YGFK%%4I!1K+T&:%Q8O)9I])S%S0;
M/4)Z_"HR@NPR.4^DH!@7>\!<!N)[F>A=<PP@U$@6U$ZV<]]*="KYMS XUJ[=
MH5 O/62NDYV=[^&U-9I.KRB\=@*7[F1J]:7:%,)PH3X_B]/'?\91KM2X&3D/
M_"B5LAAM"IKL&F8C+FT@81VP9"QT&TBX =J_O@=5T@QYJ]Z5G!  .XK)8D>^
MQ'XK3"%WKL=[DQ&:]%A>;T%33N/<9+ANA:8+8#*P\"IYP!R:<Y(_3"R(%@LG
ME_37B4%M,,AGC++0*2_N(<LI+R?;U8"VG#M8<NEI1]#$M4AH"&T3#8>F+JII
M_+TJCLD(,]N#-?C2!OH\JPY.BQ"888TE^S;D%5J 0R;BS\;"H(1]E7)X&;&?
M:=.,F0&)I3BR\(@*1T%4'LJ377^7;\I:7L9CX??SM[%<0<:LPT>] "NCK$K+
MQO"A!XK3%>9E#8K*A]9SG:RF07<-IPH:79IZUH 3E"ZTM!KKUFH0W&=ROX([
MJR>_2>2_' L_U\4A;&-RH*_276(Y^WYGAUOV5#&QJA2Q/B<DT4_5;;#,W%4X
MP!P4#T&/^XQE"=(9>L(G' $#+E>W[)DE2EX(;!.J%9Z<G8-!%96*#XUN0K(
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ML.F5WO:"8%J68Y&E X(Z"S=N /TH9H>SJ6F(F\FD_.T^A.">\$#*%,3'TR[
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M7AZ?K.YE/%DF) Y(COR$S?P\ZHZ368:JO)=""N+WY^QA$! JH=UCM>&H#>?
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MBAM&\,0.)7IXXL=LKNY$K]_)Q5%>WB&O3;ZKGS7.=]'LQWWEGO\!4$L#!!0
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M!E*N0/QWU"5^W =>(LIB=^TX:@S1R@0:MJ83HJH]6%YNYR#6H@B+T;4SIXG
MYH=,XTTRY95OM7M&#@+<4Y#1.W7M5,GVPZMUM,!L#G6>3RNW=9!EN1"+U,W3
MHZL$Q%QWT%\%?U(+?0M98E;S.9<#+AP$?%2/Y?P_'""=!X6<Z9B_F-\[;C\Q
M_\RO]W3)/U!+ 0(4 Q0    ( .*#?U*O=1 N.R<  +/G   .
M  "  0    !D,3,U-#DP9#AK+FAT;5!+ 0(4 Q0    ( .*#?U+)UQM9>0<!
M +SR!0 1              "  6<G  !D,3,U-#DP9&5X,3 Q+FAT;5!+ 0(4
M Q0    ( .*#?U)0=JU>S5D  /@R @ 0              "  0\O 0!D,3,U
M-#DP9&5X,S$N:'1M4$L! A0#%     @ XH-_4AASX-<[!   /A$  !$
M         ( !"HD! &EI=FDM,C R,3 S,S N>'-D4$L! A0#%     @ XH-_
M4O':DK/M!0  :S8  !4              ( !=(T! &EI=FDM,C R,3 S,S!?
M9&5F+GAM;%!+ 0(4 Q0    ( .*#?U+1*69^#@@  !U:   5
M  "  923 0!I:79I+3(P,C$P,S,P7VQA8BYX;6Q02P$"% ,4    " #B@W]2
MV,-?;Z<%   V.@  %0              @ '5FP$ :6EV:2TR,#(Q,#,S,%]P
<<F4N>&UL4$L%!@     '  < P0$  *^A 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
